Immunological and molecular genetic studies on trophoblast membrane proteins by Nickson, Debra Ann
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
IMMUNOLOGICAL AND MOLECULAR GENETIC STUDIES 
ON TROPHOBLAST MEMBRANE PROTEINS
A thesis submitted for the Degree of 
Doctor of Philosophy at the 
University of Glasgow
by
Debra Ann Nickson
Institute of Genetics 
Church Street 
Glasgow
October 1985
ProQuest Number: 10907152
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10907152
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
This thesis is dedicated to my mother and father, 
for all their love and help.
ACKNOWLEDGEMENTS
Firstly it is with much gratitude that I thank my 
supervisor, Dr. Roger Sutcliffe, for his help, advice and 
especially his enthusiastic encouragement throughout the course 
of this work.
I wish to thank Dr. P.M. Johnson for gifts of antisera
(
and Dr. J. Scaife for his advice and gifts of E.coli host 
strains. For their time, assistance and gifts of material I am 
indebted to, the staff of the labour suite at the Queen Mother's 
Hospital, Glasgow, and the staff of the Royal Samaritans Hospital 
for Women, Glasgow.
I am grateful to all members of the department who have 
given assistance and advice. For their help, freindship and 
tolerance my special thanks go to the "placental group" Nael Abu- 
Hasan, Salwa Khalaf, Craig Livingstone and particularly Susan 
Henderson for her technical assistance. My studies were financed 
by a studentship from the Medical Research Council and I wish to 
thank Professor David Sherratt for allowing me to persue my 
studies in the Institute of Genetics.
Finally, my acknowledgement would not be complete 
without thanking Birkbeck for his skill at the drawing board.
C O N T E N T S
page
number
SUMMARY i
ABBREVIATIONS # v
CHAPTER 1 : INTRODUCTION
1:1 The placenta 1
1:1:1 Development of the placenta 3
1:1:2 Syncytiotrophoblast and cytotrophoblast 4
1:1:3 Placental proteins 6
1:1:4 Monoclonal antibodies against placental determinants 9
1:1:5 Trophoblast specific antigens 11
1:2 Alkaline Phosphatase 13
1:2:1 Different human alkaline phosphatase Isoenzymes 13
1:2:1:1 Tissue un-specific alkaline phosphatase 14
1:2:1:2 Tissue specific alkaline phosphatase 14
a Intestinal alkaline phosphatase 16
b Placental alkaline phosphatase 16
1:2:2 Placental alkaline phosphatase polymorphism 17
1:2:3 Synthesis of alkaline phosphatase during pregnancy 19
1:2:4 Molecular heterogeneity of placental alkaline
phosphatase 20
1:2:5 Tumour alkaline phosphatase 24
1:3 Transplantation antigens 26
1:3:1 HLA and the placenta 27
1:4 Molecular analysis of the placenta 29
1:4:1 Placental mRNA 31
1:4:1:1 In vitro translation of mRN A 32
1:4:1:2 Immunoprecipitation 32
1:4:2 Cloning of placental genes 33
1:4:2:1 Synthetic olignucleotides 35
1:5 Cloning Vectors 41
1:5:1 Lambda vectors gt10 and gt11 41
1:5:1:1 Lambda gt 10 42
1:5:1:2 Lambda gt11 44
1:5:1:3 Lambda amp3 46
CHAPTER 2 : Serological study of trophoblast membrane components
4
2:1 Introduction 47
2:2 Materials and methods 49
2:2:1 Preparation of solubilised placental plasma
microvillous membrane proteins 49
2:2:2 Preparation of protein-coated formalized red blood
cells 49
2:2:3 Passive haemagglutination assay 50
2:2:4 Serum Fractionation 51
2:2:5
2:2:6
2:2:7
2:2:8
2:2:9
2:3
2:3:1
2:3:2
2:3:3
2:4
CHAPTER 3 :Preparation and analysis of mRNA from
syncitiotrophoblast and eytotrophoblast tissue
3:1 Introduction 70
3:2 Materials and methods 72
3 :2 :1 Preparation of placental RNA 72
3 :2 :2 Agarose gel electrophoresis 73 *
3:2:3 Quantitating the RNA 74
3:2:4 Preparation of polyadenylated RNA from total
placental RNA 74
3:2:5 In vitro translation of placental mRNA 75
3 :2 :6 Analysis of translational protein products using TCA
precipitation 75
3:2:7 Analysis of translational protein products using SDS
polyacrylamide gel electrophoresis 76
3 :2 :8 Immunoprecipitation assay 76
3:2:9 Competition assay to test the specificity of
precipitated polypeptides 78
3 :2 :1 0 Synthetic oligonucleotides 79 «
3 :2:11 Labelling oligonucleotides . 79 «
3 :2 :1 2 Northern blotting using 14 base oligonucleotides as
probes 80
3:2:13 Dot hybridisation 82
3:3 Results . 83
3:3:1 Agarose gel electrophoresis of RNA 83
3:3:2 Optimisation of in vitro translation of placental RNA 83
3:3:3 Analysis of placental syncytiotrophoblast RNA
translational products 87
3:3:4 Analysis of placental eytotrophoblast RNA
translational products - 90
3:3:5 Analysis of immunoprecipitated proteins 93
3:3:6 Competition assay to test the specificity of 
polypeptides precipitated with antisera directed
against PLAP 100
3:3:7 Labelling of oligonucleotides using T4 kinase 103
3:3:8 Northern blots 103
3:3:9 Dot hybridisation 105
3:4 Discussion 108
Determination of IgM and IgG concentrations in serum 
fractions 51
Cyanogen-bromide activation of sepharose 52
Iodination of antibody 52
Radioimmunoassay 53
Removal of IgM and IgG from maternal and control sera 54
Results * 55
Optimisation of the sensitivity of the passive 
haemagglutination assay 55
Titres in maternal sera 55
Partial characterisation of the agglutinins 59
Discussion 68
CHAPTER 4 : Preparation and screening of a syncytiotrophoblast
cDNA library
4:1 Introduction 111
4:2 Materials and methods 113
4:2:1 \gt10  ^ 113
a E.coli strains used ' 113
b Media used 113
4:2:3 ^gt11 113 .
a E.coli strains used 113
b Media used 114
4:2:3 Preparation of plating cells 114
4:2:4 Preparation of \ vector gt10 115
4:2:5 Preparation of \, vector gt11 115
4:2:6 Preparation of \ vector DNA 116
4:2:7 EcoR1 digestion of \ vector DNA 116 I
4:2:8 Commercially obtained \ vector DNA 117
4:2:9 Preparation of cDNA 117
4:2:10 Size distribution of the cDNA 120
4:2:11 EcoR1 methylation of cDNA 121
4:2:12 EcoR1 linker addition to the double stranded cDNA 121
4:2:13 Removal of excess linkers 121
a Isopropanol precipitation 122
b Size fractionation 123
4:2:14 Ligation of cDNA:(EcoR 1)1 inker with EcoR1 digested
\ vector DNA 123
4:2:15 In vitro packaging 124
4:2:16 Plating of packaged phage 124
4:2:17 Screening the cDNA library with nucleic acid probes 125
4:2:18 Preparation of DNA probes 126
a Placental cDNA probe 126
b Oligonucleotide probes 128
c pDP001 : HLA probe 128
d PHPL815 : hPL probe 128
4:2:19 Screening the cDNA library with antibody probes 128
4:2:20 Aplification of the cDNA library 129
4:2:21 Phage mini preps 130
a Liquid culture 130
b Plate lysate 130
4:3 Results 132
4:3:1 Estimate of the amount of cDNA synthesised 132
4:3:2 Analysis of the size distribution of the cDNA 132
4:3:3 Analysis of the EcoR1 linker addition to the double­
stranded cDNA 132
4:3:4 Size fractionation of the cDNA 135
4:3:5 Screening of the ^ gt10 cDNA library with nucleic acid
probes 4 135
4:3:6 Screening N^ gtl 1 clones 143
4:4 Discussion 145
CHAPTER 5 : DISCUSSION 147
BIBLIOGRAPHY 155
SUMMARY
1. In recent years the plasma membrane components of the
human trophoblast have attracted increasing interest. Many 
investigators have wondered about the extent to which trophoblast 
components may contribute to the outcome of pregnancy, in 
particular the extent to which genetic variation in trophoblast 
components contributed to diseases of pregnancy. The HLA 
transplantation antigens play a major role in the success of 
organ transplants, HLA determinants have been detected on the 
extravillous eytotrophoblast of the placenta. The role these 
determinants' play in the outcome of pregnancy is unknown, as is 
the relationship of these placental HLA determinants to the 
classic HLA A and B allotypes. Classical HLA determinants are not 
detected on the placental syncytiotrophoblast microvilli. 
Placental alkaline phosphatase is the major external component of 
placental microvilli and is known to show genetic variation, 
having three common alleles and also 15 rare alleles which 
account for 2.5% of the FLAP phenotypes. The function of this 
genetic variation to date is unknown. Though trophoblast specific 
antigens have been identified xenogeneically no conclusive work 
has been done to detect antibodies in maternal sera to 
trophoblast surface components.
2. This thesis describes two lines of investigation. The
4
first was a serological approach to find out whether placental 
surface determinants are recognised by the maternal immune 
system. For this, syncy tiotrophoblast plasma membranes prepared 
from term placentae were tested in a passive haemagglutination
assay for their ability to function as antigenic determinants 
with term maternal sera. The second was a molecular genetic 
approach involving the creation of placental cDNA libraries. 
These libraries were screened for cDNA clones which would aid in 
thq characterisation of (a) the histocompatibility antigens 
present in the eytotrophoblast cells of the term chorionic plate 
and, (b) the enzyme placental alkaline phosphatase (PLAP) which 
has a high level of genetic polymorphism and is quantitatively 
the major cell membrane protein of the syncytiotrophoblast.
3. Using the passive haemagglutinin assay, agglutinins
against trophoblast components were detected in term maternal 
sera at titres above those of non-pregnant control sera. These 
agglutinin titres were independant of the family relationship 
between individual sera andtrophoblast samples. They were 
uneffected by adsorption with excess packed fetal or paternal red 
blood cells or paternal lymphocytes. The agglutinins of both 
normal control and term maternal sera were found to elute in the 
macroglobulin fraction of serum having a mw of >350Kd and were 
shown to be a component of euglobulin precipitates. The 
agglutinin titres remained in sera and were unaffected by the 
adsorption of IgM and IgG from the sera. It was concluded that 
these agglutinins were not a maternal antibody response against 
trophoblast surface components.
4. mRNA prepared from syncy tiotrophoblast cells, and from
4
purified eytotrophoblast cells of the chorionic plate were 
analysed by in vitro translation and immunoprecipitation. The 
major polypeptide synthesised from syncytiotrophoblast mRNA was 
hPL, accounting for 15-20% of the translated polypeptides. In
ii
eytotrophoblast mRNA preparations this polypeptide accounted for 
only 1-5$ of the synthesised polypeptides. Immunoprecipitation of 
the in vitro translated polypeptides from syncytiotrophoblast 
mRNA using anti-PLAP specifically precipitated polypeptides of 
56Kd and 58Kd. Both PLAP and hPL mRNA levels were shown to 
increase with gestational age.
5. cDNA was synthesised from syncy tiotrophobl ast mRNA, sized 
fractionated and the cDNA of 1Kb and greater (42% of the total 
cDNA synthesised) was cloned. The library constructed in the 
lambda vector \gt10 consisted of 7.8x10^ recombinants. It was 
screened with PLAP oligonucleotides and 26 clones were isolated 
from the amplified library. These clones are in the process of 
being further characterised. The library was also screened with 
the HLA class I cDNA probe pDP001 and clones which hybridised to 
the probe were detected. This is of great interest since the 
avaliable serological evidence indicates that class I 
determinants are absent from the syncytiotrophoblast.
6 . If the clones detected with the PLAP oligonucleotide
probe are PLAP cDNA they will be used to obtain an independent 
DNA assessment of the number of PLAP alleles and characterisation 
at the molecular level of the three forms, A,B and M, of PLAP. 
Also the molecular relationship between placental alkaline 
phosphatase, intestinal alkaline phosphatase and tissue 
unspecific alkaline phosphatase can be assessed and compared with
4
the PLAP-like molecules found in tumour cells. If the clones 
detected by the HLA probe pDP001 are homologous to known HLA 
sequences one can determine the relationship between these 
syncytiotrophoblast determinants, the eytotrophoblast HLA
iii
determinants, once cloned, and those expressed on other tissues.
7. The usefulness of molecular genetics is the ability to
study genes which cannot be studied easily by classical methods, 
but this requires the availability of probes to detect the genes. 
At present the syncytiotrophoblast cDNA library can only be 
screened with probes for genes which have already been 
discovered. The importance of independent serological methods is 
that they may provide evidence for new immunological systems. The 
ability to acquire human monoclonal antibodies to placental 
determinants by forming hybridomas from Epstein-Barr transformed 
maternal lymphocytes may enable one to screen for new placental 
systems and the use of an expression vector, such as \gt11 
containing a placental cDNA library, might then provide a means 
of establishing the molecular genetics of such systems.
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CHAPTER 1
INTRODUCTION
1:1 Hie Placenta
The human placenta’s role in its limited life span of 
forty weeks is to maintain the fetal environment, thus the 
structure and function of the placenta change during its period 
of growth as is required by the developing embryo and fetus. It 
acts as a physical barrier separating the maternal and fetal 
circulations but allowing the exchange of substances such as 
metabolites and hormones between the mother and fetus. The 
placental microvilli which effectively increase the surface area 
of the placenta in contact with the maternal blood are thought to 
facilitate this transfer (Jones & Fox, 1979). One of the 
quantitatively major cell membrane proteins of these 
syncytiotrophoblast microvilli is placental alkaline phosphatase 
(PLAP). PLAP is a member of a well studied group of enzymes 
(McComb et alT 1979). Though having many common structural and 
functional features PLAP differs from the other alkaline 
phosphatases due to its polymorphism. Although not involved in 
maternal immunity PLAP is a highly heterogenous protein having 
three common alleles, which encode for 97.5% of PLAP phenotypes, 
and 15 rare alleles (Harris .gt al, 1974; Doellgest & Fishman,
1976). Abu-Hasan (1983) demonstrated the existance of a membrane 
bound form of PLAP (M-PLAP). The different properties expressed 
by M-PLAP when compared with the previously described A-PLAP and 
B-PLAP suggested that a membrane associated form of heterogeneity 
existed and raised the question as to whether this was due to
1
post-translational processing or differential splicing of primary 
RNA transcripts, as is the case for immunoglobulins.
It is not yet clear how the fetus is protected from the 
maternal immune system during pregnancy. Though the microvilli 
and all villus trophoblast seem to lack HLA class I determinants, 
HLA class I determinants of some sort are expressed on the 
extravillous trophoblast. The principal antigens recognised as 
foreign on an allograft are the major histocompatibility (HLA) 
antigens, and women have been shown to mount humoral immune 
responses against paternally-derived HLA antigens during 
pregnancy. Since the fetus expresses those histocompatibility 
antigens, its survival in utero suggests that either the fetal 
antigens are shielded from significant maternal attack by 
trophoblastic tissue, or that there is some local modification 
in the mother's immune response leading to a failure to recognise 
or adequately respond to fetal antigens. Such local modifications 
could involve the production of immunosuppressive molecules 
(Waltman et al 1971), or the elicitation of blocking factors 
(Hellstrom et al 1969). The success of the placenta as an 
allograft was at first thought to be a property of the uterus, 
but the successful development of fetuses in non-uterine ectopic 
sites, and the ability of the uterus to support the rejection of 
allografts (see Beer and Billingham, 1976) showed that the uterus 
per se is not an immunologically privileged site. Nevertheless, 
suppressor cell accumulation in the uterine decidua of murine 
pregnancies has been shown to be correlated with successful 
pregnancies (Slapsys & Clark, 1983 and Clark gt al 1983). The 
supressor cells are thought to protect the fetal allograft from 
cell mediated immune rejection. In human pregnancies the lack of
2
blocking factor production is thought by some’to be correlated 
with chronic aborters (Rocklin et al, 1979).
Trophoblastic tissue is £ priori a good candidate for 
protecting the fetus. The trophoblast syncytium is known to be a 
highly specialised membrane which covers the chorionic villi of 
the placenta and its zone of contact between the maternal and 
fetal tissues. It is trophoblast cells which invade the uterus 
and, though in direct contact with the maternal immune system, 
survive without eliciting an immune response. For this reason 
alone the trophoblast tissue is worthy of study. Also, most 
placental proteins such as PLAP are localised in the syncytial 
trophoblast, thus for a greater understanding of this tissue it 
has become necessary to investigate the role these trophoblast 
components play.
1:1:1 Development of the placenta
The maternal uterus provides the implantation site and 
the blood supply necessary for placental development. Even 
before implantation the outer layer of the blastocyst 
proliferates to form the trophoblast cell mass. The trophoblastic 
cells which derive from the polar trophectoderm and give rise to 
the placenta are morphologically different from the inner cell 
mass of the blastocyst which forms the embryo proper (Edwards,
1977). Due to the trophoblast infiltration of the endometrial 
epithelium the blastocyst becomes completely embedded by the 11*j 
12th day. After implantation the trophoblast cells begin to 
differentiate into the peripheral layer of primitive 
syncytiotrophoblast and an inner layer of eytotrophoblast which 
proliferates to for™the precursors of the primary villi (Enders, y.
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1965; Boyd & Hamilton, 1970). Between the 9th to 25th day of 
gestation there is a period of intense growth and differentiation 
which results in the chorionic villi becoming established. The 
primary villi are solid trophoblast which arise from the Langhans 
cells. After developing a mesenchymal core, which contains 
fibroblasts, phagocytotic Hofbauer cells and collagen fibres, the 
villi are classed as secondary villi. The tertiary villi arise 
from the secondary villi with the development of fetal 
capillaries in the mesenchymal cores. The mature villi have an
outer layer of syncytiotrophoblast, a layer of eytotrophoblast
1 aye r
and an inner^of connective tissue containing the fetal 
capillaries. The diameter of the villi decreases throughout 
pregnancy from 170um in the first trimester to 40um at term (Fox,
1978). In addition to the chorionic villi, there is another class 
of villi whose function would seem to be to anchor the placenta 
to the maternal endometrium. These villi are composed of solid 
trophoblast and are structurally identical to the primary 
chorionic villi. These cells subsequently proliferate to form the 
cytotrophoblastic shell (Clint et al, 1979). The cytotrophblastic 
cell columns which extend through the peripheral syncitium join 
together to form the cytotrophoblastic shell are derived from the 
eytotrophoblast found in the Langhans layer of the placenta (Boyd 
and Hamilton 1970; Wynn, 1972).
1:1:2 Syncytiotrophoblast and eytotrophoblast .
There are considerable morphological differences between 
the syncytiotrophoblastic and cytotrophoblastic cells. The 
eytotrophoblast cells show considerable variation in shape, which 
is dependant on their positioning in the placental structure and
the gestation period. They have little endoplasmic reticulum and 
a scarce population of organelles (Boyd & Hamilton 1970). The 
uninucleated eytotrophoblast cells fuse to form the 
syncytiotrophoblast cells which have a high concentration of 
mitocondria, lysosomes, vesicles, vacuoles, microtubules, > 1  
microfilaments and a high abundance of endoplasmic reticulum and 
ribonucleoprotein. Enders (1965) suggested that it was the 
syncytiotrophoblast which was the endocrinologically active 
tissue of the placenta (Wynn, 1975). These syncytiotrophoblast 
cells form the outer multinucleated syncytial layer of the 
placenta and they invade the maternal endometrium. The 
syncytiotrophoblast of the term placenta is the predominant 
trophoblastic component as the ratio of eytotrophoblast to 
syncytiotrophoblast decreases through gestation. The external 
surface of the syncytiotrophoblast is invested with a thick coat 
of microvilli bathed by extra-endothelial maternal blood, which 
is outside the confines of the endothelium of the mothers 
vascular system (Truman & Ford, 1984 and Hamilton & Hamilton, 
1977). In early pregnancy the microvilli are long and close 
together but as pregnancy progresses they become shorter, 
branched and more seperated. At term their length is only 0.8um 
compared to 1.5um at 10 weeks (Tighe et al 1967). The function of 
the microvilli is uncertain but as they efficently increase the 
surface area of the placenta in contact with the maternal blood 
and since it is known that if the maternalwu.trient supply is4 
restricted the microvilli proliferate, thus they may facilitate 
placental transfer and absorption (Jones and Fox, 1979).
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1:1:3 Placental proteins
Studies of placental proteins were stimulated with the 
discovery by Smith , Brush and Lucket (1974) that microvillous 
preparations could be obtained by differential centrifugation of 
the saline extract from whole placental tissue. Besides their use 
as placental markers it was hoped that placental specific 
proteins would play a role in the monitoring of placental 
function and wellbeing during pregnancy. Using SDS gel 
electrophoresis, Carlson et al (1976) identified 16 major protein 
and 10 major glycoprotein subunits from trophoblast microvilli 
membrane preparations. By 32p labelling experiments, a 
glycoprotein of 66 Kd was shown to be placental alkaline 
phosphatase. Smith et al (1977) observed trophoblast protein 
bands from 33-200 Kd and the prominant band of 40 Kd was thought 
to be actin. Kelley et al (1979) found 20 peptide bands. One of 
the principal bands seen was a glycoprotein of mw 69 Kd, 
placental alkaline phosphatase. Using 2-D SDS gel electrophoresis 
and isoelectric focusing Wada £t al (1977) observed 17 major 
si^loglycoprotein subunits ranging in isoelectric points from pH 
4.6- 7.2. Placental alkaline phosphatase was identified as a 66 
Kd protein with an isoelectric point of 6.3, transferrin was 
identified as a 69 Kd protein. Many groups have analysed the 
constituents of placental membrane preparations and due to 
differing preparation protocols there are discrepancies in the 
actual number of protein components identified on SDS gel. 
electrophoresis. Though many of the proteins have not been 
positively identified, albumin, transferrin and placental 
alkaline phosphatase are found to be major components of all 
trophoblastic preparations (Ogbimi et al, 1979; Okamura et a!,
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1981; Kantor .gt al, 1981). PLAP is a structural component of the 
placenta whereas albumin and transferrin, though present in the 
placental membrane preparations, are not synthesised by the 
placenta. Albumin derives from the placenta's blood supply and 
transferrin is present due to its uptake by receptors on the 
surface of the trophoblast membranes (Faulk & Galbraith, 1979).
Hormonal function can be detected in the maternal sera 
during pregnancy. Human chorionic gonadotrophin (hCG) is a 
placental glycoprotein hormone found predominantly in the 
syncytiotrophoblast (Kurman .et al, 1984). hCG reaches its peak of 
activity in maternal sera at 10-12 weeks of pregnancy. It is 
structurally and functionally related to luteinizing hormone 
(LH), follicle stimulating hormone (FSH) and thyroid stimulating 
hormone (TSH) (Fiddes & Goodman, 1979). Other protein hormones 
secreted by the placenta which have biological properties similar 
to the FSH and TSH are human chorionic thyrotrophin (hCT) and 
human releasing hormone (hRH) (Pattillo et al, 1983). Human 
placental lactogen (hPL) is a placental hormone which cross 
reacts with antisera against human growth hormone (hGH). HPL's 
biosynthesis also occurs predominantly in the syncytiotrophoblast 
(Tabarelli .gt al 1983a&b) and its detectable level in the 
maternal serum during pregnancy parallels placental growth 
(Friesen, 1973; Handwerger .gt al, 1981). With the exception of 
hCG, the concentrations of all placental proteins in the maternal 
circulation substantially parallels the growth of the placenta 
(Hytten & Leitch, 1971).
The human placenta produces a wide range of proteins in 
addition to the trophoblast specific protein hormones and enzymes 
which have been shown to have analogs in non-pregnant adults. The
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placenta synthesises a number of placental specific proteins that 
have no known function or analog. Using antisera directed against 
placental extracts in gel-diffusion experiments, Thornes (1958) 
demonstrated the presence of protein antigens in the sera of 
pregnant women which were absent from the sera of non-pregnant 
adults (Bohn £t al 1983). From Thornes’ findings of placental 
specific proteins in pregnancy sera many more placental specific 
proteins in placental extracts and pregnancy sera have been 
identified with antisera directed against different placental 
fractions. The placental proteins a2 ~globulin and B2 “globulin 
were of the first to be detected in pregnancy sera by 
immunoelectrophoresis (for review see Bohn et al, 1983). Bohn 
(1979) described several different placental proteins, SP1 from 
pregnancy sera and PP-j-PP^  from placental extracts, all but PP^  
being trophoblast specific. More recently Bohn and co-workers 
(1983) have identified specific soluble tissue proteins PP-jo"^^ 
as well as several other soluble antigens which though they were 
derived from placental membranes their tissue specificity has not 
been established. Using antisera to pregnancy plasma Lin et al 
(197*0 detected four specific proteins PAPP-A,B,C and D. PAPP-C 
was found to be identical to SP1 and PAPP-D was later identified 
as the placental hormone hPL.
Not all the placental proteins detected by 
immunochemical methods were specific for trophoblast tissue or 
even pregnancy. The placental proteins having no identified, 
comparable material in normal adults are characterized as being 
specific to placental trophoblast and classed as pregnancy 
proteins. The pregnancy proteins which are secreted into the 
maternal sera are SP1, PAPP-A and PAPP-B. SP1 and PAPP-A were
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shown to be localised and most probably synthesised in the 
villous syncytiotrophoblast (Lin & Halbert, 1976; Bohn 1979). The 
pregnancy proteins concentrated in the placental tissue are PP^ , 
PP«I0 > PPn and Ppl2’ concentration of the placental proteins 
in the maternal circulation parallels the growth of the placenta 
for those proteins studied. Thus it would seem that the 
production of almost all placental proteins depends on the mass 
of the trophoblast. The concentration of placental proteins shows 
a slow rise in the first trimester, rapid in the second trimester 
and plateauing by 36 weeks (Hytten & Leitch, 1971). The placental 
proteins fall into three groups (1) proteins with hormonal 
functions, (2) proteins with enzymic functions and (3) proteins 
with unknown function. Many of these placental proteins have not 
been shown to be essential for fetal or placental well being 
during pregnancy, apparently normal pregnancies have come to term 
without the synthesis of one or more of the placental proteins 
(Chard, 1982; Gordon & Chard, 1979). Though many of the proteins 
produced by the placenta have no proven function they are studied 
with the hope that the more that is known about the structure of 
the proteins the closer one will be in deducing their function.
1:1:4 Monoclonal antibodies against placental determinants
Since the advent of somatic cell hybridisation 
technology (Kohler & Milstein, 1975) a wide variety of monoclonal 
antibodies have been raised against human placental trophoblast, 
preparations (Sunderland at al, 1981; Johnson at al, 1981 a&b & 
1982; Johnson & Molloy, 1983; Brown al al 1983; Loke afc al, 
1984). Several of the trophoblast monoclonals are non-specific, 
being raised against surface membrane proteins common to both
9
trophoblast and other tissues. These non-specific monoclonals 
raise the possibility of shared membrane complexes between the 
placenta and other tissues. H310 and H316 are examples of non 
specific monoclonals showing shared membrane complexes. They 
both recognise an antigenic epitope specificity to trophoblast 
and lymphocytes (Brown .gt al, 1983). Among Johnson et als(1Q8la&b 
& 1982) monoclonals which were found to be trophoblast specific 
are H315 which recognised PLAP and first trimester 
syncytiotrophoblast and H3IT which is specific for PLAP. 
Sunderland et al (1981c) has also produced monoclonal antibodies 
which are specific for human syncytiotrophoblast, ND0G1 and 
ND0G2. Both ND0G1 and ND0G2 antigens were secreted placental 
proteins. ND0G2 was shown to be specific for PLAP. The ND0G1 
antigen is present in pregnancy sera for only six hours after 
delivery thus it is neither SP1, PAPP-A or PLAP as these secreted 
proteins have longer half-lives.
Monoclonal antibodies have been used to show the 
distribution of different antigens on placental tissue. Loke & 
Day (1984) monoclonal 18B/A5 which is raised against first 
trimester trophoblast preparations reacts discretely with 
eytotrophoblast from the chorionic villi. H310 and H317 detect 
the eytotrophoblast layer on amniochorionic membranes and all the 
villous trophoblast in the placental bed tissue (Johnson & 
Molloy, 1983). Bulraer^i al (1984) showed that H315 also reacts 
strongly with villous syncytiotrophoblast. H316 and ND0G1 can bo 
used to stain for syncytial sprouts and cytotrophoblastic cell 
columns. As all the trophoblast monoclonals available react with 
villous trophoblast the monoclonals used as tissue markers for 
the non-villous trophoblast are TR0MA1 and LE61. These are
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specific for intermediate filaments. Using monoclonal antibodies 
raised against HLA determinants (W6/32, B2 M) Sunderland gt al 
(198lb&c) showed that non-villous trophoblast expresses class I 
HLA antigens determinants but not class II HLA DR antigen 
determinants. The syncytial layer of trophoblast and the 
underlying zone of eytotrophoblast has not been shown to express 
any HLA antigens; for further discussion see pp 25-28.
1:1:5 Trophoblast specific antigens
The fetal/placental unit constitutes an allogeneic graft 
of which the trophoblast cells are a priori a good candidate for 
eliciting a maternal immune response. They are in direct physical 
contact with the cells of the maternal endometrium and are found 
in the maternal circulation (Goodfellow & Taylor, 1982). Whether 
mothers make antibodies to trophoblastic proteins is not known. 
Davies and Sutcliffe (1982) and Davies et al (1982a&b) have 
provided evidence for maternal recognition of trophoblast using 
isotope release in the presence of maternal lymphocytes by 
chromium-labelled syncytiotrophoblastic cells. Davies & Brown 
(1985) have detected anti-trophoblast antibodies in the sera of 
pregnant women though these results have yet to be confirmed by 
other groups. Faulk .gt al (1978) prepared rabbit anti-human sera 
from trophoblastic tissue. The antisera was made specific for the 
trophoblastic tissue by absorption with normal human adult
4
tissue. Anti-trophoblast sera was separated into two catagories 
anti-trophoblast antigen 1 (anti-TA1) and anti-trophoblast 
antigen 2 (anti-TA2). Anti-TA1 recognised TA1 antigens present on 
the syncytiotrophoblast microvilli and on certain human cell 
lines whereas anti-TA2 recognised TA2 antigens found on
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trophoblast, lymphocytes, villous fibroblasts and endothelium. 
The TA2 antibodies could be absorbed from anti-trophoblast sera 
to leave TA1 antisera. The anti-trophoblast sera were studied for 
the ability to interact or inhibit immunoassays using known 
placental proteins, the results indicated that the TA1 antigens 
were tissue specific for the trophoblastic derivatives of human 
amniochorion (McIntyre & Faulk, 1979). Whyte and Loke (1979) 
described another unique anti-trophoblast antigen TrPM which was 
raised against syncytiotrophoblast and found to react against 
surface membrane components of syncytiotrophoblast using 
immunohistology. The trophoblastic antigens specified by antisera 
which would seem to be structural components of the 
syncytiotrophoblast membrane have been described as placental 
proteins (KLopper & Chard, 1979).
Faulk .gt al (1978) noted that anti-trophoblast sera 
directed against different placentae trophoblast preparations 
were cytotoxic for some but not all donor lymphocytes and bore no 
correlation with the ABO or HLA types of the donors (McIntyre & 
Faulk, 1982a). Thus the presence of allotypic trophoblast- 
lymphocyte cross reactive antigens (TLX) was proposed. Though 
the TLX antigen system has not been adequately defined 
recognition of paternally derived TLX specificities on the 
placental surface has being suggested for the maintainance of 
pregnancy (Faulk, 1981). Recent results from a controlled trial
4
of immunisation treatment of recurrent aborters showed that 7856 
of pregnancies were successful followed immunisation of women 
with their husband’s lymphocytes compared with 37% for the women 
immunised with their own lymphocytes (Mobray et al, 1985).
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1:2 Alkaline Phosphatase
Although placental alkaline phosphatase (PLAP) is not 
involved in maternal immunity, it is polymorphic, expressed in 
tumours and a member of the well1 studied group of Alkaline 
phosphatases [orthophosphosphoric-monoester phosphohydrolase 
(alkaline optimum) E C 3.1.3.13 (for review see McComb et a!,
1979). AP's, which hydrolyse a wide range of monophosphates at 
alkaline pH (10-10.5), are present in most human tissues. The 
AP’s are glycoproteins which are membrane associated and detected 
as cell surface antigens. The greatest AP activity is shown in 
liver, bone, kidney, intestine and placenta as the APs from these 
tissues show many common structural and functional features
f
suggesting that they are involved in., similar biological 
processes.
1:2:1 Different Human Alkaline Phosphatase Isoenzymes
The different molecular forms of the enzyme are 
characterised and distinguished from each other by their 
thermostability, differential inhibition, by antigenic 
specificity and electrophoretic properties (Fernley, 1971; 
Stinson & Seargeant, 1974; Goldstein .gt al,1980a, Fishman, 1974; 
Moss, 1982). The enzymes also show different peptide maps on 2-D 
gels and differ in their N-terminal amino acid sequences 
(Seargeant & Stinson, 1979; McKenna g£ gl, 1979; Badger &
4
Sussman, 1976; Komoda gt al, 1981). Using these properties two 
distinct types of of human AP were distinguished;tissue un­
specific AP and tissue specific AP. A comparison of properties 
suggests one locus encodes for the tissue un-specific AP of the 
liver, bone and kidney and two loci for the tissue specific
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forms; one for the placental form and one for the intestinal 
form. The evidence for this is summarised in table 1.1. There is 
some evidence of a fourth locus in humans expressed in testis and 
thymus, these tissues express trace * amounts of placental-like AP 
(Millan, Erikssan & Stigbrand 1982).
1:2:1:1 Tissue un-specific Alkaline Phosphatase is the major AP 
isoenzyme found in liver, kidney and bone. Though the isoenzymes 
from these tissues differ in their thermostability (Moss & 
Whitby, 1978), using polyclonal antisera the AP enzymes of these 
tissues have been shown to be immunochemically identical (Boyer, 
1963). The inhibition of the isoenzyme's catalytic activities by 
L-homoarginine is also identical for the AP enzymes of these 
tissues (Fishman & Sie, 1970). They all contain terminal sialic
ej\
acid and partially bind to Con^avalin A and lentil lectin 
Sepharose (Butterworth & Moss, 1966; Lehmann, 1980). The 
difference in the electrophoretic properties of these enzymes is 
thought to be due to their differing levels of sialic acid as the 
desialated forms have the same isoelectric point (Smith et a!, 
1973; Stinson & Seargeant, 1981).
1:2:1:2 Tissue specific Alkaline Phosphatases are distinguished 
from the tissue unspecific AP by thermostability, immunochemistry 
and by enzyme inhibition. L-homoarginine inhibits the catalytic 
activities of tissue unspecific AP whereas the tissue specific 
APs are not inhibited by L-homoarginine but by L-phenylalanine
4
(Ghosh & Fishman, 1966). The tissue specific APs intestinal AP 
and placental AP (IAP & PLAP) were shown to be related to each 
other by their cross reactivity to polyclonal antisera raised 
against either IAP or PLAP neither reacted to polyclonal antisera 
raised against liver, bone or kidney AP's.
TABLE 1.1
Isoenzyme
type
Tissue unspecific 
AP
Tissue specific 
IAP PLAP
mw
N-terminal 
sequence
pH optima
Heat stability 
56°C 15 min 
65°C 5 min
Amino acid 
sensitivity (5mM) 
L-phenylalanine 
L-homoarginine 
L-leucine
Neuraminidase
sensitivity
Lectin binding
Immunoreactiv i ty 
withoantisera to: 
Liver. AP 
Bone AP 
Kidney AP 
Intestinal AP 
Term placental AP
136-170Kd
Leu-Val-Phe
10.1-10.2
+/++
+++
+
140-170Kd
Phe-Ile-Pro
10.1-10.2
+++
-/+
1l6-125Kd
Ile-Ile-Pro
10.7
+++
+++ 
—/+ 
+
+
+-H-
Table 1.1: Properties of the major occuring human alkaline 
phosphatases; adapted from Stigbrand (1984). -
j
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a Intestinal Alkaline Phosphatase this AP isoenzyme is found in 
the small intestine, its catalytic activity is inhibited by L- 
phenylalanine (Ghosh & Fishman, 1966). Though a glycoprotein, IAP 
does not contain sialic acid and so it does not bind to ConA or 
lentil lectin Sepharose (Lehmann, 1980).
b Placental Alkaline Phosphatase PLAP is found in the term
placenta. PLAP can be distinguished from the other AP's due to 
its heat stability; at 65°C the other human AP's are completely 
inactivated whereas PLAP resists denaturation (Moss e£ al, 1972;
Berdalis & Hirschlorn, 1972). Like IAP the catalytic activity
of PLAP is inhibited by L-phenylalinine (Ghosh & Fishman, 1966). 
In common with the tissue unspecific AP PLAP is a glycoprotein 
containing terminal sialic acid and binds completely to ConA and 
lentil lectin Sepharose (Lehmann, 1980). Trace amounts of heat 
stable AP besides PLAP are also present in human tissue. These 
are defined as PLAP-like as they differ from PLAP in their 
greater sensitivity to L-leucine. PLAP-like AP have been found in 
normal testis, endocervix, and in lung and thymus tissue (Chang 
et al, 1980; Goldstein jet al, 1980b; Nozawa at al, 1980; 
Goldstein jet al, 1982).
The human AP's are similar in that they all occur as 
dimers composed of monomeric units of near identical structure. 
From the different properties they display it would seem that 
they are a multilocus enzyme family, encoded for by at least 3
4
gene loci whose location in the genome is not known (Harris, 
Hopkinson & Robson, 1974). One loci encodes for the tissue 
unspecific AP,two seperate loci encode for the tissue specific 
AP, IAP and PLAP and a fourth loci may encode for the low levels 
of PLAP-like AP found in normal adult tissue (Seargeant gt al,
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1979; McKenna .gt al, 1979). An explanation for the occurence of 
the different human AP loci is that they have depended from a 
common ancestral gene which has duplicated during evolution to 
give rise to several different genes by continual divergence. 
PLAP would be assumed to be a late evolutionary gene product as 
it is only detected in orangutan, chimpanzee and human placentae 
(Goldstein gt gl, 1980a). The absence of the PLAP isoenzyme in 
lowland gorillas is unexpected as there is no evidence of 
divergence of lowland gorillas and man after their divergence 
from orangutans (Donald & Robson, 1974). The PLAP isoenzyme also 
displays a high degree of polymorphism. Using starch gel 
electrophoresis 18 different allelic variants are evident for 
PLAP which is in contrast to the tissue unspecific AP’s and IAP 
which show no allelic variants (Harris gt al, 1974). This 
suggests that the mutants which affect the PLAP loci are not 
present in the other AP loci indicating that PLAP has arisen 
later in the evolutionary trail than the other human AP’s.
1:2:2 Placental Alkaline Phosphatase Polymorphism
Electrophoretic variation in PLAP extracted from 
different term placentae was first reported by Boyer (1961). 
Three common types of electrophoretic patterns were found as 
well as a rarer band termed the D-variant which migrated slower 
than the other bands. Based on the population frequency of the 
electrophoretic variants three common PLAP alleles were 
genetically determined. Boyer's findings were confirmed by Robson 
and Harris (1965 & 1967). Six common phenotypes and nine rare 
phenotypes of PLAP were identified using single and dizygotic 
twin placentae from different racial populations (Robson &
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Harris, 1965 & 1967). The rare phenotypes were usually found in 
combination with one of the common alleles. The D-variant was 
reported as a rare allelic variant by Beckman and Beckman (1968 & 
1969) and it was shown to be inhibited by L-leucine (Doellgest & 
Fishman 1976). Besides the 3 common alleles there is now 
evidence for 15 or more rare alleles. The incidence of these rare 
allele heterozygotes is 2-3%, whereas with 22 other enzyme loci 
tested only in 5 loci did the frequency of heterozygotes exceed 
0.3% (Donald & Robson, 1973; Harris .gt al 1974). The 3 alleles 
which encode for the six common phenotypes are, PI** which shows a 
slow mobility on starch gels, PI2 which has a fast mobility and 
PI^  that has an intermediate mobility. These alleles make up 97- 
98% of the PLAP variants.
The nomenclature for the PLAP alleles was altered to a 
numerical system by Donald & Robson (1973). The common alleles 
are numbered 1-3 and the rare alleles 4-18. Thus the common 
homozygous phenotypes are 1-1, 2-2 and 3-3 and the heterozygotes 
2-1, '3-1 and 3-2. The electrophoretic patterns of the six common 
phenotypes in starch gels shows that heterozygotes have 3 bands, 
compared with the homozygotes single band. As PLAP is a homodimer 
two of the bands seen for the heterozygotes are the same as those 
seen for the two homozygotes. The third band, which migrates in 
an intermediate position, is a hybrid molecule created from the 
monomeric subunits of the two alleles. The gene frequencies of
4
the common alleles vary in different racial groups though in all 
groups PI^  is the most common, being between 57-94%. In Caucasian 
populations the PI2 allele has a frequency of 24-34% whereas in 
both Asiatic Mongoloid and African Negro populations the 
frequency of PI2 is lower, 2-8% and 2-5% respectively. The PI 3
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allele is present at a low frequency in both Caucasian and Negro 
populations (4-9?) but in the Chinese and Japanese populations 
the frequency is between 20-24? (Beckman & Beckman, 1969; Donald 
& Robson, 1973).
The variant allele phenotypes of PLAP were identified 
and can be distinguished using starch gel electrophoresis by the 
different mobilities of their bands (Boyer, 1963; Donald & 
Robson, 1973). The variants can also be distinguished by 
antigenic variation (Wei & Doellgast, 1980) and by variations in 
thermostability (Holmgren & Stigbrand, 1976). The variant 
phenotypes are identical with respect to their pH optima, Km 
values and inhibition by L-phenylalanine and L-leucine. The 
structural basis for the polymorphism of the PLAP alleles has not 
been elucidated (Jemmerson .et a!, 1984). Amino acid substitutions 
account for the allelic electromorphs Adh-f and Adh-s in 
Drosophila alcohol dehydrogenase (Krietman, 1983). Thus amino 
acid substitutions could also account for the different alleles 
of PLAP. Some amino acid substitutions, though altering the 
antigenic determinants, would not affect the electrophoretic 
mobility. This is seen with the PLAP variants since monoclonal 
antibodies recognise the different PLAP phenotypes seen on starch 
gels and other phenotypes which are not distinguished on starch 
gels (Slaughter .g£ al, 1981; Millan .gt al, 1982b).
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1:2:3 Synthesis of Alkaline Phosphatase during pregnancy
Three forms of AP are detected in the placenta and 
maternal sera during gestation (Sakiyama et al, 1979). (1) Heat 
labile AP, specific to the first trimester between 6-10 weeks.
(2) Heat stable PLAP, found in the second and third trimesters.
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(3) The third form of AP in the placenta is visualised between 
11-13 weeks of pregnancy and is a hybrid of first trimester AP 
and PLAP (Fishman et alT 1976; Sakivama et alT 1979).
The first trimester heat labile AP is inhibited by L- 
homoarginine and inactivated by antisera directed against human 
liver AP, though not by antisera directed against PLAP. Thus the 
first trimester AP is a tissue unspecific AP having properties 
similar to liver AP. It differs in its electrophoretic mobility 
in nondenaturing polyacryamide gels, two bands are seen the 
slower band corresponding to liver AP but the faster band lacks 
any known antigenic determinants (Sakyama et al, 1973). In early 
pregnancy the heat stable PLAP activity is low in concentration 
and it begins a progressive increase from 28 weeks to term, when 
over 90% of the alkaline phosphatase in term placenta is PLAP 
(Sussman & Bowman, 1968; Fishman et al, 1976; Sakiyama £t al, 
1979). PLAP is detectable in the serum of pregnant woman from 
about 16 weeks onwards with the highest levels occuring at term 
(200-300ng/ml). After delivery the level of PLAP detectable in 
the maternal sera decreases, until by the sixth day there is no 
detectable PLAP in the maternal serum (Holmgren £t al, 1978; 
Fishman et al, 1976). Using a radioimmunoassay Holmgren et al 
(1978) showed that there was no correlation with placental 
weight, blood type, parity of the mother, sex of the baby and the 
levels of PLAP. /
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1:2:4 Molecular Heterogeneity 9L Placental Alkaline Phosphatase
Being a placental surface membrane enzyme PLAP shows up 
to 10-fold greater enzyme activity levels in 
syncytiotrophoblastic tissue compared with the enzyme activity
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levels in the whole placenta. The expression of PLAP is limited 
to the syncytiotrophoblastic microvilli where it is exposed to 
the circulating maternal blood (Whitsett & Lessard, 1975; Jones & 
Fox, 1976). PLAP is a sialoglycoprotein composed of pairs of 6 9 K 
mw disulphide bonded polypeptide chains and when extracted from 
homogenates of whole placentae it shows two forms of 
heterogeneity. On starch gels they resolve as two zones of enzyme 
activity, A and B which are detected in all human placentae 
(Ghosh et al, 1968: Beckman et alT 1966; Robson & Harris, 1965). 
The A form (A-PLAP) has a greater electrophoretic mobility than 
the B form (B-PLAP). Having three times the specific activity of 
B-PLAP A-PLAP constitutes the major zone of enzyme activity in 
both total placental extracts and maternal serum during 
pregnancy. The native mw of these forms is 140Kd for A-PLAP and 
200Kd for B-PLAP (Doellgast al, 1977). Both A-PLAP and B-PLAP 
share similar heat stability, express the same polymorphism and 
when treated with neuraminidase they both show retarded zones of 
enzyme activity (Robson & Harris, 1965). It has been suggested 
that B-PLAP is an aggregate of A-PLAP associated with a non-AP 
protein. As B-PLAP resists chromatographic resolution in several 
systems it may be a membrane-associated form of A-PLAP, poor 
chromatographic resolution seems to be a property of membrane 
bound proteins. (Wallach & Winzler, 1974; Contractor, 1983).
Placental microvillous plasma membrane fractions were
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shown biochemically to be enriched in PLAP when compared with 
total placental extracts Smith and Brush (1978), using a 
modification of Smith et al (1974) method for the preparation of 
placental microvillous membranes, showed a 14 fold enrichment for 
PLAP. Ogbimi al (1979) reported a 3.8-7.6 fold enrichment
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whereas Booth ,g£ si (1980) using a modified method from Smith .gt 
a! (197*0 observed PLAP enrichment of 24.6 fold. PLAP extracted 
just from the syncytiotrophoblastic microvilli shows three zonal 
bands when resolved on starch gels containing detergent (Abu- 
Hasan et si, 1984; Abu-Hasan & Sutcliffe, 1984a&b & 1985). The 
bands were the A and B forms of PLAP as seen in whole placental 
extracts and a third (M-PLAP) which ran between the A and B 
forms. Abu-Hasan (1984) showed the presence of small amounts of 
M-PLAP in whole placental extracts on starch gels containing 05% 
triton X-100. M-PLAP is the major form of PLAP found in the 
syncytiotrophoblastic microvilli. It has a native mw of 725Kd, 
expresses the same genetic polymorphism as the A and B forms and 
it gives reactions of identity with antibodies directed against 
A-PLAP. On non-reducing SDS gels the mobility of A-PLAP dimers is 
140Kd and that of M-PLAP is 116—118Kd which suggests that M-PLAP 
is hydrodynamically a more compact molecule than A-PLAP (Abu- 
Hasan & Sutcliffe, 1984a, 1984b & 1985). The structural basis for 
the differences between the three isoenzymes of PLAP is not known 
but that they are polypeptide products of the same translational 
system is indicated by their identical genetic polymorphism.
The high mw M form of PLAP suggested that this was a 
molecular aggregate form of the other PLAP isoenzymes or an 
artifact aggregate arising from the insolubility of the extracted 
membrane proteins. There is evidence against M-PLAP being an
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aggregation artifact, the yield of M-PLAP is not affected by the 
use of detergents in the extraction of PLAP from the microvilli. 
M-PLAP and A-PLAP can be seperated using hydrophobic 
chromatography, M-PLAP bound to an alky 1-agarose column and was 
eluted with hydrophobic solvents whereas A-PLAP did not bind to
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the column (Abu-Hasan & Sutcliffe, 1984a&b & 1985). M-PLAP can be 
cleaved from the surface of the syncytiotrophoblast microvilli 
using the protease subtilisin; the Subtilisin cleaved M differing 
from native M-PLAP in being 2Kd smaller. The 2Kd region was shown 
to be cleaved from the carboxy-terminus of M-PLAP as both native 
and subtilisin cleaved M have a common N-termini (Abu-Hasan & 
Sutcliffe, 1984b & 1985). The N-terminal amino acid sequence for 
M-PLAP was in common with the N-terminal amino acid sequence of 
A-PLAP (extracted from the syncytiotrophoblast microvilli) and 
agreed with the Dansyl-Edman sequencing studies on PLAP extracted 
from total placental extracts (Green & Sussman 1973).
The majority of PLAP in the maternal serum is of the A 
form rather than the M form (Abu-Hasan unpublished). It has been 
recently found that a serum protein factor, which is not 
inhibited by a wide range of exogenous protease inhibitors, has 
the ability to convert M-PLAP to the A and B forms 
(Livingstone, J.C. personal communication). The factor behaves as 
a glycoprotein in binding to ConA sepharose. Though hepatic and 
endothelial forms of serum lipoprotein lipase bind to ConA 
sepharose they did not stimulate conversion. The factor was shown 
to elute as an unimodal peak on DEAE sepharose at the same point 
as Lecithin cholesterol acyl transferase (LCAT), which can act as 
a lipoprotein phospholipase (Doi & Nishida, 1981). The ability of 
LCAT to convert M to the A and B forms is being tested. The
4
evidence indicates that the A and B forms of PLAP are the 
conversion products of the M form, but since the native sizes of 
A-PLAP and B-PLAP are a lot less than that of M-PLAP the M form 
is not just a simple aggregate of A and B. The A and B forms of 
PLAP would seem not to exist in their native forms until after
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conversion of the M complex with the serum factor.
The expression of PLAP is limited to the 
syncytiotrophoblastic microvilli the enzyme being present on the 
plasma menbrane surface (Tokumitsu et al, 1979). With the active 
site of the enzyme located on the maternal facing side of the 
microvilli one would assume that its function involves its 
contact with maternal blood. It has been demonstrated that ADP- 
ase is a strong inhibitor of platlet aggregation and placental 
extracts have been shown to contain ADP-ase activity (Hutton et 
al, 1980). PLAP may be involved as an ADP-ase in the degradation 
of ADP in the placenta and its role may be to maintain the 
fluidity of the blood in the placental sinuses. It has also been 
suggested that PLAP may be associated with transport mechanisms 
across the placenta (Truman & Ford, 1984; Shirazi et al).
1:2:5 Tumour Alkaline Phosphatases
Fetal and embryonic proteins are expressed in tumours at 
high levels. The re-expression of genes normally active only in 
the early stages of development suggests that the tumour 
malignancy may involve regulation disturbances in the expression 
of these genes (Manes, 1974; Fishman & Sell, 1976). As detectable 
low levels of these proteins are found in some normal tissue it 
is not known whether the proteins are tumour specific or just the 
over production of existing fetal proteins (Ruoslahti & Seppala, 
1972; Usategui-Gomez ai, 1974; Millan^i^l, 1982c). Some of 
the oncofetal antigens expressed in tumours are carcinoembryonic 
antigen (CEA), alpha fetoprotein (AFP) and PLAP (Abelev £t al, 
1963; Gold & Freeman, 1965; Fishman et al, 1968a&b; Wahren §t jal,
1979). n
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Tumour PLAP was first observed as an oncofetal antigen 
in a male patient (Regan) who had an oat cell carcinoma of the 
lung (Fishman .gt al, 1968abc). With regards to immuno cross 
reactivity and catalytic properties amino terminal sequence, 
peptide mapping, isoeletric point, subunit mw Regan and PLAP were 
found to be identical (Fishman et al, 1968a; Green & Sussman, 
1973; Lehman, 1975). Another tumour related PLAP was found in a 
patient (Nagao) with pleural carcinomatosis:this Nagao isoenzyme 
was found to be distinct from the PLAP and Regan isoenzyme due to 
its increased sensitivity to L-leucine (Nakayama et .§1, 1970). 
This would suggest that the Nagao isoenzyme represents the 
expression of a gene related structurally but distinct from the 
PLAP gene whereas Regan would seem to be the re-expression of the 
PLAP gene. The re-examination of 39 cancer patient sera 
containing AP which had been classified as PLAP.+ on 
electrophoretic and calalytic properties showed that many were 
inhibited by L-leucine and on starch gels they showed the 
phenotype of the very rare D-variant of PLAP (Wei & Doellgast, 
1981; Millan <gt al, 1982c).
PLAP and PLAP-like isoenzymes are clinically useful 
tumour markers as elevated levels of PLAP and PLAP-like AP are 
found in several different malignancies; pancreas, lung, breast, 
colon, lymphnodes, kidney, stomach and bladder (Fishman & 
Stolbach, 1979; Stigbrand & Engvall, 1982; Lange e£ al, 1982;
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Jeppsson et al, 1983). The highly sensitive and specific, solid 
phase enzyme immunoassay (EIA) for the identification of PLAP 
with monoclonal antibodies such as H317 detected measurable 
levels of circulating PLAP-like isoenzyme in 34% of ovarian and 
25% of cervical carcinoma patients. H317 has also been used
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successfully in detection of tumour recurrences in ovarian cancer 
patients by antibody guided in vivo radionucleotide imaging 
techniques (McLaughlin £t al, 1983). This and the sensitive 
sandwich enzyme-linked immunoassay reported by Millan and 
Stigbrand (1982) increase the diagnostic value of PLAP and PLAP- 
like isoenzymes. AP with PLAP and PLAP-like properties have been 
demonstrated in cell lines derived from carcinoma of the cervix 
(Hela) and other human tumours. Out of eight Hela cell lines 
studied by Benham al (1978) six contained PLAP-like AP the 
others were liver-like AP and an unidentified AP isoenzyme, this 
was distinguishable from the known human AP’s. Though cross 
reactive with PLAP, using polyclonal antibodies directed against 
PLAP, the cell line AP isoenzymes can be distinguished from PLAP 
by their sensitivity to inhibition using L-leucine and by the 
fact they fail to show the electrophoretic polymorphism of PLAP 
(Millan et al, 1982b&c).
1:3 Transplantation Antigens
The major reason for graft failure between genetically 
dissimilar individuals (allogenic grafts) is a host immune 
response to the cell surface antigens of the donor which differ 
from those of the host. These surface antigens are the 
histocompatibility antigens. The genes of which can be divided 
into two main categories, major histocompatibility complex (MHC)
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and the minor histocompatibility antigens, which represent 
allogeneic polymorphism to a much lesser extent. The MHC encodes 
for three classes of genes I, II and III. The MHC of humans (HLA) 
and mouse (H-2) appear extremely homologous with both encoding 
the same three classes of genes (Hood ill, 1984; Bodmer &
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Bodmer, 1984). The three class I antigens which are responsible 
for graft rejection are designated A, B & C in humans and K, D &
L in mice. The mouse hematolymphoid differentiation antigens Qa- 
1, Qa-2, Qa-3 and TL (Tla gene) are also being described in 
humans (Hood g£ al, 1984; Bodmer & Bodmer, 1984). The HLA class 
II antigens are called DR, DQ and DP which correspond to the H-2 
class II antigens A alpha, A beta, E alpha and E beta. These are
found on macrophages, T and B cells. Their function is to provide
helper t
self recognition. This self recognition element allows the^cells 
to interact with foreign antigen to produce
lymphokines which stimulate the
proliferation of cytotoxic T cells or"suppressor T cells (Hood et 
al, 1984; Steinmetz, 1984). The HLA complex class III genes code 
for the complement components C2, C4 and BF.
1:3:1 HLA and the Placenta
Matching donor and host HLA antigens and the suppression 
of any residual immune response is standard practice for organ 
graft success (Playfair, 1982; Hood £t gi 1984). The placenta, 
though fed by its own fetal vessels, is a semi-allogenic graft 
which survives in direct physical contact with the maternal 
immune system without rejection (Lala .gt al, 1983). Usually for 
maximum allograft rejection response the HLA antigens of both 
class I and II are needed to be recognised by the alio reactive T
4
cells of the host. Precursors of the cytotoxic T cells (Tc) 
bearing class I receptors respond to the grafts class I 
antigens, whereas precursors of the helper cells (Th) recognise 
the class II antigens. After clonal expansion and maturation, 
the Tc, with the help of the Th in the form of interleukin 2,
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destroys the graft cells by recognition of the class I antigens.
The distribution of HLA antigens on early and term 
placentae has been studied using immunohistology. Both class I 
and II antigens were shown to be absent from villous trophoblast 
(Faulk & Temple, 1976; Goodfellow .§£ al, 1976; Sunderland al, 
1981a&b). More recent studies of extra-villous trophoblast 
locations has shown class I expression (Sunderland et alT 1981a; 
Redman et al, 1984). The cy to trophoblast of the uteroplacental 
interface which invades the uterine decidua, the 
cytotrophoblastic columns cell islands and the cytotrophoblasts 
of the chorionic plate all express HLA class I antigens, as 
detected by the monoclonal antibodies W6/32 and B£M. However the 
syncytial layer of trophoblast and the underlying zone of 
cytotrophoblast lacks HLA class I antigens (Sunderland et al, 
1981a; Redman jit al, 1984). The extra-villous trophoblast which 
reacts with the monoclonal W6/32 did not express the expected 
fetal HLA A and B allotypes (Redman, 1983). Thus the class I 
determinants detected on the placenta are qualitatively different 
from those detected on other tissue. They either belong to HLA C 
or to a yet unknown HLA class I locus. The latter possibility 
would mirror murine H-2 where of 36 distinct class I genes from 
BALB/C genomic cosmid library 10 are uncharacterised (Goodenow et 
alT 1982; Steinmetz, 1984; Redman, 1983). Class II antigens were 
not expressed on the villous or non villous trophoblast using the
4
monoclonal antibodies (Sunderland 1981a&b, Redman, 1983). In 
culture Brami and co-workers (1983) found cells of trophoblastic 
origin from 9-12 week placentae which expressed HLA-DR. Greater 
investigation of trophoblast cells in culture is needed to 
confirm this result. Khalaf (1985) isolated cells from the
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chorionic plate and the uteroplacental interface (Nitabuch's 
layer). These placental cells were cultured for 2-4 months and 
their antigenic determinants studied using monoclonal antibodies. 
Both cell preparations showed positive staining for HLA class I 
antigens with only a few cells staining positively for HLA class 
II antigens (Khalaf et .§!, 1985a&b).
The antigenic status of the trophoblast is the key 
determinant for immune interactions between the mother and the 
fetus. The absence of HLA class II antigens could possibly make 
the trophoblast immune from graft rejection though class I 
antigens alone, in the mouse, are sufficient for tissue rejection 
(Lala et al, 1983; Billington & Bell, 1983; Klien, 1975). Also 
the expression of the class I or Class I-like determinants on the 
extra-villous invading trophoblast might be important in 
eliciting the maternal immune system to respond ineffectively 
(McIntyre & Faulk, 1982a&b).
1:4 Molecular analysis of the placenta
During gestation the human placenta synthesises and 
secretes into the maternal serum, many proteins and peptide 
hormones which are unique to pregnancy. The syncytiotrophoblastic 
and probably the cytotrophoblast cells are actively involved in 
this synthesis and secretion (Contractor et al, 1977). From this 
it is apparent that the transcription of mRNA and its translation
4
into protein is occurring in the placenta (Sybulski & Tremblay, 
1967; Dancis et al, 1976; Klopper & Chard, 1979). By the study of 
mRNA from different placental tissues one will be able to 
localise gene expression. The analysis of the placental genes at 
the mRNA and cDNA cloning level will give an insight to the
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possible mechanisms involved in the regulation of gene 
expression; whether proteins are encoded by single genes or gene 
clusters. Also sequence data derived from cDNA clones will enable 
the similatities and differences between placental and other non- 
pi acental related genes to be specifically charecterised.
Analysis during placental development of nucleic acids 
showed that the RNA content per cell was 2.5 times higher in the 
first trimester placenta compared with term placenta. Total RNA 
and protein synthesis increased linearly with gestational age and 
DNA synthesis and cell division ceased after 36 weeks. The 
analysis of nuclease activity showed that deoxyribonuclease 
activity declined during gestation whilst the ribonuclease 
activity remained constant throughout (Brody, 1953; McKay et al, 
1958; Winick et al, 1967). That the levels of specific mRNA 
present vary during placental development according to the 
placenta's requirements was shown by Chatterjee et al (1976). By 
extracting mRNA from polyribosomes in early and term placentae 
Chatterjee et .al (1976) studied the synthesis of two placental 
peptide hormones, hOG and hPL. The mRNA was in vitro translated 
in a wheat germ cell free system. In vitro translated mRNA from 
early placenta synthesises eight fold more hOG alpha protein than 
mRNA from term placentae. This corresponds to the peak of hCG 
detected in maternal sera at 10-12 weeks of gestation and its 
decline in later pregnancy (Chatterjee & Monro, 1977; Daniels-
4
McQueen jgt .gl, 1978). The hPL hormone reaches its maximal level 
in the maternal serum at term3 which is reflected in the in vitro 
translated mRNA. Term placental mRNA synthesised 4-5 times more 
hPL when compared with mRNA from first trimester placentae (Boime 
et alT 1976). Synthesis of hPL using an equal amount of mRNA from
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term and first trimester placentae showed that the enhanced 
synthesis of hPL at term is the result of an increased proportion 
of the mRNA coding for hPL. Thus the proportion of the total mRNA 
available which codes for a specific protein varies and this 
determines the amount of protein formed at different stages in 
pregnancy.
1:4:1 Placental mRNA
RNA can be extracted from the syncytiotrophoblastic tissue 
of placenta using a strong denaturant and separated from the 
placental DNA by centrifugation through a caesium chloride 
cushion (Boime et al, 1976; Seeburg et al, 1977; Fiddes & 
Goodman, 1979). To obtain intact RNA of high quality the rate of 
denaturation of the RNase present in tissue must exceed the rate 
of RNA degradation by RNase. Chirgwin £t al (1979) reported that 
the rate of denaturation was maximized by the combined use of a 
strong denaturant (5M guanidinium thiocyanate) and reductant 
(0.1 M B-mercaptoethanol). The denaturant eliminates nucleolytic 
degradation of the RNA by its denaturation of all the cellular 
proteins present, while the reductant breaks the protein 
disulphide bonds which are necessary for RNase activity. For 
eukaryotic cells only \% to 5% of the total cellular RNA is mRNA. 
This mRNA is heterogeneous in size from a few hundred bases to 
several kilobases and encodes for the synthesis of all the
4
proteins in the cell. Due to the poly(A) tail at the 3' end of 
nearly all mRNAs the mRNA can be purified from the rest of the 
cellular RNA by chromatography using oligo(dT) cellulose (Aviv & 
Leder, 1972).
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1:4:1:1 in vitro translation of mRNA After enriching for 
polyadenylated RNA by repeated chromatography on oligo(dT) 
cellulose (Aviv & Leder, 1972) the placental mRNA was in vitro 
translated, in the presence of ^^S-methionine, into various 
polypeptides which were analysed using SDS-polyacrylamide gels 
(Boime et al, 1976; Seeburg e£ a!, 1977; Fiddes & Goodman, 1979 &
1980). The reticulocyte cell free system was used in preference 
to other translational systems for the synthesis of the placental 
translation polypeptides as it has a very low background of 
endogenous protein synthesis and the capability to synthesis 
polypeptides of high molecular weights (Pelham & Jackson, 1976). 
The major proteins in vitro synthesised by mRNA extracted from 
first trimester placenta were of apparent mw 13Kd and 16Kd. These 
were shown to be the pre-forms of the alpha and beta subunits of 
hCG by immunoprecipitation, using antisera directed against the 
mature hCG. The 13Kd and 16Kd pre-forms of the alpha and beta 
subunits of hCG were visible in only trace amounts in in vitro 
synthesised term mRNA. The major in vitro synthesised protein at 
term was of apparent mw 24Kd. Up to 20$ of the incorporated 35s_ 
methionine was present in this polypeptide whereas there was only 
low incorporation of ^^S-methionine in the rest of the 
synthesised term polypeptides. This 24Kd polypeptide was shown to 
be the preform of hPL by its specific immunoprecipitation with 
antisera directed against the mature hPL protein.
4
1:4:1:2 Immunoprecipitation It is possible to isolate by 
immunoprecipitation procedures nearly any cellular protein to 
which specific antibodies are available, as long as the 
extraction procedures retain the antigenicity of the protein 
(Kessler, 1975). Immunoprecipitation is usually performed in two
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stages. The specific antibody is first added to the solution 
containing the antigen to be isolated and the antigen-antibody 
complex is then precipitated. Precipitation is facilitated using 
an agent that by binding to the antigen-antibody complex gives it 
sufficient mass to precipitate. Protein A, a protein component of 
certain strains of Staphlococcus aureus cell walls has a high 
affinity for the Fc region of IgG molecules, binding specifically 
and strongly (Kronvall et al 1970). Since formalin fixed 
aureus retain this cell wall protein, these cells precipitate 
antigen-antibody complexes and thus act as a solid phase 
immunoadsorbent (Kessler, 1975). The advantages of using Protein 
A compared with double antibody techniques are that the uptake of 
the antigen-antibody complex occurs very rapidly and there is no 
need for a second antibody. Once bound, the complex cannot be 
displaced by excess free antibody or normal IgG and the antigen 
can then be eluted from the cells using SDS and B-mercaptoethanol 
at high temperatures. Immunoprecipitation using protein A has 
been successfully used to to detect specific translational 
products of placental mRNA using antibodies directed against hPL 
and hCG (Seeburg, jgt al 1977, Fiddes & Goodman, 1979 & 1980). 
Therefore it was used to detect whether PLAP and other placental 
proteins were translated from cytotrophoblast and 
syncytiotrophoblast mRNA.
4
1:4:2 Cloning SL placental genes
Of the in vitro synthesised polypeptides in placental 
mRNA it is the two major synthesised polypeptides, hOG and hPL, 
which have been studied in the most detail. Due to the 
differences in translational activities between first trimester
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and term placental mRNA, cDNA synthesised from these two sources 
show differences in their restriction enzymes digestion pattern. 
By this approach discrete restriction fragments were generated 
for the predominant cDNA species. Comparison of the cDNA 
restriction enzymes fragment patterns from first trimester and 
term mRNA samples enabled the cDNA fragments corresponding to 
alpha hCG, beta hCG and hPL to be identified. The DNA fragments 
generated by Haelll and Hhal digestion of single stranded cDNA 
from term mRNA enriched for hPL enabled sequence analysis and 
cloning of this cDNA species. From the hPL cDNA clones, four 
hPL-like genes have been isolated two of which have been shown to 
produce the same mature hormone (Barrera-Saldana .gt al, 1982). 
The analysis of cDNA clones bearing sequences corresponding to 
Beta hCG has shown that the this subunit is encoded for by at 
least three non allelic genes (Policastro et al, 1983).
As the other in vitro synthesised polypeptides are at 
low abundances they can not be studied by the elution of the 
predominant cDNA fragments from gels and the direct cloning of 
these DNA fragments. The analysis of placental genes which cannot 
be directly cloned involves the synthesis and cloning of total 
cDNA from placental mRNA. The identification and isolation of 
cDNA clones for genes which are expressed at low levels requires 
probes. A knowledge of the amino acid sequence of the gene 
product enables synthetic oligonucleotides to be used as
4
hybridisation probes (Suggs gl, 1981). Whereas the expression 
of the gene in E.coli and the availability of antibodies to the 
gene product enable specific clones to be identified by 
immunoassays (Broome & Gilbert, 1978; Kemp & Cowman, 1981; Young 
& Davis, 1983).
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1:4:2:1 Synthetic Oligonucleotides When the sequence of at least 
part of the polypeptide product for the gene of interest is known 
synthetic oligonucleotides can be designed. From the amino acid 
sequence alone a single oligonucleotide probe could not be 
synthesised which was 100% homologous to the DNA sequence as the 
genetic code is almost totally degenerate with 61 of the possible 
64 triplets coding for 20 amino acids. Only two amino acids, 
methionine and tryptophan, are represented by a single codon. To 
minimize ambiguities in the synthetic oligonucleotide the amino 
acid sequences which have the fewest codon possibilities are 
chosen (Suggs §t al, 1981; Anderson & Kingston, 1983; Jaye et al,
1983).
The use of oligonucleotides for probing or priming cDNA 
depends on the availability of amino acid sequence data. Up to 
1982, the only data available for PLAP was for the residues 1-4 
(Green & Sussman, 1973):
Ile-Ile-Pro-Val-
In 1983, N.S. Abu-Hasan in this laboratory sequenced the residues
1-13 of M-PLAP and A-PLAP (Abu-Hasan & Sutcliffe, 1984 & 1985):
5 10 
II e-Il e-Pro-Val-Glu-Glu-Glu-Asn-Pro-Asp-Phe-Trp-Asn-
4
Analysis of Abu-Hasan!s data showed that short oligonucleotides 
with acceptable redundancies could be deduced (table 1.2). This 
sequence was confirmed when data appeared for residues 1-42 (Efcra 
et al, 1983):
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5 10 15
IIe-Ile-Pro-Val-Glu-Glu-Glu-Asn-Pro-Asp-Phe-Trp-Asn-Arg-Glu- 
20 25 30
Ala-Ala-Glu-Ala-Leu-Gly-Ala-Ala-Ly s-Lys-Leu-Gln-Pro-Ala-Gln- 
35 40
Thr-Ala-Ala-Lys-Asn-Leu-(IIe)-IIe-Phe-Leu-Gln-Asp-
Consider in table 1.2 the amino acid sequence for the 
amino terminal end of the PLAP polypeptide. At position 12 there 
is a tryptophan residue coded for by an unique codon (UGG) the 
flanking amino acids at positions 10-13 are each coded by pairs 
of synonymous codons. Thus a synthetic oligonucleotide of 12 
bases from the first base of codon 10 would contain 3 mixed 
sites each with a pair of alternative bases (table 1.2). Thus to 
obtain an oligomer which would be =. 100% complementary to PLAP 
mRNA, 8 different oligonucleotide sequences are needed. A larger 
perfectly matched oligonucleotide is highly desirable however, 
the cost of synthesising one is also high. Covering all the 
possible arrangments of codons for a amino acid sequence limits 
the size of oligonucleotides which can be practically synthesised 
(Sood .gt al, 1981; Suggs jg£ si, 1981; Breslow .gi 21, 1982; 
Stetler si 2l, 1982; Orkin si si, 1983). For example an 
oligonucleotide of 26 bases from the first base of codon 27 to 
the second base of codon 35 would contain 8 mixed sites, 3 with a
4
pair of alternative bases and the others with a choice of four 
alternative bases (table 1.2). Thus 8192 unique oligonucleotide 
sequences are needed to obtain one which is 100% homologous.
Although 100% homologous oligonucleotides have been used 
successfully to probe and detect cDNAs it is possible and perhaps
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5 10 15
a .  I l e - I l e - P r o - V a l - G l u - G l u - G l u - A s n - P r o - A s p - P h e - T r p - A s n - A r g - G l u - r A l a - A l a - G l u - A l a -
b. ATC ATC CCT GTG GAG GAG GAG AAC CCT GAT TTC TGG AAC AGG GAG GCC GCC GAG GCC
{ A A A T  A A A T  A i C | T  ! j T  A A T T A T
{ T T C C c  ! ! ! OGG A A A
{ G A G ! ! ! j A G G G
1 1 1 1 T
i i i i i
i i i i rf i l l  b
cDNA: CT£ AaJ ACC TT^
I. Short Oligonucleotides covering all the possible codon sequences
(1 ) 3 1-CTAAAAACCTTA-51
(2 ) 3 ' -CTAAAAACCTTG-5'
(3 ) 3 ' -CTGAAG ACCTTA-5'
(A) 3 1 -CTGAAG ACCTTG-51
(5 ) 3 ' -CTGAAAACCTTA-51
(6 ) 3 ' -CTGAAAACCTTG-5'
(7 ) 3 '-CTAAAGACCTTA-5'
(8 )  3 ' -CTAAAGACCTTG-5'
20 25 30 35 40
Leu -G ly-A la -A la-Ly s-Ly s -L eu -G ln -P ro -A 1a-G ln -T hr-A la -A la -L y  s -A s n -L e u -IIe -IIe -P h e -L e u -G ln -A s p
CTG GGA GCC GCC AAG AAG
C
A
T
TTG
A
CTG
C
A
T
TTG
A
CAG CCT GCC CAG ACC GCC GCC AAG 
A
AAC 
T
CTG ATC ATC TTC CTG GGA GAT
C
A
T
TTG
A
C
A
T
TTG
A
cDNA: GT^ GGJjj CG£ GTjf TGj CG£ 0G£ T T j TT
I I .  Long O lig on u cleo tid e  based o n |-
i  codon usage : 3 ' -GT0GGA0GGGTCTGG0GG0GGTTCTT-51
i i  codon usage a t  3 ' end and covering a l l  the codon p o s s ib i l i t ie s  a t  the 5 ' end
(1 )  3 ’ -GTOGGAOGGGTCTGGOGGOGGTTCTT-51
(2 ) 3 1-GTCGGACGGGTCTGGCGGOGATTCTT-51
(3 )  3 ' -GTOGGAOGGGTCTGGOGGOGTTTCTT-5'
(4 ) 3'-GTCGGACGGGTCTGGOGGOGCTTCTT-5'
(5 )  3 ' -GTOGGA0GGGTCIGG0GG0GGTTTTT-5'
(6 ) 3 '^TCGGACGGGTCTGGCGGOGATTTTT-5'
(7 )  3 ’ -GTOGGAOGGGTCTGGOGGOGTTTTTT-5'
(8 ) 3 , -GTCGGAOGGGTCTGGOGGOGCTTTTT-5l
Table 1.2: Amino acid sequence for the N-terminal end of the PLAP 
polypeptide, showing all the possible codon sequences for these 
amino acids. The cDNA sequences used for the deduction of the 
PLAP oligonucleotides I and II are aligned with their codon4 
sequences.
a. The amino acid sequence data for PLAP, Ezra et al, 1983 
and Abu-Hasan & Sutcliffe, 1984 & 1985.
b. The statistically favoured codons, specified from the 
codon usage known for human fetal beta globins and X^, 
Smithies jgt al, 1981 and Shen et al, 1981.
c. The other possible codons
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more successful to use longer oligonucleotides and to tolerate a 
certain level of mismatch. When the codon uncertainty is ignored 
the increased length of the oligonucleotide is used to confer 
probe specificity (Agarwal e£ al; 1981; Jaye et al, 1983; 
Anderson & Kingston, 1983; Ullrich al, 1984). The use of a 
longer unique oligonucleotide as a specific probe involves:
(1) The selection of the amino acid sequence which has the least 
codon redundancy. By avoiding regions containing amino acids 
encoded for by 6 codons the degeneracy of codons is limited to 
the third base position and thus a oligonucleotide probe would be 
at least 66$ homologous.
(2) The selection of statistically favoured codons. Codon usage 
is determined from sequenced cDNAs corresponding to related 
proteins.
(3) The selection of nucleotides giving the greatest stability 
of mismatches during hybridisation where no preference is seen 
with codon usage. Jaye et al (1983) found that a G:T mismatch at 
the codon third position though less stable than the G:C base 
pair contributed to the stability of the oligonucleotide/mRNA 
duplex whereas an A:C mismatch would not. However, Lathe (1985) 
suggests that the base pairing energy associated with a G:T 
mismatch generates a less stable oligonucleotide/mRNA hybrid for 
human coding sequences. Also Smith (1983) noted that the 
stability of G:T pairs in DNA was substantially less than that in 
RNA.
(4) The selection of an oligonucleotide sequence with minimum 
secondary structure which would reduce hybridisation.
For a longer unique oligonucleotide for PLAP a region 
where the degeneracy of codons was limited to the third base
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position was chosen and the statistically favoured third base was 
chosen. The degenerate third base positions for the PLAP amino 
acid codons was specified by the codon usage known for human 
fetal beta globins C and A (Smithi*es et al, 1981; Shen et al,
1981) and verified from the human codon usage table of Lathe 
(1985). Thus with codon usage the oligonucleotide of 26 bases 
from the first base of codon 27 to the second base of codon 35 
would have 8 bases selected on the basis of statistically 
favoured codons and it would be at least 69% homologous (table 
1.2).
A combination of the above two methods can also be used 
for the synthesis of oligonucleotides. At the 3'end of the 
oligonucleotide the third base of each codon is specified by 
codon usage whereas at the 5'end, where 100% homology is more 
important, especially when the oligonucleotide is being used to 
prime cDNA synthesis, each alternative arrangment of bases is 
specified (table 1.2).
As even a single base pair mismatch alters the thermal 
stability of the oligonucleotide/DNA duplex by altering the 
hybridisation conditions one can select for perfect homology or 
for specified levels of mismatch. The hybridisation and washing 
stringencies are based on the dissociation temperature of the 
duplex calculated from the proportion of G/C and A/T in the 
oligomer ( Gill am & Smith, 1979; Suggs al, 1982; Winter el al,
4
1982; Norrander si, 1983). The dissociation temperatures for 
the different PLAP oligonucleotides, given as examples above, are 
shown in table 1.3.
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TABLE 1.3
DISSOCIATION TEMPERATURE TD = [ dG.dC x 4°C ] + [dA.dT x 2°C]
PLAP oligonucleotides TO
I. homologous bases 3 ’ -CT_AA_AC_TT_-5’ 24°C
I. (1) 3 *-CTAAAAACCTTA-5’ 30°C
(2) 3’-CTAAAAACCTTG-5' 32°C
(3) 3’-CTGAAGACCTTA-5’ 34°C
(4) 3’-CTGAAGACCTTG-5f 36°C
(5) 3’-CTGAAAACCTTA-5’ 32°C
(6) 3’-CTGAAAACCTTG-5’ 34°C
(7) 3’-CTAAAGACCTTA-5’ 32°C
(8) 3’-CTAAAGACCTTG-5’ 34°C
II. homologous bases 3’-GT GG CG GT TG CG CG TT TT-5' 58°C
II.i 3’-GTCGGACGGGTCTGGCGGCGGTTCTT-51 88°C
II.ii (1) 3' -GTCGGACGGGTCTGGCGGCGGTTCTT-5 ’ 86 °C
(2) 3’-GTCGGACGGGTCTGGCGGOGATTCTT-5’ 86°C
(3) 3 ’ -GTCGGACGGGTCTGGCGGCGTTTCTT-5 ’ 88 °C
(4) 3 ’-GTCGGACGGGTCTGGCGGCGCTTCTT-5 ’ 86°C
(5) 3' -GTOGGACGGGTCTGGCGGCGGTTTTT-5' 84 °C
(6) 3 ’ -GTCGGACGGGTCTGGCGGCGATTTTT-5 ’ 84 °C
(7) 3 ’ -GTCGGACGGGTCTGGCGGCGTTTTTT-5 ’ 84 °C
(8) 3 ’ -GTCGGACGGGTCTGGCGGCGCTTTTT-51 86°C
Table 1.32 The dissociation temperatures for the different PLAP 
oligonucleotides shown in table 1.2.
no
1:5 Cloning Vectors
The use of a \ vector for the preparation of cDNA 
libraries in preference to a plasmid vector makes use of the 
efficency and reproducibility of in vitro packaging of ^  DNA as a 
method of introducing the cDNA sequences into E.coli compared 
with DNA transfection employed by plasmids (Young & Davis, 1984). 
In vitro packaging of \ DNA uses cell extracts derived from two 
induced \ lysogens whose prophage have complementary mutations in 
genes required for mature phage assembly, by mixing the two 
extracts with ^ DNA the DNA is packaged into infectious ’’phage1’ 
particles (Becker & Gold, 1975). The frequency of which cDNA 
clones of specific mRNAs appear in a cDNA library is usually 
dependent on the abundance of that message in the mRNA 
population. To isolate cDNA clones of PLAP which is assumed to be 
a low abundence mRNA a much larger cDNA library needs to be 
constructed; compared with that needed for the isolation of cDNA 
from a high abundant mRNA. This is not just because of the 
minimum number of clones required to obtain a complete 
representation of the low abundance mRNAs but also due to the 
sampling variation and preferential cloning of certain mRNA 
sequences (Huynh, Young & Davis, 1984).
1:5:1 Lambda Vectors gt10 and gt11
The choice between the lytic cycle, the release of
4
progeny phage, and the lysogenic pathway which leads to the 
intergration of the \DNA into the host genome is dependant on 
both ’phage and host factors. The phage ell protein is the 
primary control function in the establishment of lysogeny 
(Herskowitz & Hagen, 1980). To establish lysogeny the regulatory
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activities carried out by ell and cIII are the negative 
regulation of lytic functions and the positive regulation of the 
cl gene repressor protein for the maintainance of lysogeny by the 
repression of early transcription and the consequent blocking of 
late gene expression (Echols & Green, 1971; Reichardt & Kaiser, 
1971). The positive regulation of the int gene is also under the 
control of ell and cIII, the int protein recognizes sequences at 
the att sites of both host and ’phage genomes and calalyzes the 
prophage insertion into the host genome (Chung & Echols, 1977).
Thus bacteriophage which are mutant in genes cl, ell or 
cIII are unable to follow the lysogenic pathway and form clear 
plaques. Both \gt10 and \gt11 are suitable cloning vectors as 
both are mutant in cl \gt11 has a temperature sensitive cl 
repressor which is inactive at 42°C whereas ^gt10 becomes cl” by 
the insertion of foreign DNA at its EcoR1 site, \gt10 produces 
phage libraries which can be screened using nucleic acid probes; 
genomic DNA, cDNA, RNA, cloned DNA fragments or synthetic 
oligonucleotides. Whereas \gt11 libraries can be screened with 
antibody probes as the inserted cDNA fragments are expressed as 
polypeptides.
1:5:1:1 \gt10: The cloning vector \gt10 contains a unique EcoR1 
site within the phage repressor gene (cl); figure 1.1 gives the 
structure of \gt10. Fragments of cDNA up to 7.6 Kb pairs in
4
length can be inserted into this EcoR1 site to obtain packagable 
^gt10 DNA/cDNA molecules. As ^ gt10 is not a replacement vector an 
insert fragment is not required for packageable \gt10 DNA 
molecules (Murry .gt £l, 1977). Therefore cDNA libraries cloned 
into Agt10 can consist of up to 99$ parental phage (Huynh al»
cr
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Figure 1.1: Map of .\gt10 with restriction endonuclease cleavage4 
sites in kilobase pairs. The b527 deletion represents 8.3% of 
the DNA sequences removed from the wild type lambda and the 
lmm434 subsitution replaces 6.4% of the wild type lambda. The 
insertion of cDNA into the unique EcoR1 site inactivates the cl 
gene enabling recombinant clones to be identified by 
morphological differences. Reproduced from Huynh, Young & Davis, 
1984.
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1984). Parental \gt10 phage are cl+ and form turbid plaques 
whereas the presence of inserted cDNA inactivates the repressor 
gene generating cl" phage which form clear plaques. Thus the 
recombinant phage are distinguished from parental, 
nonrecombinant, phage by their plaque morphology. By using an 
E.coli hflA host for the amplification of a ^ gt10 library one can 
select against the parental phage (Hoyt .§£ al, 1982). On E.coli 
hflA hosts cl+ phage lysogenize efficiently and plaque 
formation is supressed. However, cl" phage have the same plaque 
forming efficiency on E.coli hflA+ or E.coli hflA" host strains. 
Thus the amplification of \gt10 cDNA libraries on an E.colliflA g- 
host eliminates the nonrecombinant phage from the library and 
produces large recombinant plaques of uniform size and shape for 
screening with nucleic acid probes.
1:5:1:2 lgt11 : The expression vector ^gt11 produces a 
temperature sensitive repressor (c 1857), which is inactive at 
42°C;it also contains the amber mutation (S100) which renders it 
lysis defective in E.coli host cells which lack the amber 
supressor supF; the structure of this vector is shown in figure 
1.2. When incubated at 42°C using an E.coli supF host the \gt11 
vector is capable of producing a polypeptide specified by the 
inserted cDNA therefore one can screen cDNA libraries with
i
antibodies directed against the inserted DNA polypeptide 
sequences (Young & Davis, 1983) Up to 8.3 Kb pairs of cDNA can
4
be ligated into the unique EcoR1 site of the ^ gt11 DNA within the 
structural gene for B-galactosidase. It is because of this 
insertion site, 53bp upstream from the B-galactosidase 
translation termination codon and within the Lac Z gene, that the 
vector is capable of expressing foreign DNA sequences as B-
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Fig 1.2
Amp 3 
1 • 7
LEFT END
Bgl II
BAM HI
PVU
■ KPN I
■ K P N  I
■ ECO R I
: - S S T  I 
■ ^ P V U  I 
‘^ PVU I 
■ O P V U  I 
X P V U  I
■ —X B A I 
: - S S T  I
■ H I N D  III 
BAM HI\
" X H O  I 
■ B A M  H I
: \ B g  I II 
- X P V U  I 
- N i  I N D I 
V  H I  N D I 
Bg I I I  
\ B g  I 11 
XBgI  I I
■ H I N D  I I
5 - 5 3
11- 95
17 0 7
R I G H T  E N D
3 1 - 5 0
3 2 - 5 0
3 3 - 7 1
3 3 - 7 8
3 4 - 9 0
3 5 - 4 7
3 6- 1  
3 6 - 7 5  
3 6 - 8
3 9  35
4 3 - 7 0
Figure 1.2: Map of \gt11 with restriction endonuclease cleavage 
sites in kilobase pairs. The transcriptional orientation of lacZ 
is indicated by the horizontal arrow. The unique EcoR1 site is 
situated within the structural gene for B-galactosidase. Foreign 
DNA inserted at this site is expressed as a B-galactosidase 
fusion protein. Reproduced from Huynh, Young & Davis, 1984.
45
galactosidase fusion proteins. Also the positioning of the 
insertion site within the LacZ gene enables recombinant phage to 
be distinguished from the non recombinant, parental, phage by 
their morphology. Using a E.coli SUpFlacl+ host strain in the 
presence of the lac operon inducer, IPTG (Isopropyl B-D- 
thiogalactopyranoside), and the B-galactosidase substrate, X-gal, 
parental \gt11 phage produce blue plaques whereas recombinant 
phage plaques are colourless (Young & Davis, 1983). To overcome 
the problems associated with the production of foreign proteins 
that may be toxic to the host, E.coli which produce large amounts 
of lac operon repressor are used. The lac repressor prevents lac 
Z directed expression of the fusion product until the lac 
repessor is inactivated by the addition of IPTG. In this way 
detectable amounts of fusion protein can be made before the IPTG 
is added. Another problem associated with fusion proteins in 
E.coli is their stability, for this reason Ion mutant hosts are 
used as a deficiency in Ion protease increases the stability of 
the fusion protein and thus facilitates the antibody screening 
procedure.
1:5:1:3 ^Amp3: The cl temperature sensitive ?phage \Amp3 is 
identical to \gt11 except for the insertion at the
Xba1 site of \gt11 of a 1.7 Kb fragment from pBR322 (the B- 
lactamase gene) which codes for ampicillin resistance (Young & 
Davis, 1983a&b).
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CHAPTER 2
SEROLOGICAL STUDIES OF TROPHOBLAST MEMBRANE COMPONENTS
2:1 INTRODUCTION
Trophoblast-specific antigens have been identified 
xenogeneically using heterologous antisera and monoclonal 
antibodies (Faulk etai 1978, McIntyre & Faulk 1979, Loke et al 
1980, Sunderland £t .il 1981, Johnson et al 1981, Brown et al 
1983). Also investigations of abortion prone couples have 
indicated that inadequate maternal recognition of allotypic fetal 
trophoblastic-lymphocyte cross reactive (TLX) antigens leads to 
pregnancy failure (McIntyre & Faulk 1982a). Allotypic TLX 
antigens would seem to be to a stimulus to signal the mother to 
mount a blocking response to inhibit allograft rejection 
reactions but this system has not been studied in detail and 
antibodies against TLX have not been detected in the maternal 
sera.
While studying trophoblast-lymphoblast interactions Dr 
M. Davies in this laboratory developed a passive 
haemagglutination assay, using preparations of human 
syncytiotrophoblast microvilli, to determine the titre of 
xenogeneic anti-syncytiotrophoblast sera. In pilot experiments he 
detected anti-trophoblast agglutinins in term maternal sera. The 
aim of the work in this chapter was to discover whether these 
agglutinins were maternal antibodies directed to alloantigenic or 
isoantigenic trophoblast antigens. Firstly I had to establish the
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haemagglutination assay techniques in my own hands. Several 
syncytiotrophoblast microvilli preparations were assayed against 
serial dilutions of different term maternal sera and control 
sera. Then an attempt was made to absorb the agglutinins from the 
sera with potential antigens. Finally, several different antibody
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purification systems were used to determine whether the 
agglutinins co-purified with the maternal antibodies, either IgG 
or IgM.
The passive haemagglutination assay was used in 
preference to the more sensitive ELISA assay because there was 
concern that Fc receptors present on the syncytiotrophoblast 
plasma membrane might lead to false positive results in the ELISA 
assay.
2:2 MATERIALS and METHODS
2:2:1 Preparation of solubilised placental plasma microvillous 
membrane proteins
The microvillous membrane vesicles were prepared 
according to the method of Smith, Brush and Luckett (197*0. 
Briefly, a fresh term placenta from which cord and membranes had 
been removed was washed rapidly in ice-cold 0.11M calcium 
chloride followed by ice cold saline 0.9$ (w/v). The washed 
tissue was cut into small pieces, suspended in 0.9$ (w/v) saline 
and agitated for 30 minutes at 4°C. The saline wash was removed 
and centrifuged at 80xg for 10 minutes. The supernatant was 
centrifuged first at 10,000g for 5 min then at 100,000g for 30 
minutes. The resulting pellet of placental villous membrane 
vesicles was resuspended in phosphate buffered saline (PBS) pH 
7.4 in a tight fitting glass homogenizer and washed by 
centrifugation at 100000g for 30 minutes. The pellet was 
solubilized by resuspending in 1$ Nonidet NP40 (v/v) 10mM glycine 
in 3.8 mM Tris HC1 (pH9.2) to a final protein concentration of 
3mg/ml. This was stirred for 60 minutes at 4°C then centrifuged 
at 100000g for 60 minutes. The supernatant was dialysed against 
PBS (pH 7.4) for 18 hours at 4°C. The amount of solubilized 
membrane present was estimated by determination of the protein 
content using the Folin method, bovine serum albumin was used as 
the standard (Lowry et al 1951).
2:2:2 IfcgpaiaUfln of protein-coated formalized red blood cells.
Formalized red blood cells were prepared using tannic 
acid (Herbert, 1978). Briefly, washed and packed human red blood
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cells (RBC) were prepared by centrifugation of whole blood at
/
3000g for 5 minutes. The RBC pellet formed was washed with saline 
(0.15M NaCl) three times then resuspended to 12.5% (v/v) in PBS. 
The RBCs were then formalized at room temperature by dialysing 
against formalin for three hours, then the dialysis sac was 
ruptured and the mixture stirred for a further 18 hours. The 
formalized RBC (FRBC) were washed and resuspended to 25%(v/v) in
j
PBS and then incubated with an equal volume of tannic acid (0.1 
mg/ml) for 15 minutes at 37°C. After washing with PBS the tanned 
FRBC were resuspended to 25%(v/v) in PBS and incubated for 30 
minutes at 37°C with an equal volume of solubilized placental 
microvillous membrane protein (1 mg/ml). The protein coated FRBC 
(target cells) were washed three times in PBS containing 
stabilizing protein and resuspended in the same buffer to a final 
concentration of 1% (v/v) target cells. The pretreatment of FRBC 
with tannic acid can cause agglutination of FRBC in the absence 
of added agglutinin. This effect was prevented by the addition of 
a protein stabilizer to the final buffer. The optimal 
concentration of three different stabilizing proteins were 
determined by titration.
2:2:3 Passive Haemagglutination Assay
Sera from patients at term and non-pregnant females and 
male controls were adsorbed with equal volumes of 25% FRBC for
4
30 minutes at room temperature. The adsorbed sera were serially 
diluted in PBS containing the protein stabilizer. To 50ul 
aliquots of each dilution were added 20ul of 1% target cells and 
incubated overnight. The agglutinin titre of each serum was 
determined as the highest dilution that showed agglutination.
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2:2:4 Serum Fractionation
A column (1.5x30 cm) of AcA34 Sepharose (LKB) was 
equilibrated in PBS. Samples (1ml) of maternal and control sera 
were adsorbed with FRBC and passed over the column at a flow rate 
of 5ml per hour; 1ml fractions were collected. For euglobulin 
precipitation (Schwick .gt jl 1978), adsorbed sera were dialysed 
against water at 4°C overnight. The euglobulin precipitates which 
formed were precipitated by centrifugation and redissolved in 
PBS to the original volume of serum. The supernatants and 
euglobulin samples were assayed for agglutinins to placental 
microvillous membrane proteins and for IgM and IgG.
2:2:5 Determination of IgM and IgG concentrations in serum 
fractions
Radial immunodiffusion is one of the simplest gel 
precipitation methods for quantitative assessment of protein 
concentration is (see Thompson, 1977). The gels used were 1mm 
thick' and contained a standard concentration of antibody (anti- 
IgM or anti-IgG) in 1% agarose buffered with barbitone buffer 
pH8.6 (1.1/5 barbituric acid, 7% Na barbitone, 1 % calcium 
lactate). The serum fractions were placed in wells 2cm apart and 
allowed to diffuse into the gel. The radial diffusion of antigen 
will continue while the antigen is in excess since soluble immune 
complexes are formed. When the concentration of antigen is
4
sufficiently reduced an antibody-antigen insoluble complex forms 
and precipitates. After washing the gels with PBS to remove 
soluble protein the ring of precipitate can be stained with 
protein stain (0.2% coomassie blue, 50% methanol, 7% glacial 
acetic acid) and its diameter measured. The size of the
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immunoprecipitation ring increases in proportion to the quantity 
of antigen present (Mancini et al, 1965). Thus by measuring the 
precipitate rings for reference dilutions of a standard serum a 
calibration curve can be obtained. ’
2:2:6 Cvanogen-Brotnide activation of Senharose t.
Using the method of Porath et al (1967), 12g of 
sepharose MB (Pharmacia) was washed with 2-3 volumes of distilled 
water, drained and suspended in 10ml of distilled water. This was 
added to 1.2g CNBr dissolved in 20ml distilled water. The pH of 
the suspension was brought to pH 11.3 with 2M NaOH and kept at 
this pH by the addition of 2M NaOH and continuous stirring until 
the mixture equilibrated. It was then poured into a column and 
washed several times with cold water and finally with 0.1 M 
NaHCO^.. Aliquots of the drained and activated sepharose were 
added to the anti-human immunoglobulins (Seward) and the 
mixtures stirred for 16 hours at room temperature. Unbound 
sites were blocked with 1M ethanol amine pH8 (Sigma) for 1-2 
hours.To remove non-covalently absorbed protein the 
antibody:sepharose was washed three times with 1M NaCl then 
finally washed with PBS until no more absorbance was detected in 
filtrates.
2:2:7 Iodination of Antibody
Purified immunoglobulins were iodinated using a 
modification of the method of Hunter & Greenwood (1962), in which 
the final concentration of chloramine-T and NaS20^ were 5ug/10ul 
and 12ug/10ul respectively. To 5ul of (20MBq) was added 10ul 
of 0.5M phosphate buffer to bring the pH of the mixture to pH
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7.5. To this was added 10ul of the immunoglobulin sample to be 
iodinated (1 mg/ml) and 10ul (0.5mg/ml) of chloramine-T. The 
mixture was left for 20 seconds then 10ul solution of NaS2 0 |j 
(1.2mg/ml) and 40ul of 0.12M KI in PBS was added to saturate the 
solution with cold iodine. The solution was separated into 
immunoglobulin bound and unbound by passing over a 
Sephadex G-25 column (Pharmacia), equilibrated using 1mg/ml BSA 
in PBS. Two peaks of activity were seen, the first is bound 
* ^ 1  and the second the free salt. The fractions of the 
first peak were pooled and again fractionated to remove any free 
125l remaining in the bound ^5x peak. The second fractionation 
column was either sepharose CL-6B or sephadex G-200 (Pharmacia) 
depending on whether or 2^5j_igQ was to be fractionated.
Fractions which gave the highest specific binding to their 
respective anti-HuIg sepharose were used in the 
radioirununoassays.
? ; ? : 8 '  Radioirmtunoassav
Serum antibodies, IgM and IgG, were assayed indirectly 
by competition with ^I-Hulg for binding to anti-HuIg sepharose 
conjugate in 1mg/ml BSA in PBS. Aliquots (20ul) of each dilution 
were added to 50ul of anti-HuIg sepharose. To this was added 20ul 
of 2^5];_HUig (5000 cpm). This was shaken overnight at room 
temperature and the unbound **25l-HuIg supernatant was removed
4
after centrifugation at 4000g for 15 minutes. The sepharose was 
washed 3 times with 2ml PBS and recentrifuged (4000g 15 minutes). 
The sepharose bound fraction of **25j_HuIg was counted on an LKB 
minigamma counter.
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2:2:9 Removal of IgM and IgG from maternal and control sera
After adsorption with FRBC several maternal and control 
sera were adsorbed overnight with an excess amount of anti-HuIg 
sepharose, specific for either* human IgG or IgM. After 
centrifugation, at MOOOg for 15 minutes, the supernatants were 
assayed for the presence of agglutinins with the passive 
haemagglutination assay. The supernatants were also assayed for 
the presence of residual IgM or IgG using radial immunodiffusion 
plates and radioimmunoassays.
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2:3 RESULTS
2:3:1 Optimisation of £&e sensitivity of tiie passive 
haemagglutination assay
The sensitivity of targets is affected by the method of 
tanning the FRBC (Herbert 1978). Placental microvillous targets 
differing only in their tanning procedures were tested using 
antisera against the microvillous protein. The results (table
2.1) show that maximum sensitivity was achieved by tanning the 
cells in a 25% (v/v) solution of FRBC using 0.3-0.4 mg/ml tannic 
acid. Since the stabilising protein used may also affect the 
sensitivity of the assay, different proteins (FCS, BSA and NRS) 
were assayed to find optimal concentrations to stabilize target 
cells. The results (table 2.2) show that all three sources of 
proteins can stabilize targets. Although BSA increased the titre 
of the assay 10-fold compared with FCS, the increase in 
agglutinin titre for term maternal sera was accompanied by an 
increase in control sera agglutination. Thus the difference in 
titre between maternal and control sera was not greatly increased 
by the use of BSA for stabilisation in place of FCS. NRS was 
found to be unsatisfactory for use as a stabilizer as there was 
difficulty in determining the agglutiij'end point when titering 
maternal and control sera.
4
2:3:2 Titres in maternal sera
Maternal and control sera were assayed against four 
different placental microvillous targets (T10-T13). The results 
(table 2.3) show that the maternal sera have consistantly higher 
agglutinin titres than the control sera. Maternal and control
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TABLE 2.1
Target
number
% FRBC Tannic acid 
mg/ml
Agglutinin titres * 
log2
1 25% 0 .1 19
2 25% 0 .2 18
3 25% 0.3 20
4 25% 0.4 20
5 25% 0.5 16
6 5% 0 .1 16
* The agglutinin titres are minus the background titre. The mean 
background titre was 8 with a range of 7 -9
Table 2.1: Placental microvillous protein targets differing only 
in their tanning procedure were tested for their agglutibility 
using rabbit antisera against placental microvillous protein. The 
sensitivity of the targets as shown by the agglutinin titres is 
effected by the different tanning procedures.
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TABLE 2.2
percentage number A g g lu t in in , t i t r e s  log  2
S ta b ilis in g  p ro te in  to  s ta b i l iz e  o f expts m aternal term sera human male sera
p r o te in 1% t a r g e ts mean range mean range
FCS 1.5% 7 8 6-10 4 3-5
BSA 0.2% 7 10 8-13 5 4-6
NRS* 3.0% - _ _ - -
Table 2.2: Different proteins were assayed to find the optimal 
percentage of each protein needed to stabilise the targets. The 
effect of the different protein stabilisers on the agglutinin 
titres for term maternal and male sera is shown. The mean and 
range of agglutinin titres for both term maternal and male sera - 
differed depending on the stabilizer protein used.
* NRS this protein though capable of stabilizing the targets was 
found to be unsatisfactory as difficulty in determining 
agglutinin end-points was experienced.
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TABLE 2.3
Targets
Agglutinin
T10
titres
T11
Log2
T12 T13
maternal 40136 6 6 7 7
serun
ti 40147 7 7 8 7
u 40754 8 8 8 7
ii 36350 7 7 8 7
ti 22525 7 7 7 7
it 28572 7 7 7 7
ii 40250 8 8 7 6
male A 4 5 3 3
serun
it B 3 3 3 3
it C 4 4 4 3
ii D 4 4 4 4
ti E 4 4/5 3 3
ii F 3 3 3 3
ti G 4 6 5 3
Table 2.3: Agglutinin titres of maternal term and human male, 
control, sera assayed using four placental microvillous membrane 
protein targets; the stabilising protein being \% FCS.
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sera had similar background titres of agglutinins against control 
targets coated with human serum albumin. The agglutinin titre of 
each maternal serum was assayed against placental microvillous 
membrane samples from the same pregnancy and from different
pregnancies. The results (table 2.4) showed that the agglutinin
(
titres were independent of the relationship between individual 
sera and the samples of placental microvillous membrane.
Adsorption of maternal sera with an excess of packed 
paternal or fetal RBC and paternal white blood cells was 
ineffective in adsorbing out the agglutination activity of 
maternal sera tested (table 2.5).
2:3:3 Partial characterisation q£ the ggg3tutjnjns
The passive haemagglutination assay was used to compare 
the agglutinin titres of maternal sera euglobulin precipitates 
and their supernatants (table 2.6). The majority of the 
agglutinins and the serum IgM were present in the euglobulin 
fraction. Three of the four sera tested showed no detectable 
agglutinins or IgM in the supernatant.
Gel filtration on AcA 34 showed that the maternal serum 
fractions with maximum agglutinin titre (15—18ml; figure 2.1) 
correlated with the peak of IgM concentration (12-20 ml; figure 
1). The actual agglutinin peaks differed for individual maternal 
sera when assayed with different placental microvillous targets
4
(TI1—TI3; figure 2.1). Comparing the fractionated term maternal 
and control sera showed that, though control agglutinins appeared 
in the same range of fractions, there was a considerably higher 
titre of agglutinins present in the term maternal sera (figure 
2.1).
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TABLE 2.4
Agglutinin titres log2
Targets T2 T3 T4 T6 T8
Maternal 2 IQ 9 9 8 8/9
serum
tt 3 9 10 9 8 9/10
ii 4 9 10/11 8/9 8 10
it 6 9 9/10 7 7/8 8/9
it 8 9/10 10 9/10 8/9 10
control titre: mean=5, range=4-6
Table 2.4: The agglutinin titre of maternal sera assayed ,in 
duplicate, with targets made from placental samples from the same 
source (underlined) were compared with the agglutinin titres of 
the same sera assayed with targets made from placental samples 
from different sources. The protein stabiliser used was \% FCS.
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TABLE 2.5
AGGLUTININ TITRES LOG
CONTROL SERUM
Blood
mother
groups 
baby father
Adsorbtion:
Targets: T11
None
T12 T15
Paternal 
Til T12
RBC
T15 T11
Fetal
T12
RBC
T15
Paternal 
T11 T12
tec
T15
Maternal 28572 A+ A- 04- 7/8 8 8 7 6 6 4/5 5/6 4 7 8 8
aerun
■ 40353 0+ A+ A4- 7 6/7 8/9 5 4/5 5 5 5 5 7 6 8
■ 40142 A+ 0+ 0- 8 6 7 6 6 6 5/6 4 6/7 7 5/6 7
■ 40250 0+ 0+ O- 8 8 9 7 7 7/8 7 6/7 7/8 8 8 8
. « 40014 Ch- Ch- 04- 7 6 7 6 6 6/7 6/7 5/6 6 7 6 7
» 40754 04- 0+ B+ 9 8 8 8 7 7 6 6/7 6 8 8 8
• 40136 0+ 04- 04- 8 7 8 7/8 7 7 NT NT NT 8 7 7
■ 40147 B+ ' 04- A+ 8 8 9 7 6 6 7 6 6 7/8 7 7/8
3
2/3
Table 2.5: The agglutinin titres of term maternal sera were 
assayed in duplicate with three different targets after adsorbing 
the sera with paternal and fetal red blood cells. Details of ABO 
and Rh-D blood groups for the maternal, paternal and fetal groups 
are also shown.
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TABLE 2.6
Maternal
Sera
serum
fractions
Agglutinin titres Logo
using targets ~ IgM
T12 T13 mg/1
40250
40136
40147
40148
Euglbn
Supnt
Euglbn
Supnt
Euglbn
Supnt
Euglbn
Supnt
6
2
6
<1
6
<1
4
<1
4
2
4
<1
6
<1
6
<1
1000
117
880
78
880
39
660
23
CONTROL Euglbn
Supnt
ND
ND
Table 2.6: The agglutinin titres of term maternal sera were 
assayed using two different targets after the sera had been 
fractionated by euglobulin precipitation into supernatant and 
euglobulin fractions. Both fractions were assayed for IgM 
concentration using radial immunodiffusion. The assay was 
calibrated with standard human serum (Seward).
ND= Not determined
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Figure 2.1: Gel fractionation on AcA 34 shows that the serum - 
fractions with the maximum agglutinin titres for both term 
maternal and control sera appear in the first peak of the serum 
proteins (12-20 ml). The serum fractions showing maximum IgM 
activity are 14-19 ml whereas IgG appears in serum fractions 22- 
28 ml.
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In a further experiment to characterize the agglutinins 
serum agglutinin titres were determined after IgM or IgG had been 
removed from the sera by adsorption with sepharose coupled with 
anti-human IgM or anti-human IgG. Maternal sera adsorbed with 
unconjugated sepharose was used as a absorption control. The 
efficiency of antiboby adsorption was determined indirectly by a 
radioimmuno-competition assay. The results of figures 2.2a & 2.2b 
show that after adsorption with anti-HuIg sepharose the levels of 
antibody remaining were below the detection level of the assay as 
no competition for the binding of was detected. Thus less
than 0.5mg/l of IgM remained after adsorption with anti-IgM 
sepharose (figure 2.2a) and less than 2.5mg/l of IgG after 
adsorption with anti-IgG sepharose (figure 2.2b). Sera adsorbed 
with unconjugated sepharose displayed the same competition 
profile as unabsorbed sera (figures 2.2a&b). Quantitative results 
were obtained by radial immunodiffusion. When compared with sera 
adsorbed with unconjugated sepharose a 6000 fold reduction of 
both IgM and IgG concentrations was seen after adsorption with 
anti-IgHu sepharose (tables 2.7 & 2.8). The results tables 2.7 & 
2.8 also show that no significant difference was seen between the 
agglutinin titres for maternal sera after adsorption with anti- 
IgM sepharose or anti-IgG sepharose when compared with the 
agglutintin titres of sera adsorbed with control sepharose. Thus 
as the maternal sera agglutinin titre remains after the 
successful removal of IgM or IgG from the maternal sera the 
agglutinin seen is not an antibody of the IgM or IgG class.
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Figure 2.2: This shows the percentage bound ^5i_HuIg when in 
competition with maternal sera for binding to anti-HuIg 
sepharose.
a. Shows the mean and range percentage bound to anti-
IgM sepharose (listed in table 6) before and after adsorption 
with either anti-IgM sepharose or unconjugated sepharose. The 4 
sensitivity of this competition assay, was 0.5mg/l of IgM.
b. Shows the mean and range percentage bound 125i_igG to anti- 
IgG sepharose (listed in table 7) before and after adsorption 
with either anti-IgG sepharose or unconjugated sepharose. The 
sensitivity of this competition assay was 2.5mg/l of IgG.
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TABLE 2.7
Agglutinin titres logo 
Maternal adsorption TARGETS IgM
serun treatment T5 T7 T9 mg/1
40014 untreated ND ND ND
control seph. 8 8 8 660
anti-IgM seph. 10 10 11 0.07
40148 untreated ND ND ND
control seph. 8 9 8 880
anti-IgM seph. 8 9 8 0.18
40142 untreated ND ND ND
control seph. 8 9 8 880
anti-IgM seph. 8 9 8 0.09
40163 untreated 11 12 10
control seph. 11 12 11 1170
anti-IgM seph. 11 11 12 0.23
22525 untreated 11 12 10
control seph. 10 11 12 1170
anti-IgM seph. 11 12 12 0.12
28572 untreated 11 10 12
control seph. 11 12 11 880
anti-IgM seph. 11 11 12 0.18
29605 untreated 12 12 13
control seph. 11 11 12 880
anti-IgM seph. 11 11 13 0.18
control untreated 6 6 5/6
serun control seph. 5 5 6 1170
anti-IgM seph. 5 6 6 0.10
Table 2.7: The agglutinin titres and IgM .concentration of
maternal sera, after adsorption with either anti-IgM sepharose or 
control sepharose were assayed. The stabilising protein used in - 
the agglutinin assays was 0.2$ BSA.
ND= Not determined
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TABLE 2.8
Agglutinin titres logo
Maternal adsorption TARGETS IgG
serun treatment T10 T12 T13 mg/1
401.00 untreated 12 11 10
control seph. 8 7 7 7120
anti-IgH seph. 8 7 7 0.7
30686 untreated 10 9 9
control seph. 8 8 8 7120
anti-IgG seph. 8 8 . 8 1.4
40142 untreated 9 9 9
control seph. 8 8 8 6000
anti-IgG seph. 8 8 8 1.2
40014 untreated 7 7 7
control seph. 7 7 7 6000
anti-IgG seph. 7 7 7 1.2
40148 untreated ND 10 9
control seph. 8 9 8 10000
anti-IgG seph 8 9 8 2.0
control untreated 5 5 5
serum control seph. 4 4 4 8500
anti-IgG seph. 4 4 4 1.6
Table 2.8: The agglutinin titres and IgG concentrations of
maternal sera after adsorption with either anti-IgG sepharose or
control sepharose. The stabilising protein used in the
agglutination assay was 0.2% BSA. 
ND= Not determined
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2:4 DISCUSSION
Using the passive haemagglutination assay, agglutinins 
against plasma membrane proteins' of the syncytiotrophoblast 
microvilli were detected in term maternal sera at agglutinin 
titres above those of non-pregnant control sera (table 2.3). In 
an attempt to characterise the agglutinins term maternal and 
control sera were fractionated on an AcA 34 column, the 
agglutinins of both the maternal and control sera were found to 
elute, together with IgM, in the macroglobulin fraction of serum 
having a molecular weight greater than 350 000 dal tons (figure
2.1). The agglutinins were also found to precipitate in 
euglobulin precipitation experiments which precipitated IgM 
(table 2.6). As the agglutinins co-elute and precipitate in the 
IgM fraction of serum it was thought that they were IgM, though 
an IgG antibody:antigen complexes could also have mw of greater 
than 350Kd. Thus the agglutinins were tested to see whether they 
could be adsorbed with anti-IgM or anti-IgG (figures 2.2a&b). The 
term maternal sera showed the same agglutinin titres after 
either adsorption with anti-IgM sepharose, anti-IgG sepharose or 
unconjugated sepharose. Since the anti-globulin sepharoses were 
very effective at specificly adsorbing either IgM or IgG, these 
results indicate that the maternal agglutinins are not an 
antibody of either the IgM or IgG class.
4
This study indicates that the agglutinin response seen 
in term maternal sera is not an antibody response against plasma 
membrane proteins of human syncy tiotrophoblast microvilli. It can 
be speculated that the agglutinins seen in term maternal sera may 
be increased levels, due to pregnancy, of agglutinins found in
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all sera. The control sera agglutinins properties parallel those 
of maternal agglutinins, the agglutinins appearing in the same 
serum fractions, after gel fractionation and are shown to be 
components of euglobulin precipitates. The origin and nature of 
this agglutinin response in term maternal sera to the 
syncytiotrophoblast microvilli is unclear but the agglutinin has 
no specificity for individual placenta since sera show similar 
agglutinin titres against different preparations of placental 
microvillous membranes.
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CHAPTER 3
PREPARATION AND ANALYSIS OF mRNA FROM 
SYNCYTIOTROPHOBLAST AND CYTOTROPHOBLAST TISSUE
3:1 INTRODUCTION
The aim of the work described in this chapter was to 
prepare and analyse placental mRNA populations. This was an 
essential step before cDNA could be made or cloned (chapter 4). 
The guanidinium thiocyanate method of Chirgwin .§1 a! (1979) was 
used to isolate RNA from the placental cytotrophoblast or 
syncy tiotrophoblast tissue. The mRNA preparations were assayed 
for protein synthesis by in vitro translation using rabbit 
reticulocyte lysate and the translate visualised on SDS-PAGE 
gels.
As PLAP can be purified from placental microvilli in mg 
amounts it was hoped that its mRNA would be detectable in the 
placental syncytiotrophoblast mRNA. Thus the detection and 
specific immunoprecipitation of PLAP and other placental proteins 
from the in vitro translated polypeptides of syncytiotrophoblast 
mRNA was attemped with both polyclonal and monoclonal anti-PLAP 
sera.' The in vitro translation of syncytiotrophoblast and 
cy totrophoblast mRNA populations enabled a comparison to be made 
between the placental polypeptides synthesised by both. This was 
of some significance since it has emerged that the monoclonal 
antibody H315 which stains both syncy tiotrophoblast and 
cytotrophoblast tissue is directed against PLAP (P.M. Johnson 
personal communication). Thus PLAP may also be detected in 
cytotrophoblast mRNA in vitro translated polypeptides.
The cytotrophoblast mRNA was prepared from the chorionic 
plate of the placenta. This cytotrophoblast has been shown by 
immunohistology to express HLA class I determinants and it was 
hoped that mRNA for these determinants would be detected
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As well as the in vitro translation of mRNA populations 
DNA probes were also used to screen the placental mRNA by dot 
hybridisation. As part of the amino acid sequence of PLAP is 
known, oligonucleotide sequences of PLAP could be deduced. The 
chemically synthesised PLAP oligonucleotides were used to screen 
placental syncytiotrophoblast and cytotrophoblast mRNA in search 
of PLAP mRNA. As a control, for the specificity of the PLAP 
oligonucleotide, an hPL oligonucleotide of the same length and a 
similar base composition was also used. The mRNA dot blots were 
also screened with a cDNA probe (pDP001) for the HLA class I 
sequences.
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3:2 MATERIALS and METHODS
3:2:1 Preparation of placental RNA
To minimise ribonuclease activity during the 
preparation of placental poly(A+) RNA, sterile disposable 
plastic-ware was used wherever possible as it is essentially free 
of ribonucleases (RNase). All solutions were prepared using 
chemicals reserved for work with RNA and were treated with 0.1% 
-diethylpyrocarbonate (DEPC Sigma) overnight and autoclaved. As 
DEPC is unstable in the presence of Tris buffers these solutions 
were just autoclaved.
Syncytiotrophoblast and cytotrophoblast RNA were 
extracted from human term placentae. Syncy tiotrophoblast RNA was 
also extracted from the placentae of premature births ( 3 0 weeks 
onwards) and from first trimester clinical abortions (10-14 
weeks). To protect the RNA from degradation by ribonucl eases a 
solution of guanidinium thiocyanate and 2 -mercaptoethanol was 
used (Chirgwin, et al 1979). The protocol used for the extraction 
of the RNA was an adaptation of the method of Fiddes & Goodman 
(1979). Fresh human placentae were washed in saline to remove 
blood. The syncytiotrophoblast tissue obtained from the 
microvillous membranes was cut into small pieces and RNA was 
either extracted immediately or the tissue was snap frozen for 
later use. Cytotrophoblast tissue was obtained from the chorionic
4
plate. This material was either snap frozen for later use or 
washed in trypsin for an hour to remove any contaminating 
material (Khalaf, 1985; Khalaf et al, 1985a&b). After the trypsin 
treatment the tissue was snap frozen. With the aid of a blender 
10g of fresh or snap frozen tissue was dissolved in 200ml of 4M
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guanidinium thiocyanate in 50mM Tris HC1 pH 7.5, 10mM EDTA , 5% 
2-mercaptoethanol. The solution was centrifuged at 10,000 rpm for 
10 minutes in a Beckman JA-14 rotor. The supernatant was adjusted 
to 2% sarcosyl then heated at 65°C for 5 minutes. After adding
0 .1g of caesium chloride per ml of the solution, it was layered 
over 5ml cushions of 5.7M caesium chloride in 10mM EDTA and 
centrifuged at 25 000 rpm for 16 hours at 20°C in a Beckman SW28 
rotor. The supernatant was removed by aspiration to leave the RNA 
pellet which was transferred into sterile plastic tubes and 
dissolved in 10mM Tris HC1 (pH 7.5), 1mM EDTA, 5% sarcosyl and 5% 
phenol. Then the RNA was extracted twice with an equal volume of 
phenol/chloroform and once with an equal volume of chloroform. 
The RNA was precipitated from the aqueous phase with two volumes 
of ethanol in the presence of 0.2M sodium acetate (pH 5.5) 
overnight at -20°C. After centrifugation the RNA pellet was 
washed in cold 95% ethanol and recentrifuged. The RNA pellet was 
then dried and dissolved in sterile DEPC-treated distilled water 
and stored at -70°C until needed.
3:2:2 Agarose Gel Electrophoresis
To determine the purity and quality of the placental RNA
0 .1 -1 .0 ug samples were diluted to 2 0 ul in the final sample 
buffer, FSB (5xFSB=0.25% bromphenol blue, 0.25% xylene cyanol, 
30% glycerol in H2 O) and electrophoresed through a 1 .2 % agarose
4
gel in TBE buffer (89mH Tris, 89mM boric acid, 2mM EDTA) at 50mA 
for 1 hour. After staining the gel for 30 minutes with the 
fluorescent intercalating dye ethidium bromide the gel could be 
examined in ultraviolet light. RNA of a high quality and purity 
shows three distinct ribosomal bands.
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3:2:3 Quantitating the RNA
To determine the amount of RNA in a preparation which 
was without significant amounts of contaminants, as determined by 
agarose gel electrophoresis, spectrophotometric measurement of 
the amount of UV irradiation absorbed by the bases was 
quantified. Readings are taken at 260nm and 280nm. From the 2 6 0 nm 
reading the amount of RNA in the sample can be calculated as an 
OD2 6 0  1 corresponds to 40ug/ml of RNA. Pure preparations of
RNA have OD2 6 0 /OD2 8 0  protein or phenol contamination
reduce this value.
3:2:4 Preparation of polvadenvlated RNA from total placental RNA
Chromatography on oligo (dT) cellulose (Aviv & Leder, 
1972) was the method used to separate the polyadenylated RNA 
[p}oly (A+) RNA] from the total RNAs. A small volume of oligo (dT) 
cellulose (BRL) was equilibrated in sterile RNase-free high salt 
buffer (0.5mM KC1, 20mM Tris HC1 pH 7.5, 1mM EDTA). A 1ml column 
was poured into a plastic pipette plugged with non-absorbent 
DEPC-treated cotton wool. The column was washed with 5 volumes of 
high salt buffer. After adjusting the RNA sample to 1mM EDTA it 
was heated to 65°C for 5 minutes, cooled, and adjusted to 0 .5 M 
KCl. The RNA sample was then diluted to at least 10 times the 
column volume with high salt buffer and applied to the column. 
The flow-through was collected and reapplied to the column. After
4
binding the RNA the column was washed with several column 
volumes of high salt buffer to remove the bound poly(A”) RNA. To 
elute the poly(A+) RNA the column was washed with sterile DEPC- 
treated distilled water. The eluted poly(A+) RNA was adjusted to 
1mM EDTA, heated to 65°C for 5 minutes, cooled, adjusted to 0.5M
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KC1, diluted with high salt buffer and reapplied to the column 
for one further cycle of chromatography. The peak poly (A+) RNA 
fractions were precipitated in 2 volumes of ethanol in the 
presence of 0.2M sodium acetate -at -20°C overnight. After 
centrifugation in a microfuge for 15 minutes the poly (A+) RNA 
pellet was washed in 95? ethanol and recentrifuged. The resultant 
pellet was dried and then dissolved in sterile RNase-free water 
and stored at -70°C.
3:2:5 In vitro translation of placental RNA
Placental RNA samples were translated in the presence of 
35s-methionine (NEN) using a rabbit reticulocyte lysate cell free 
system (Amersham International pic.). RNA translation was carried 
out in a mixture containing 8 0 ? (v/v) lysate with 35g_ 
methionine to give a final concentration of 1uCi/ul. The samples 
were incubated at 30°C for 90 minutes. An equal volume of a 
RNase solution (RNase 2.5ug/ml, 40mM EDTA, 1? methionine) was 
then added and the samples incubated for a further 15 minutes. 
The samples were assayed for the incorporation of 35s-methionine 
into synthesised protein products by TCA-precipitation and SDS- 
PA3E gels.
3:2:6 Analysis of translational protein products using fCA 
precipitation
The percentage incorporation of 35s-methionine into the 
translational products was assayed by TCA-precipitation. Samples 
of the cell free translation mix were spotted onto filter discs 
and dried. The discs were washed 3 times with ice cold 10? TCA to 
precipitate protein and hence the incorporated 35s-methionine.
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The discs were then washed in methanol, dried and counted using
liquid scintillation.. Duplicate sample discs, which had not been 
at
TCA precipit^ed, and blank discs were counted to get the total 
reaction counts (35s-methionine present in the translation mix) 
and the radioactive background counts.
3:2:7 Analysing translational protein products using Sodium 
Dodecylsulphatg Polyacrylamide Electrophoresis (SDS-PAGE)
The 35S labelled translational protein products were 
resolved on either 9% or 5—15% SDS-PAGE gels, table 3.1 (Laemmli, 
1970). To the translation samples was added 25ul SDS-PASE sample 
buffer (30% glycerol, 6 % SDS, 15% 2-mercaptoethanol, 150mM Tris 
HC1 pH 6.7, 0.05% bromophenol blue). The samples were boiled for 
2 minutes and loaded on SDS-PAGE gels. The gels (15x20x0.2cm) 
were electrophoresed at 40mA for 4 hours then soaked for 1 hour 
in 1 0 % acetic acid/5 0 % methanol to precipitate and fix the 
proteins in the gel. After fixing, gels were washed in 7% acetic 
acid then enhanced for autoradiography by soaking for 1 hour in 
ENHANCE (NEN). Following impregnation of the enhancing solution, 
the fluorescent material in the gel was precipitated by washing 
the gel in tap water for 1 hour. The gel was then dried, under 
vacuum, on Whatman 3MM paper and exposed on X-ray film (Kodak X- 
Omat S) and developed, using Kodak developing fluids.
4
3:2:8 Immun.QBr.€cipitatipn As?ay
The immunoprecipitation of lysate translated proteins 
was carried out using the procedure of Kraus et.il (1981 & 1982). 
Firstly, the translated protein sample was diluted to 200ul with 
buffer A (150mM NaCl, 1 0mM EDTA, 0.5% Triton X-100, 2% methionine
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RESOLVING GEL
a
9%
b
5% 15%
Acrylamide:bis (30:0.8) 1 0 .5 ml 3 .0 ml 9 .0 ml
Resolving buffer 
I8.15g Tris] to 1 0 0ml 
0.4g SDS ] H20 pH 8.9
9 .0 ml . 4.5ml 4.5ml
Distilled H20 16.2ml 1 0 .5 ml -
50% Glycerol - — 4.35ml
1055 Ammonium Persulphate 225ul 150ul 75ul
TEMED 15ul 15ul 15ul
STACKING GEL 4.5%
Acrylamide:bis (30:0.8) 1 .8 ml
stacking buffer 
5.9g Tris ] to 100ml 
0.4g SDS ] H20 pH 6.7
3 .0 ml
Distilled H20 7 .2 ml
1055 Ammonium Persulphate loom
TEMED 1 0ul
Running buffer/litre i- 6.3g Tris
4.0g Glycine 
1.0g SDS
Table 3.1: Solutions used in the preparation of (a) 9% and
(b) 5-1555 sodium dodecylsulphate polyacylamide gels.
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pH7) and incubated at RT for 30 minutes with 3-5ul of normal 
rabbit serum. This step removed non-specific antigen complexes. 
After incubation 30ul of 10# (w/v) formalin fixed Staph A cells 
(BRL) washed and resuspended in buffer A were added and incubated 
for a further 10 minutes. The sample was centrifuged and the 
supernatant added to 5 -1 Oul of rabbit antisera which were 
specific for human placental proteins. (DAKO & Seward). After 
incubating at RT for 30 minutes the sample was diluted to 1ml 
with buffer A, adjusted to 0.1# SDS and incubated at 4°C 
overnight.
To precipitate the antibody-antigen complex 50ul of 10#
(w/v) formalin fixed Staph A cells washed and resuspended in
buffer A were added and the mix incubated at 4°C for 15 minutes,
then another 50ul of 10# (w/v) formalin fixed Staph A cells were
added and the mix incubated for a further 15 minutes. After
centrifuging the cell pellet was washed 3 times with 500ul of
buffer B (150mM NaCl, 1# Na deoxycholate, 1# Triton X-100, 0.1#
SDS, 10mM Tris HC1 pH 7.2).The final pellet was resuspended in
50ul of SDS-PAGE gel sample buffer (6 # SDS, 15# B-
mercaptoethanol, 30# glycerol, 150mM Tris HC1 pH 6.7), and heated
at 100°C for 2 minutes. After centrifugation the supernatant was
ak
analysed on 9# SDS-PAGE gels for the immunoprecipitpd proteins.
3:2:9 Con)pe.fcit4pn essay test specificity jpf precipitated 
polypeptides.
The specificity of the polypeptides precipitated by the 
anti-PLAP sera was demonstrated by competition for 
immunoprecipitation using PLAP protein extracted from term 
placenta (prepared in this laboratory) and commercially obtained
78
PLAP (Sigma). To the lysate translated protein samples uwk added 
log«|Q dilutions of PLAP protein in Buffer A. The samples were 
then diluted to 200ul with Buffer A and the immunoprecipitation 
assay continued as* normal.
3:2:10 Synthetic oligonucliotides
Three synthetic oligonucleotides each 14 bases long were 
obtained from Pfizer Central Research: 
hPL 5'-TTTCCTCCATGTTG-3'
PLAP-1 5' -TCqTTCCAq AMTC-3'
PLAP- 2 5' -TC^TTCCA^MGTC-B'
The purity of these olignucleotides was assessed by gel 
electrophoresis. The oligonucleotide for hPL was also sequenced 
at Pfizer to verify its base composition. For the mixed PLAP 
probes the percentage of each probe was assessed by using 
different butyl groups for each base:
PLAP-1 a 5'-TCATTCCAAAAATC-3' 22%
PLAP-1 b 5'-TCGTTCCAGAAATC-3' 28%
PLAP-1c 5'-T0GTTCCAAAAATC-3' 25%
PLAP-1d 5'-TCATTCCAG AAATC-3' 25%
PLAP-2a 5' -TCATTCCAAAAGTC-3' 22%
PLAP-2b 5'-TOGTTCCAGAAGTC-3' 28%
PLAP-2C 5' -T0GTTCCAAAAGTC-3' 25%
PLAP-2d 5'-TCATTCCAG AAGTC-3' 25%
3:2:11 Labeling Oligonucleotides
The oligonucleotides were labelled with T4 
polynucleotide kinase (Maniatis et al, 1982). In a total volume 
of 20ul 1x kinase buffer (5x kinase buffer 0.5M Tris HC1 pH 7.6,
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0.1 M MgC]^ , 1mM EDTA, 50mM dithiothreitol, 1mM spermidine) 40ng 
of the oligonucleotide were phosphorylated with 5 units of T4 
kinase (BRL) and 50uCi of [X^P]ATP (specific activity= 
7000Ci/mMole). This mix was incubated at 37°C for 30 minutes 
then the reaction stopped using 2ul of 0.5mM EDTA. After 
adjusting the volume to 100ul with TE the labelled DNA was 
separated from the unincorporated [X?2 P]ATP by chromatography on 
a Sephadex G25 column (8 cmx0 .5 cm).
3:2:12 Northern blotting using 1*Uner oligonucleotides as probes
Under high salt conditions denatured poly (A+) and 
ribosomal RNA transfer efficiently to nitrocellulose filters. To 
remove salt and other contaminants from the RNA (10ug/track) it 
was extracted with phenol/CHCl^. The aqueous phase was 
precipitated in two volumes of ethanol at -20°C. After 
centrifugation in a microfuge for 15 minutes the RNA precipitate 
was washed with ice-cold 95% ethanol and recentrifuged. The RNA 
was then denatured with 2 0 ul freshly made glyoxal mix (1 5 % 
deionised glyoxal [pH>6 ], 50% dimethylsulphoxide, 10mM sodium 
phosphate buffer, pH 7) at 50°C for 1 hour. The mix was cooled on 
ice and 5 ul of sample buffer (0 .0 2 % bromophenol blue in 50% [v/v] 
glycerol) was added. The samples were electrophoresed overnight 
at 30V on a 1.5% agarose horizontal gel (size) using 10 mM 
phosphate buffer (pH 6 .8-7.0) as the running buffer, the buffer 
recirculating to maintain the pH. TVjo extra lanes were run on the 
gel over and above those needed for the blot; one of non­
denatured RNA and the other of glyoxal denatured RNA. These two 
lanes were stained with acridine orange (30ug/ml) to check that 
the RNA had been denatured and not degraded. The rest of the gel
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was blotted by placing on a sheet of Whatman 3MM paper saturated 
with 20xSSC OxSSC: 0.15NaCl,15mM Na citrate) from a reservoir. A 
nitrocellulose filter (Schleicher & Schuell) cut to the same size 
as the gel and with the positions of the the gel lanes marked 
with biro was soaked in distilled H2 O, then in 20xSSC and laid 
over the gel. Sheets of Whatman 3MM paper followed by paper 
towels were laid over the filter ensuring that the only contact 
between the 20xSSC reservoir and the paper towels above the gel 
was through the gel. The transfer of RNA from the gel to the 
nitrocellulose was complete after blotting overnight (Thomas, 
1980). The nitrocellulose was then removed from the gel and baked 
at 80°C for 3 hours. The filter can now be probed using specific 
DNA sequences (McMasters & Carmichael, 1977 and Thomas, 1980). 
The filter was soaked in 6xSSC, then sealed in a bag with
0.5ml/cm^ of prehybridisation solution (6xSSC,10x Denhardt's 
buffer, 0.2$ SDS, 0.25mg/ml sperm DNA) at 65°C for 1hour and 20°C 
overnight. The filter was washed in 6xSSC for 2 minutes then 
sealed in a bag containing the hybridisation solution (6xSSC, 10x 
Denhardt's buffer, [X^P]-labelled probe 5x10^ cpm (Cherenkov) 
per filter) and hybridized overnight at 20°C. After hybridization 
the filter was washed in 6xSSC at RT for 5 minutes then at 
several intermediate temperatures until the dissociation 
temperature (Tp) of the probe was reached. To estimate Tp for 
the oligonucleotide probe the equation Tp= 2°C per dA.dT and 4°C
4
per dG.dC nucleotide pair was used, shown in table 1.3. (Suggs 
et jal, 1981). The filter was then autoradiographed using Kodak X- 
Omat S film.
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3:2:13 Dot hybridisation
Instead of running the RNA on denaturing gels then 
transferring to nitrocellulose filters by northern blotting the 
denatured RNA samples were diluted in 15xSSC and spotted onto dry 
filters. Both denatured cytotrophoblast RNA samples from term 
placentae and syncytiotrophoblast RNA samples from various stages 
of gestation were diluted and spotted onto dry filters. After air 
drying for 30 minutes the filters were baked at 80°C for 3 hours. 
They were probed with PLAP or hPL 32 p 5 ' encj labelled 14 base 
oligonucleotides using the prehybridisation, hybridisation and 
washing conditions described for the northern blots. The MHC 
class I DNA probe, pDP001, was also used to probe the dot 
filters. Here the filters were hybridised overnight at 65°C with 
5x10^ cpm (Cherenkov) per filter. The filters were washed at 65°C 
under various salt concentrations 5xSSC to O.IxSSC. ’
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3:3 RESULTS
3:3:1 Agarose Gel Electrophoresis of RNA
1.2$ agarose gels were run to determine the purity of 
the placental RNA. Distinct ribosomal RNA bands (28S, 18S & 5S), 
with a background smear of heterogeneous mRNA, suggested that the 
mRNA sample was undegraded. Comparison of "good" and "poor" RNA 
preparations as determined by RNA agarose gels with the in vitro 
translation of polypeptides showed that no high molecular weight 
polypeptides were synthesised using RNA shown to be degraded on 
agarose gels (figure 3.3).
3:3:2 Optimisation of In vitro translation of placental RNA
Several concentrations of total RNA and poly(A+) RNA, 
purified from the syncy tiotrophoblast, were used to optimise the 
translation of mRNA. The translation was assessed, using TCA 
precipitation, by the incorporation of 35s_methionine into 
translated polypeptides. Figure 3.1 shows that the addition of 
increasing amounts of both total and poly(A+) RNA to the in vitro 
translation mix resulted in a biphasic rise of^^S-methionine 
incorporation. For poly(A+) RNA this terminated in a plateau with 
the maximal incorporation at RNA levels greater than 25ng. The 
maximal incorporation for total RNA was observed with 900ng of 
RNA. The translation of greater concentrations of total RNA
4
resulted in a decrease in polypeptide synthesis. Thus 36 times 
less poly(A+) RNA than total RNA is needed to saturate the 
system (figure 3.1). This is as expected since only 1-5$ of 
total cellular RNA from eukaryotic cells is message.
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Figure 3.1: The optimum RNA concentrations necessary for in vitro 
translations was assayed by the TCA precipitable incorporation of 
35s-methionine into the synthesised polypeptides.
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The RNA optima were also seen with gel electrophoresis 
of the translated polypeptides. Figures 3.2a & 3.2b show that 
that the number of polypeptide bands visible increased with 
increased RNA concentration until saturation of the system with 
RNA. In figure 3.2a track 4 (30ng total RNA) and figure 3.2b 
track 3 (0.78ng poly(A+)) the only placental translated 
polypeptide visible was of mw 24Kd. This polypeptide was shown by 
immunoprecipitation to be pre-hPL and represents 15-20% of the 
translated polypeptides of syncytiotrophoblastic RNA (results 
shown in the next section). The band of mw 48Kd was endogenous 
to the lysate system and seen in the absence of RNA. A gradual 
increase of protein synthesis which duplicates the TCA 
precipitation results (figure 3.1) is seen in figure 3.2a tracks 
5-8 (60-450ng total RNA) and figure 3.2b tracks 4-7 (1.5-12.5ng 
poly(A+)).
The maximal protein synthesis using poly(A+) RNA was 
seen in figure 3.2b, tracks 8-10 (25-1 OOng). There was no 
significant difference in the intensity of the polypeptide bands 
in these tracks indicating a plateau of 35s-methionine 
incorporation due to the saturation of polypeptide production at 
concentrations of poly(A+) RNA greater than 25ng. For total RNA 
the greatest protein synthesis was seen with 0.9ug of RNA (figure 
3.2a, track 9). Figure 3.2a tracks 10-12 (3.6-7.2ug) show a 
decrease in translation though more was visible in track 11
4
(3.6ug) compared with tracks 10 & 12 (1.8-7.2ug). Even with this 
anomaly, a trend of decreased 35§ methionine incorporation was 
evident when more than 1ug of total cellular RNA was in vitro 
translated. This decrease may be due to the accumulation of 
translational inhibitors or just due the actual concentration of
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Figure 3.2: Autoradiograph of the 35s-labelled i_n vitro 
translated products of human placental RNA separated on 9% SDS- 
PAGE gels, (a) Several concentrations of total (unfractionated) 
syncytiotrophoblast RNA samples, (b) Several concentrations of 
poly (A+) syncytiotrophoblast RNA samples.
(a) 1. 
2.
Translation 
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positive control, using HSV-1 mRNA
3. Translation negative control, using HpO in place of RNA
4. Translation products obtained using 30ng total RNA
5. ii it it ii 60ng M 11
6. it ii ii it 120ng " 11
7. ii it ii it 240ng " 11
8. it ti ii it 480ng w ti
9. ii ii ii it 900ng " 11
10. ii ii n ii 1.8ug " 11
11. ii ti ii ii 3.6ug n 11
12. it it n ii 7.2ug « 11
(b) 1. Translation positive control, using HSV-1 mRNA
2. Translation negative control, using H2 O in place of RNA
3. Translation products obtained using 0.78ng total RNA
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ribosomal RNA present.
From these results the placental RNA concentration 
optima can be determined for the reticulocyte cell free 
translation system. The optimal concentration of poly (A+) RNA 
and total RNA was 2ng/1ul and 75ng/1ul of translation mix.
3:3:3 Analysis of £lacerjtal syncytio:fcrg£hoblast M A  
translational products
Before enrichment for poly(A+) RNA the quality, purity 
and ability to synthesise polypeptides was determined for total 
cellular RNA by RNA agarose gels, OD2 6 0 /OD2 8 0  ratios and in 
vitro translation. Figure 3.3 shows that RNA preparations which 
have degraded ribosomal bands have degraded mRNA which is only 
able to synthesise low molecular weight polypeptides. Thus RNA 
preparations where ribosomal RNA was shown to be very degraded 
were not enriched for poly(A+) RNA.
Figure 3.4 shows a comparison of polypeptides translated 
before (track 1) and after (track 2) enrichment for poly (A+) 
RNA. A more distinct protein profile was seen after poly (A+) 
enrichment. The protein profiles of tracks 1 and 2 (figure 3.4) 
indicate no loss of translated polypeptides after poly(A+) RNA 
selection. The RNA which did not bind to the oligo (dT) cellulose 
but eluted from the column in the high salt wash was able to 
synthesise translation proteins (track 5), which were comparable
4
to those synthesised by the unfractionated RNA (track 1). After 
the second cycle of chromatograpy the material eluted, from the 
oligo (dT) cellulose column, in the high salt wash was unable to 
synthesise polypeptides (track 6).
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Figure 3.3: Autoradiograph of the 35s_iabelled in vitro 
translated products of human placental RNA which were shown to 
have degraded ribosomal bands, using 1.2% agarose gels. The 
translational products were separated on a 5-15% SDS-PAGE gel.
1. Slightly degraded ribosomal RNA bands
2  # tt tt tt tt tt
3. Degraded ribosomal RNA bands
tt u n tt
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6. Very degraded ribosomal RNA bands
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Figure 3.4: Autoradiograph of 35s-labelled in vitro translated 
products of human placental RNA, separated on 5—15% SDS-PAGE gel. 
1ug of total RNA and 50ng of (polyA+) RNA were translated in a 
cell-free translation system in the presence of 35s-methionine. 
From 50g of placental syncytiotrophoblastic tissue 10ug of 
(polyA+) RNA could be extracted.
1. Total RNA translation products
2. Poly(A+) RNA translational products
3. mw markers
4. Translation system blank
5. Poly(A”) RNA translational products
6. Final high salt wash material
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The 35s label was incorporated into polypeptides which 
had molecular weights of up to 100Kd (figure 3.5a). The greatest 
proportion, 15—20%, was present in a 24kD band which was shown 
to be pre-hPL (results shown in the’next section). This profile 
of the synthesised polypeptides was seen using 12 different full- 
term and 5 different premature placental mRNA preparations. The 
translation of RNA from three first trimester placentae gave 
polypeptide profiles similar to those of term placentae, though 
the intensity of some of the bands differed (figure 3.5b). 
This may be due to actual differences between first trimester and 
term placentae or due to differences in the RNA extraction 
protocol. RNA from term was extracted either from 
syncytiotrophoblast or cytotrophoblast whereas due to the small 
size of first trimester placentae RNA was extracted from the 
total placentae.
3:3:4 Analysis of placental cytotrophoblast RNA translational 
products
Figure 3.6 shows that cytotrophoblast RNA and 
syncytiotrophoblast RNA have very similar polypeptide profiles. 
The major difference being the intensity of the 24kd, pre-hPL, 
band. The intensity of this band is greatly reduced in 
cytotrophoblast RNA preparations especially when the 
cytotrophoblast cells had been treated with trypsin to remove
4
contaminating cells before the RNA was extracted.
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Figure 3.5: Autoradiograph showing the polypeptide profile 
obtained after the in vitro translation of:
1. Full-term syncytotrophoblast mRNA sample
2. Premature syncytotrophoblast mRNA sample
3. First trimester mRNA sample
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Figure 3.6: Autoradiograph comparing the 35s_iabelled in 
synthesised polypeptide profiles of:
1. Full-term syncytotrophoblast mRNA sample
2. w cytotrophoblast mRNA sample
3. 11 trypsinised cytotrophoblast mRNA sample
vitro
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3:3:5 Analysis of immunprecipitated proteins
The proteins synthesised in the presence of placental 
RNA, using the lysate cell free system, were immunopreci pita ted 
with both polyclonal and monoclonal rabbit antisera specific for 
the placental proteins listed in table 3.1. Normal rabbit sera 
was used as the control negative serum.
The incorporation of 35s-rnethionine during the in vitro 
translation of both syncytiotrophoblast and cytotrophoblast mRNA 
was assayed by the measurement of the TCA precipitable counts in 
the immunoprecipitated proteins (figure 3.7). The results show 
that the two RNA samples contain different levels of placental 
proteins. The major polypeptide of syncytiotrophoblast was hPL; 
15-20% of the incorporated ^ S-methionine was precipitated with 
anti-hPL. Less than 1% of the synthesised polypeptides from 
trypsinised cytotrophoblast and 4.5-6% from non-trypsinised 
cytotrophoblast were precipitated with anti-hPL. Anti-FN and 
anti-^M precipitated 5% of cytotrophoblast RNA translated 
polypeptides but less than 0.1% of the syncytiotrophoblast RNA 
translated product. With anti-PLAP this was reversed. An average 
of 7% of the syncytiotrophoblast polypeptides were precipitated 
with polyclonal antisera for PLAP but with PLAP monoclonal 
antisera this percentage dropped (figure 3.7). From the 
cytotrophoblast RNA translation <0.1% of the polypeptides were 
precipitated with either monoclonal or polyclonal PLAP antisera.
4
The immunoprecipitated polypeptides were also analysed 
on SDS-PAGE gels. No polypeptide bands were visualised from 
immunoprecipitates which were less than 5% of the total 
synthesised polypeptides. Antisera specific for hPL precipitated 
a single protein band 24Kd, from syncytiotrophoblast RNA
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ANTISERA SPECIFICITY
anti-hPL hPL
anti-PLAP(DAKO) PLAP
anti-PLAP tt
TA 76 ti
TA 78 11
PIG 17 n
H17E2 it
anti-SP-j SP1
anti-hCG hCG
anti-PAPP-A
anti-cytker
ker//£8
7A11
Anti-FN
W6/32
B2 M
PAPP-A
cytokeratin
fibronectin 
HLA class I
table 3.1: List of the polyclonal and monoclonal antisera used in 
the analysis of the in vitro translated placental RNA samples.
94
20-i
15-
00
ZDo
§*Hh-
CL
L_>
UJcc
Cl
2 5H
n:
2
$
3  x -  SYNCYTIOTROPHOBLAST
£ o -  CYTOTROPHOBLAST 
o -  TR Y P S IN IS E D  CYTOTROPHOBLAST
* *
x £
£
8 8 o
r 9 -9 - 9 9 P?a9n9 °y ¥ xp f - y y ? I
N  I*, r- C*-'OaOOlD3“<''JZ    C—  CO <f I/S
, _______o ? < < < ^ m J  c/ i  cf  a -  “
I 1 Q -1- h I- □ -» -tT QJ Cl; 2
2  CL W  *  £<c
Figure 3.7: The incorporation of 35s-methionine into specific 
placental mRNA polypeptides, as assayed by immunoprecipitation 
and TCA precipitation.
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synthesised polypeptides (figure 3.8), which corresponded in size 
to that reported for pre-hPL (Fiddes & Goodman 1979, Seeburg et 
al 1977). This band of 24Kd co-precipitated, non-specifically, 
when antisera other than anti-hPL were used. It also precipitated 
in the presence of the formalin fixed Staph A cells and normal 
rabbit serum. To reduce the amounts of hPL co-precipitated the 
samples were pre-precipitated using normal rabbit serum and 
formalin fixed Staph A cells as this precipitation in the absence 
of antisera is due to a specific reaction of the hPL with Staph 
A cells (Fiddes & Goodman, 1979). Though pre-hPL could be 
immunoprecipitated from non-trypsinised cytotrophoblast RNA 
translations only 4-5$ of the incorporated 35s_methionine was 
precipitated with anti-hPL compared with 15-20$ from 
syncytiotrophoblast RNA translations, (figure 3.7). As this pre- 
hPL band was not detected by immunoprecipitation from trypsinised 
cytotrophoblast RNA translations (figure 3.9) it was assumed that 
unless the cytotrophoblast tissue was treated with trypsin before 
RNA extraction the cytotrophoblast RNA preparation would be 
contaminated with syncytiotrophoblast RNA.
Several antisera to PLAP were used for the 
immunoprecipitation of both cytotrophoblast and 
syncytiotrophoblast RNA synthesised polypeptides. Figure 3.10a 
shows that though polypeptides were precipitated from 
syncytiotrophoblast translations with anti-PLAP none were 
detectable from comparable cytotrophoblast translations. From 
syncytiotrophoblast RNA translations the apparent mw of the bands 
immunoprecipitated using anti-PLAP (DAKO) were a doublet of 58kd 
and 56Kd, a triplet at 48Kd, 46Kd and 44Kd and a band at 35Kd 
(figure 3.10b). Rabbit antisera raised against placental villous
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Figure 3.8: Autoradiograph of the 35s~labelled in vitro 
translated products of syncytiotrophoblast mRNA, 
immunoprecipitated with rabbit antiserum against hPL(DAKO) or 
PLAP(DAKO), separated on a 9% SDS-PA3E gel. The precipitated band 
of 24KD corresponded in size to pre-hPL.
1. Poly(A+) RNA translation products precipitated with antiserum
against PLAP (DAKO)
2. Poly(A+) RNA translation products precipitated with antiserum
against hPL (DAKO)
3. Poly(A+) RNA translation products
4. Translation system blank
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Figure 3-9: Autoradiograph of the 35s..iabeiied in vitro
translated products of syncytiotrophoblast, cytotrophoblast and 
trypsinised cytotrophoblast mRNA; immunoprecipitated with rabbit 
antiserum against hPL(DAKO) and separated on a 9% SDS-PAGE gel.
1. Translation system blank
2. Syncytiotrophoblast mRNA translation products
3. Syncytiotrophoblast mRNA translation products precipitated 
with antiserum against hPL
4. Cytotrophoblast mRNA translation products
5. Cytotrophoblast mRNA translation products precipitated 
with anti serum against hPL
6. Trypsinised cytotrophoblast mRNA translation products
7. Trypsinised cytotrophoblast mRNA translation products 
precipitated with antiserum against hPL
8. rnw markers
Figure 3.10: Autoradiograph of 35s_iabelled in vitro translated 
products of term placental mRNA samples immunoprecipitated with 
rabbit antiserum against PLAP(DAKO) and separated on a 9% SDS- 
PAGE gel band at 35KD.
(a) 1. Cytotrophoblast mRNA translation products
2. n translation precipitated with anti-PLAP
3. Trypsinised cytotrophoblast mRNA translation products
4. M M translation precipitated with
anti-PLAP
5. mw markers
(b) 1. Poly(A+) RNA (p1) translation products precipitated with
anti-PLAP (DAKO)
2. Poly(A+) RNA (p2) translation products immunoprecipitated 
with anti-PLAP (DAKO)
3. Poly(A+) RNA (p3) translation products immunoprecipitated 
with anti-PLAP (DAKO)
4.Poly(A+) RNA (p1) translation products precipitated in 
the absence of anti-PLAP (DAKO)
5. Poly(A+) RNA (p1) translation products immunoprecipitated 
with anti-PLAP (TA76/TA78)
6. Poly(A+) RNA (p1) translation products plus 150ug of 
unlabelled PLAP immunoprecipitated with anti-PLAP (DAKO)
7. Poly(A+) RNA (p2) translation products plus 150ug of 
unlabelled PLAP immunoprecipitated with anti-PLAP (DAKO)
8. Poly(A+) RNA (p3) translation products plus 150ug of 
unlabelled PLAP immunoprecipitated with anti-PLAP (DAKO)
9. Poly(A+) RNA (p1) translation products
(c) 1. Poly(A+) RNA (p1) translation products immunoprecipitated 
with TA78
2. Poly(A+) RNA (p2) translation products immunoprecipitated 
with TA78
3. MW markers
4. Poly(A+) RNA (p1) translation products immunoprecipitated 
with TA76
5. Poly(A+) RNA (p2) translation products immunoprecipitated 
with TA76
facing page
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membranes which were found to have anti-PLAP activity (obtained 
from Dr. P.M. Johnson) immunoprecipitate bands at 44Kd and 35Kd. 
A very faint band of 77kD was also visible in some translations 
(figure 3.10c). Since there may be a decline in PLAP mRNA 
production at term, translational proteins obtained from 
placental poly(A+) RNA at different stages of gestation (30 weeks 
and 12 weeks) were immunoprecipitated using either anti-hPL or 
anti-PLAP sera. Anti-hPL precipitated the 24Kd protein in both 
samples though there was less 24Kd protein in the first trimester 
sample (figure 3.11a). Anti-PLAP (obtained from Dr. P.M. Johnson) 
precipitated bands of 44Kd, 35Kd and 24Kd for the 30 week 
placental sample, the 24Kd pre-hPL was precipitated in the 12 
week placental sample (figure 3.11a). With anti-PLAP (DAKO) a 
precipitable band of 44Kd was detected in premature mRNA samples 
and no bands were precipitated from first trimester mRNA samples 
(figure 3.11b).
Syncytiotrophoblast mRNA translates were also 
immunoprecipitated with the PLAP monoclonal antisera H317, PIG17 
and ND0G2. Though immunoprecipitated polypeptides were detected 
by TCA precipitation less than 5% of the polypeptides were 
precipitated (figure 3.7) and when analysised on SDS-PAGE gels 
no precipitable bands were visable.
3:3:6 Competition assay tq  test specificity of polypeptides
4
precipitated with antisera directed against PLAP
The specificity of the polypeptides precipitated by the 
anti-PLAP sera was demonstrated by competition with pure PLAP-A 
protein extracted from the term placenta or commercially obtained 
PLAP (Sigma). Figure 3.12 shows that the addition of excess PLAP
100
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Figure 3.11: Translation products of placental poly(A+) RNA 
obtained at different stages of gestation (30 weeks and 12 weeks) 
separated on a 5 — 15% SDS-PAGE gel. Anti-hPL (DAKO) precipitated 
the 24KD pre-hPL protein in both the samples. Anti-PLAP (TA76) 
precipitated bands of 44KD, 35KD and 24KD for the 30 week 
placental sample. Anti-PLAP (DAKO) precipitated a band of 44KD 
from the 30 week sample. The 24KD pre-hPL was precipitated from 
the 12 week placental sample with anti-PLAP (TA76) serum.
(a) 1. Poly(A+) RNA translation products from 30 week placenta
2. Poly(A+) RNA translation products from 30 week placenta 
precipitated with antisera against PLAP (TA76)
3. Poly(A+) RNA translation products from 30 week placenta
precipitated with antisera against hPL (DAKO)
4. Poly(A+) RNA translation products from 12 week placenta
5. Poly(A+) RNA translation products from 12 week placenta 
precipitated with antiserum against PLAP (TA76)
6. Poly(A+) RNA translation products from 12 week placenta 
precipitated with antiserum against hPL (DAKO)
(b) 7. rrw markers
8. Poly(A+) RNA translation products from 30 week placenta
9. Poly(A+) RNA translation products from 30 week placenta
precipitated with antisera against PLAP (DAKO)
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Figure 3.12: Competition Assay; ^S-labelled in vitro translated 
products immunoprecipitated with rabbit antiserum against PLAP 
(DAKO) in the presence of excess unlabelled PLAP. The addition of 
excess PLAP prevented the immunoprecipitation by anti-PLAP(DAKO) 
of the 58KD and 56KD polypeptide bands, whereas the 24KD 
polypeptide band remained.
1. Poly(A+) RNA translation products
2. mw markers
3. Poly(A+) RNA translation products immunoprecipitated with 
anti-PLAP (DAKO)
4. Poly(A+) RNA translation products plus 1ug of unlabelled 
PLAP immunoprecipitated with anti-PLAP (DAKO)
5. Poly(A+) RNA translation products plus 10ug of unlabelled* 
PLAP immunoprecipitated with anti-PLAP (DAKO)
6. Poly(A+) RNA translation products plus 100ug of unlabelled 
PLAP immunoprecipitated with anti-PLAP (DAKO)
7. Poly(A+) RNA translation products plus 150ug of unlabelled 
PLAP immunoprecipitated with anti-PLAP (DAKO)
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prevented the immunoprecipitation by anti-PLAP(DAKO) of the 58Kd 
and 56Kd polypeptide bands, whereas the 24Kd polypeptide band 
remained after the addition of excess PLAP. (figure 3.12).
3:3:7 Labelling of Oligonucleotides using JH kinase
After 32p labeling the oligonucleotides using T4 kinase 
the labelled DNA was separated from the unincorporated [&3^P]ATP 
by chromatography on a Sephadex G25 column (8cmx0.5cm). Two peaks 
of 32p activity were seen. That the first peak contained the 
labelled DNA and the second peak the unincorporated [X^P]ATP 
was tested by TCA precipitation. Only the first peak contained 
precipitable counts and thus the labelled oligonucleotides. The 
percentage yield of incorporated 32p for the kinasing reaction 
ranged from 55-16%,
3:3:8 Northern Blots
Placental RNA denatured using glyoxal and DMSO was 
fractionated on a 1.5$ agarose gel and transferred to a 
nitrocellulose filter as described. After hybridising overnight 
at 20°C with either PLAP or hPL 32p ^  enc[ labelled 14 base 
oligonucleotides each filter was washed at 20°C. A band of 
homology was seen with the 14 base hPL oligonucleotide probe 
(figure 3.13). No bands were seen when the two 14 base PLAP 
oligonucleotide probes were used. Washing the filter at
4
intermediate temperatures until the dissociation temperature of 
the hPL oligonucleotide probe was reached, showed a band of 1Kb 
to be present in 2 term placental RNA samples and a 33 week 
placental RNA sample. There was no band seen in the 11 week 
placental RNA sample; not enough hPL message may be present in
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Figure 3.13: Northern blot of placental syncytiotrophoblast RNA 
samples probed using a hPL oligonucleotide probe
1. Full-term RNA sample
2. Premature RNA sample
3. First trimester RNA sample
4. First trimester RNA sample
5. Premature RNA sample
6. Full-term RAJA sample
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this mRNA sample for hybridisation.
From these results one can see that the hPL 
oligonucleotide was able to hybridise to the RNA samples to a 
band of sufficient coding capacity for the pre-hPL message. The 
pre-hPL message has been shown by Shine et al (1977) and Goodman 
et a! (1980) to be 815 residues long. The PLAP oligonucleotides 
did not show any homology with the RNA samples. This could be 
due to the fact that the PLAP message is of too low an abundance 
to be detected by a short oligonucleotide probe.
3:3:9 £o£ Hybridisation
Denatured cytotrophoblast RNA samples from term 
placentae and syncytiotrophoblast RNA samples from various stages 
of gestation, were diluted and spotted onto dry filters. The dot 
blots were probed with PLAP or hPL 14 base oligonucleotides. 
After hybridisation with the oligonucleotides probes, the filters 
were washed under varying stringency conditions. The 
dissociation temperature Tp is the highest stringency wash 
possible without dissociation of the homologous probe.
Washing at 30°C with 5xSSC the TD for the 11 homologous 
bases in the PLAP 14mer oligonucleotide mixtures showed that the 
binding intensity of the PLAP probes was proportional to the 
syncytiotrophoblast RNA samples gestation stage (figure 3.14a). 
No binding of the PLAP oligonucleotide was seen with the 9 week
4
RNA sample (figure 3.14a, track 1). Very little PLAP binding to 
the cytotrophoblast RNA samples was seen. Under higher stringency 
washes the PLAP probe dissociated and hybridisation was not 
detected at any stage of gestation. The TD for the hPL 14mer 
oligonucleotide probe is 40oC. This probe hybridised to all the
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RNA samples at the low stringency wash, 30QC with 5xSSC, was 
used (figure 3-1 Mb). The intensity of probe binding to the RNA 
samples was a lot stronger with syncytiotrophoblast RNA compared 
with cytotrophoblast RNA. The hPL probe remained hybridised 
under the high stringency wash at 40QC and 5xSSC (figure 3.14c). 
At this temperature the intensity of hPL binding is proportional 
with the syncytiotrophoblast RNA samples gestation stage. The 
results also showed that decreasingly lower salt washes at 400C 
causes the hybridised hPL probe to dissociate as does stringency 
washes at temperatures above 400C.
Under the low stringency wash of 5xSSC at 650C the 
pDP001 probe hybridised with all the RNA samples though the 
.intensity of hybridisation was greatest for the trypsinised 
cytotrophoblast RNA samples (figure 3-14d) At the high stringency 
wash of O.IxSSC at 650C faint hybridisation to both 
syncytiotrophoblast and cytotrophoblast RNA samples could still 
be detected (figure 3.14e). This result indicates that there may 
be class I homologous sequences in both syncytiotrophoblast and 
cytotrophoblast placental RNA samples.
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Figure 3.14* Dot hybridsisation of samples of syncytiotrophoblast 
RNA from various stages of gestation, term cytotrophoblast and 
trypsinised cytotrophoblast RNA. Probed using (a) PLAP 14mer 
oligonucleotide probe, washing conditions 30°C with 5xSSC (b) hPL 
14mer oligonucleotide probe, washing conditions 40°C with 5xSSC
(c) hPL 14mer oligonucleotide probe, washing conditions 40°C with 
1xSSC (d) pDP001, washing conditions 65°C with 1xSSC (e) pDP001, 
washing conditions 65°C with O.IxSSC
1. 9 week syncytiotrophoblast RNA sample
2. 11 week syncytiotrophoblast RNA sample
3. 30 week syncytiotrophoblast RNA sample
4. 33 week syncytiotrophoblast RNA sample
5. 40 week syncytiotrophoblast RNA sample
6. Term cytotrophoblast RNA sample (8)
7. Term syncytiotrophoblast RNA sample (8)
8. Term trypsinised cytotrophoblast RNA sample (8)
9. Term cytotrophoblast RNA sample (7)
10. Term syncytiotrophoblast RNA sample (7)
11. Term trypsinised cytotrophoblast RNA sample (7)
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3:4 DISCUSSION
The mRNA populations extracted from syncytiotrophoblast 
and cytotrophoblast were analysed by in vitro translation. Both 
unfractionated placental RNA samples and poly (A+) enriched 
samples synthesised the same polypeptides. The polypeptide bands 
were more distinct for the poly (A+) enriched samples (figure 
3.4). Whereas increased concentrations of unfractionated RNA 
caused a decrease in translation efficiency, no decrease in the 
translation efficiency was noticed with the addition of excess 
poly (A+) RNA (figures 3.1, 3.2a & 3.2b). It was assumed that the 
decreased efficency was due to an accumulation of translational 
inhibitors present in the untranslated RNA sample. The presence 
of inhibitors was shown by the fact that the translational 
efficiency of high quality control mRNA was reduced by the 
addition of unfractionated placental RNA.
The major difference between the synthesised polypeptide 
profiles of syncytiotrophoblast and cytotrophoblast mRNA was the 
intensity of the 24kd, pre-hPL, band (figure 3.6). The intensity 
of this band is greatly reduced in cytotrophoblast RNA 
preparations especially when the cytotrophoblast cells had been 
treated with trypsin to remove contaminating cells before the RNA 
was extracted. This pre-hPL polypeptide was the predominant 
translational product for syncytiotrophoblast mRNA (figure 3.5a &
4
3.8). The other predominant polypeptides ranged in size from 86- 
20Kd with fainter polypeptide bands visible beyond 100Kd. 
Several of these proteins have been immunoprecipitated. The in 
vitro translation of human placental mRNA by Seeberg jd (1977) 
and Fiddes & Goodman (1979) centred on the low mw polypeptides
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hPL and HCG. In term placental in vitro translated mRNA they 
precipitated the predominant polypeptide of 24Kd with anti-hPL; 
this polypeptide represented 20/5 of the translated polypeptides. 
Polypeptide bands of mw 35Kd and 22Kd were also present. These 
polypeptide bands were seen in my In vitro translated 
syncytiotrophoblast mRNA samples and by immunoprecipitation the 
24Kd pre-hPL band was shown to represent 15-2055 of the translated 
polypeptides (figures 3.7 & 3.8). The band of mw 48 Kd which was 
present in the translational products even in the absence of mRNA 
was due to the labelling of proteins or macromolecules present in 
the lysate mix by mRNA independant processes.
Ito and Chou (1983) showed that the immunoprecipitation 
using anti-PLAP of the cell free in vitro translation products 
of choriocarcinoma poly (A+) RNA precipitated a protein of 
apparent mw 60Kd. The specificity of this precipitated 
polypeptide was shown by a competition assay using PLAP from term 
placentae; excess PLAP prevented the immunoprecipitation of the 
60Kd band. As PLAP and choriocarcinoma AP have been shown to 
have the same immunological reactivity it has been postulated 
that the placental form of AP and the tumouragenic forms of AP 
are encoded by the same gene (Rosen et al, 1975). Thus if anti- 
PLAP precipitates a 60Kd protein from in vitro translated 
choriocarcinoma poly (A+) RNA one would expect a band of 
similar mw from in vitro translated placental syncytiotrophoblast 
poly(A+) RNA to be immunopreci pita ted using anti-PLAP. The mw of 
the polypeptides specifically immunoprecipitated by anti-PLAP 
were 58Kd and 56Kd. Other proteins were also precipitated using 
anti-PLAP sera but they were not shown to be specific for FLAP by 
competition assays (figure 3.12). The weak intensity of the PLAP
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bands compared with the 24Kd pre-hPL band may be due to the 
antisera used. These were directed against the glycosylated form 
of PLAP and not against the non-glycosylated form produced by the 
cell free translation systems. The messenger RNA for PLAP is also 
of low abundance and thus it is not translated as efficiently as 
hPL in the cell free translation system. The hPL protein has a 
half life of 15 minutes and thus needs to have an abundant mRNA 
to keep the levels of hPL high. Whereas FLAP is a stable protein 
it was assumed that its messenger RNA was of low abundance. 
Though the data is based on a relatively small number of placenta 
(20), the evidence from immunoprecipitation and dot hybridisation 
(figures 3.11 & 3.14) suggest that the levels of PLAP mRNA in 
the syncytiotrophoblast mRNA samples increases with the 
gestational age.
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\CHAPTER 4
PREPARATION AND SCREENING OF A SYNCYTIOTROPHOBLAST
cDNA LIBRARY
'
4:1 INTRODUCTION
The aim of work described in this chapter was to 
construct cDNA libraries from- the mRNA populations of 
cytotrophoblast and syncytiotrophoblast whose preparation and 
analysis was presented in chapter 3. These libraries were to be 
to be screened for sequences coding for PLAP and subsequently 
for HLA class I antigens. The construction of a cDNA library 
involves several steps:
(1) The preparation of the vector DNA.
(2) Reverse transcription of mRNA into cDNA.
(3) The ligation of the cDNA into the vector DNA.
(4) The introduction of the ligated material into E.coli.
(5) Screening of the resultant library for cDNA clones.
(6) Amplification of the recombinant cDNA library.
Preparations of placental cDNA were ligated into the 
lambda vectors gt10 and gt11. For ease of presentation, the 
results for cloning placental cDNA into \gt10 and the screening 
of the resultant placental cDNA library will be presented before 
the work on \gt11. However, at the start of the work it was 
necessary to choose whether to clone PLAP cDNA into .\gt10 or the 
related expression vector \gt11. The only means of screening 
\gt10 clones was a short oligonucleotide sequence determined from 
the 5' amino acid sequence of PLAP. Considering that the cDNA is
4
synthesised from the 3' end poly A tail and S1 digestion of the 
hairpin structure removes 5'end sequences it seemed more 
attractive to use the Agt11 expression vector. Here cloned cDNA 
is expressed as a fusion protein which can be screened with 
antibodies. As some of the antigenic determinants on PLAP might
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be specified by through codons further towards the 3' end of the 
mRNA the cloning of placental syncytiotrophoblastic cDNA into 
\gt11 was attempted first. In retrospect this was probably not 
the best choice as there is no selection for recombinants in 
Agt11 and a library cloned into ^ gt10 can be transferred to AgtH 
for antibody screening. Further encouragement to clone into 
^gt10 came with the arrival of long oligonucleotides to PLAP as 
well as cDNA probes for HLA class I antigens.
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4:2 MATERIALS and METHODS
4:2:1 \gt10
The genotype for \gt10 is \srl\10 b527 srl\3° imm^34 
(srI434+) srl\4° srIV5° it was constructed by in vitro techniques 
using the right arm of \607 and left arm of \518 (Huynh et al, 
1984).
a. E.coli strains used:
(1) LE3921— hsdR" hsdM+ s u p E s u p F  thr met lacY1
(2) BNN102!- hsdR- hsdM* s u p E thr leu thi lacY1 tonA21 hflA150 
f chr::Tn10l
The construction of BNN102 is described by Young & Davis (1983).
b. Media used
LB broth: 10g Bacto-tryptone(Difco), 5g Bacto-yeast extract, 10g 
NaCl, H2 0  to a litre, adjusted to pH7.5 with sodium hydroxide 
LB agar: same as for LB with the addition of 15g Bacto-agar 
(Difco).
LB soft agar: same as for LB with the addition of 6.5g Bacto-agar 
(Difco) and MgSOjj to 10mM.
4:2:2 \gt11
The genotype of \gt11 is lacB /\(shindIII\2-3) sri\3° 
cl857 srl\4° ninS srl\5° Sam100 the construction of \gt11 is 
described by Young & Davis (1983). The ^gt11[amp3] is identical 
to \gt11 except for a 1.7Kb amp3 fragment from pBR322 inserted 
into its Xba1 site, 
a E.coli strains used:
(1) Y1088 !- lacU16Q s u p E s u p F  hsdR" hsdM+ metB trpR tonA21 
proC::TnS (pMC9)
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(2) Y1090 j- lacU169 proA* /\lon araD13Q strA s u p F  hsdR+ hsdM+ 
rtrpC22::Tn10l (pMC9)
The construction of Y1088 and Y1090 is described by Young & Davis 
(1983).
b. Media used
BBL broth: 10g BBL-tripticase, 5g NaCl, H20 to a litre, adjusted 
to pH7.5 with sodium hydroxide.
BBL agar: same as for BBL-broth with the addition of 15g Bacto- 
agar (Difco).
BBL soft agar: same as for BBL-broth with the addition of 6.5g 
bacto-agar (Difco) and MgSOjj to 10mM. Just before use this was 
adjusted to a concentration of 5mM IPTG (Sigma) and 0.1 mg/ml of 
Xgal (Sigma). IPTG (isopropyl B-D-thiogalactopyranoside) was 
prepared as a 1M stock solution in distilled H20 and stored at 
-20°C. Xgal (5-bromo-4-chloro-3-indolylrB-D-thiogalactopyranoside) 
was prepared as a 40mg/ml solution in dimethylformamide and 
stored at -20°C.
4:2:3 Preparation of plating cells
Host cells Y1088, Y1090, LE392 and BNN102 were used as 
plating cells. An overnight culture from a single colony was 
grown in 20ml LB medium containing 0.2$ maltose to induce phage 
receptors on the E.coli cell surface (Enquist & Sternberg, 1979). 
1ml of the overnight culture was added to 50ml of LB medium 
containing 0.2$ maltose and the culture grown with aeration td 
log phase. The cells were collected by centrifugation at 2K for 5 
minutes, resuspended in 10ml sterile 10mM MgSOjj and stored at 
4°C. The plating cells were viable for 2 weeks.
4:2:4 Preparation of \ vector gt10
Single plaque stocks which contained the lowest 
percentage of spontaneous clear-plaque phage were used for large 
scale preparation of \gt10 'phage.-From these stocks ten plate 
stocks were prepared using an adaptation of the protocol of 
Davis £t a! (1980), as follows. 5x10^pfu of phage stock were 
added to 100-150ul of plating cells (LE392), incubated at 37°C 
for 15 minutes and then plated on LB plates (90mm) supplemented 
with 0.2% glucose in 3mls of molten (45°C) soft LB agar. After 5- 
6 hours incubation at 37°c the plates were chilled and overlaid 
with phage dilution buffer, PDB, (10mM Tris HC1 pH7.4, 10mM 
MgS0j|, 0.01% gelatin). The plates were left at 4°C overnight to 
allow the 'phage to diffuse into the buffer. The overlay was 
removed and any bacterial or agar comtamination was removed from 
the phage solution by centrifugation at 6K in a JA-10 Beckman 
rotor for 10 minutes at 4°C.
4:2:5 Preparation of ^  vector gt11
The bacteriophage \gt11 [amp3]DNA was prepared by 
inducing the \gt11[amp3l lysogen c600 at 43°C using an 
adaptation of the procedure of Huynh, Young & Davis (1984). After 
testing that the c600 \gt11[amp3] lysogen is induced at 43°C 
20ml of LB medium was inoculated with a single colony of the 
lysogen and incubated overnight at 32°C. The overnight culture
4
was used to inoculate a litre of LB medium. This was incubated at 
32°C with aeration until an OD^qq of 0.6 was reached. To induce 
lytic growth the temperature of the culture was increased rapidly 
(by using pre-warmed water bath) to 43°C for 15 minutes then 
dropped to 37°C and incubated for a futher 3 hours with aeration.
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To the culture was added 10ml CHClg and incubation at 37°C with 
aeration was continued for a futher 15 minutes. The bacterial 
debris was removed from the culture by centrifugation at 6K in a 
JA-10 Beckman rotor for 10 minutes at 4°C.
4:2:6 Preparation of \ vector DNA
The gt10 or gt11 'phage were pelleted from suspension by 
centrifugation at 23K in a SW-27 Beckman rotor for 90minutes at 
4°C and the pellet resuspended in 5ml of \ buffer (10mM Tris HC1 
pH7.5, 10mM MgCl2 , 1mM EDTA) at 4°C. To this was added an equal 
volume of CsCl in \ buffer (0.71g/ml). The phage was then banded 
by centrifuging at 55K in a VTi 55 Beckman rotor for 8 hours at 
20°C. The phage band was removed in 0.5ml volume through the side 
of the tube with a syringe fitted with a 25 gauge needle. The 
phage was further purified by stepping the phage up through CsCl 
(0.71g/ml of \ buffer), the phage solution was over laid with 
CsCl (0.71g/ml of \ buffer) and centrifuged at 55K in a VTi 65 
Beckman rotor for 4 hours at 20°C. The phage band was removed 
in 0.5ml volume as above diluted with an equal volume of \ buffer 
and dialysed overnight at 4°C against TE to remove the CsCl. To 
obtain \ DNA the phage solution was extracted 3x with equal 
volumes of phenol. The final aqueous phase was dialysed against 
TE to remove any residual phenol and the \ DNA stored at 4°C.
4:2:7 EcoR1 digestion of \ vector D M
To 5ug of the \vector DNA in TE was added 5ul 10x HSB 
and 20U of EcoR1 in a total volume of 50ul. This was incubated at 
37°C for 1 hour and the reaction stopped by the addition of 2ul 
(0.5M) EDTA and heating at 70°C for 10 minutes. To check that the
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digestion had gone to completion samples of EcoR1 digested and 
undigested gt10 or gt11 were run on a 0.8% agarose gel in TBE 
buffer. EcoRI digestion of \gt11(amp3) (45.4Kb) of 19.6Kb and 
25.8Kb. EcoRI digestion \gt10 (43.34 Kb) yeilds bands of 32.71Kb 
and 10.63Kb.
4:2:8 Commercially obtained Xvector DNA
Dephosphorylated lambda gt11 arms were obtained from 
Vector Cloning Systems (3770 Tansy Street, San Diego, CA 921211).
4:2:9 Preparation of cDNA
cDNA was synthesised using placental poly (A+) RNA and 
oligo(dT) as a primer (Wickens et al 1978). In a sterile 
eppendorf was added 30ul of dH20 containing 2ug of poly(A+) RNA, 
and 10U RNasin (BRL). The sample was heated at 70°C for 3 
minutes, cooled on ice then to it was added 10U RNasin, 5ul 10x 
1st strand buffer (0.4M KC1, 0.08M MgCl2, 4mM DTT, 0.5M Tris HC1 
pH8.5) 10ul of 5mM d(A,G,C,T)TP, 1ul (0.5ug) oligo (dT), 10uCi 
[_^2p] dATP (specific activity= 800Ci/mMole), 20U reverse 
transcriptase (BRL). This' was incubated at 42°C for 2 hours. The 
cDNA product was seperated from the the mRNA template by heat 
denaturation, 1.5 minutes at 100°C, then cooled immediately on 
ice C1 % of the reaction product was kept to run on an alkaline 
agarose gel].
4
The second strand of the cDNA was synthesised using the 
3f terminus of the first strand as a the primer. To the tube 
containing the first strand reaction mix was added 20ul of 5x 2nd 
strand buffer (250mM Hepes pH6.9, 250mMKCl, 50mMMgCl2S) 2ul of 
5mM d(A,G,C,T)TP and 60U of DNA polymerase to catalyse the
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Diagrammatic scheme for double-stranded cDNA synthesis 
and cloning into lambda vector gt10 or gt11
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reaction (Efstratiadis .gt al, 1976 & Wickens et al, 1978). The 
volume was adjusted to 100ul using dH20 and the mix incubated at 
15°C for 3 hours [ 1% of the reaction product was kept to run on 
an alkaline agarose gel]
The single stranded hair pin loop connecting the two 
strands of the DNA was digested away with S1 nuclease. The S1 
nuclease (BRL) was titrated to determine the optimal amount. Two­
fold dilutions of the enzyme from 300u-4800u/ml in 4ul of S1 
buffer were incubated with 1ul of the second strand synthesis at 
37°C for 30 minutes. The digestion products were analysed on an 
alkaline agarose gel and the optimum S1 concentration was 
determined as that which reduced the size distribution of the 
cDNA smear to that seen after first strand synthesis. To the tube 
containing the second strand synthesis reaction product was added 
400ul of S1 buffer (30mM NaAc pH 4.4, 0.25M NaCl, 1mM ZnSO^) and 
S1 nuclease. This was incubated at 37°C for 30 minutes then the
•>0
reaction stopped by adding 10ul of 0.5M EDTA (pH8.0), 11% of the 
reaction product was kept to run on an alkaline agarose gel]. 
Protein contamination was removed from the cDNA mix by extracted 
twice with an equal volume of phenol:CHClg saturated with 10mM 
Tris HC1 (pH7.5) then with CHCl^. The aqueous phase was 
precipitated at -20°C using 2 volumes of EtOH. The precipitate 
was pelleted by centrifuging for 15 minutes in a microfuge at
n°c.
4
To increase the number of flush ended double stranded 
cDNA molecules the cDNA pellet was treated with DNA polymerase 1 
( Seeburg at al, 1977). After drying the pellet was resuspended 
in 10ul containing , 6U T4 DNA polymerase (BRL), 0.1mM 
d(A,G,C,T)TP, 50mM Tris HC1 (pH8), 6mM MgCl2, 25mM KC1 and 1ug
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BSA. The mix was incubated at 37°C for 30 minutes then extracted 
twice with an equal volume of phenol:CHCL^ saturated with 10mM 
Tris HC1 pH7.5), then with CHCl^. The aqueous phase was 
precipitated at -20°C using 2 volumes of EtOH and 1/10 volume of 
sodium acetate.
4^:2:10 Size distribution of the cDNA
v The 1% reaction volume reserved from the first and 
second strand synthesis of the cDNA and after S1 treatment were 
run on an agarose gel (1.2% agarose, 50mM NaCl, 1mM EDTA) in 
alkaline buffer (30mM NaOH, 1mM EDTA) to analyse the size 
distribution of the reaction product. The samples were loaded on 
the gel in 20ul of sample buffer (50mM NaOH, 1mM EDTA, 2.5% 
Ficoll, 0.025% Bromocresol Green) and run at 30V until the front 
had moved 8cm, after which the gel was soaked in 7% TCA at RT for 
30 minutes, dried and autoradiographed using X-Omat S film.
The incorporation of [32p]_cTP into the cDNA during the 
first and second strand synthesis reaction was tested by TCA 
precipitation. Knowing the amount of RNA one started with and the 
specific activity of the label an estimate of the amount of cDNA 
synthesised was calculated.
4:2:11 EcoRI Methylation of cDNA
To protect the cDNA from digestion bv EcoRI the EcoRI
4
cleavage sites were methylated using S-adenosyl-L-methionine 
(Sigma) and EcoRI methylase (BioLabs). The cDNA pellet obtained 
after flush-end treatment using T4 polymerase was dried and 
resuspended in 20ul EcoRI methylase buffer (50mM Tris HC1 pH7.5, 
1mM EDTA, 5mM DTT, 400ug/ml BSA) plus 2ul of freshly made 100uM
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S-adenosyl-L-methionine and 0.5ul EcoRI methylase. This was 
incubated at 37°C for 30 minutes followed by 70°C for 10 minutes. 
Ihe solution was extracted with an equal volume of phenoliCHCL^ 
saturated with 10mM Tris HC1 (pH7.5‘), the organic phase was re­
extracted twice with 50ul TE. The aqueous phases were pooled and 
extracted twice with CHCI3 and precipitated at -20°C using 2 
volumes of EtOH and 1/10 volume of 3M sodium acetate.
To test that the methylation reaction did indeed protect 
the cDNA, plasmid DNA was also methylated as described and then 
both EcoRI methylated and non-methylated plasmid DNA were tested 
for their restriction pattern using EcoRI. To 18u1 of either 
untreated plasmid DNA or methylated plasmid DNA were added 2ul of 
10x high salt buffer (100mM NaCl, 50mM Tris HC1 pH7.5, 10mM 
MgCl2 > 1mM DDT) and 0.2ul(2U) EcoRI. This was incubated at 3 7°C 
for 1 hour and the reaction stopped by the addition of 
0.2ul(0.5M) EDTA.
4:2:12 EcoRI Linker addition to the double-stranded cDNA
The EcoRI methylated cDNA pellet was resuspended to a 
total volume of 20ul in 5ul (1ug) kinased EcoRI linkers. 1.5ul 
10x ligation mix (250mM Tris HC1 pH7.4, 100mM MgC^, 100mM DTT, 
2mM spermidine, 10mM ATP), 5U T4 DNA ligase (BRL), 1U T4 RNA 
ligase (BRL) and incubated at 15°C overnight. The ligation 
reaction was stopped by heating at 65°C for 10 minutes. [155 of
4
the reaction product was kept to run on a polyacrylamide gel].
4:2:13 Removal of excess EcoRI linkers
After digestion with EcoRI the excess linkers were 
removed by either^ isopropanol precipitation or size
121
fractionation:
a. Isopropanol precipitation To the tube containing the ligation 
mix was added 0.2 volumes of 3M NaAc (pH6) and 0.6 volumes of 
isopropanol. The solution was mixed and-incubated at RT for 5 
minutes. This was then centrifuged in a microfuge for 5 minutes 
at RT, the supernatant removed and the pellet washed with 70%
v.
EtOH then resuspended in 40ul TE [1% of both the supernatant and 
the resuspended pellet was kept to run on a gel]. To the pellet 
resuspended in 40ul TE were added 4.2ul of 10x high salt buffer 
(100mM NaCl, 50mM Tris HC1 pH7.5, 10mM MgCl2, 1 mM DDT) and 
2ul(20U) EcoRI. This was incubated at 37°C for 3 hours and the 
reaction stopped by the addition of 0.4ul(0.5M) EDTA. A second 
isopropanol precipitation was performed again, 0.2 volumes of 3M 
NaAc (pH6) and 0.6 volumes of isopropanol were added. The 
solution was incubated at RT for 5 minutes and then centrifuged 
in a microfuge for 5 minutes at RT. The supernatant was removed 
and after washing the pellet with 70% EtOH it was dried, 
resuspended in TE and stored at -20°C. [1% of both the 
supernatant and the resuspended pellet was kept to run on a gel].
The 1% volume samples of supernatant and pellet 
solution, reserved after the isopropanol precipitation steps, 
were loaded on a 10% polyacrylamide gel in 20ul of sample buffer 
(10%glycerol, 5% mercaptoethanol, 3% SDS, 0.0625M Tris HC1 pH6.8, 
0.01% bromophenol blue). The samples were electrophoresed at
4
20mA, using TBE running buffer ( 10.8g/l Tris, 55g/l boric acid, 
9.3g/l EDTA) until the bromophenol blue marker is halfway down 
the gel. The gel was then dried and autoradiographed. From this 
gel one can check whether the ligation of the EcoRI linkers to 
the cDNA had been sucessful and that all the excess EcoRI
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linkers were removed, after digestion with EcoRI.
b. Size fractionation The cDNA can be size fractionated and the 
excess linkers removed by running the reaction mixture over a 
bio-Gel 50 column (0.2x25cm) at roorrf temperature. The column was 
washed with 50ml of column buffer (10mM Tris HC1 pH 7.5, 100mM 
NaCl, 1mM Na^  EDTA). Excess DNA was used to pre-soak the column 
before it was calibrated. To calibrate, 5'^P-end labeled Hinf I 
pBR322 fragments in loading buffer (1ul 0.25% bromphenol blue-50% 
glycerol/10ul TE pH7.5) were run through the column at a flow 
rate of 20ul per minute and 40ul fractions collected. The 
fractions were assayed using gel electrophoresis on a 1.2% 
agarose gel. After washing the column thoroughly with column 
buffer it was used to fractionate the cDNA. To the cDNA was added 
loading buffer (1ul 0.25% bromphenol blue-50% glycerol/10ul TE 
pH7.5) and the sample was run under identical conditions as used 
to calibrate the column. Thus the actual size of the cDNA in each 
fraction collected could be determined. The amount of 
radioactivity in each fraction was determined by counting the 
whole fraction on the channel of the scintillation counter. 
The column fractions containing cDNA of the desired size range 
were pooled and stored at -20°C.
4:2:14 Ligation q£ cDNA:(EcoRI)linker with EcoRI digested \ 
vector DNA
4
For good ligation of the cDNA to the phage arms a molar 
ratio of 1:1 (cDNA:gt10 or gt11) in a total DNA concentration of 
2ug was aimed at (Maniatis, Fritsch & Sambrook, 1982). Thus 2ug 
of EcoRI digested ^ vector DNA was co-precipitated with 40ng of 
cDNA at -20°C with 2 volumes of EtOH. The precipitate was
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pelleted by centrifugation in a microfuge at 4°C for 15 minutes. 
The pellet was washed once with 70% EtOH, dried and resuspended 
with 2U T4 DNA ligase in 10ul ligation buffer (25mM Tris HC1 
pH7.4, 10mM MgCl2 , 10mM DDT, 1mM ATP, 0.2mM spermidine). This was 
incubated at 15°C overnight. The success of the ligation reaction 
was tested by running samples of the ligated cDNA:gt10 or 
cDNA:gt11 next to gt10 or gt11 and EcoRI digested gt10 or gt11 
on a 0.8% agarose gel in TBE buffer. One would expect to see one 
band for the ligated material.
4;2:15 In Vitro packaging
The product of the ligation reaction was packaged using 
\ DNA in vitro packaging kit and protocol as of Amersham 
International pic.
4:2:16 Plating of packaged phage
By plating out a sample of the Mphage stock” obtained 
from packaging one can determine the packaging efficiency of the 
cDNA:^gt hybrids and the percentage of recombinant phage present. 
Dilutions of the ”phage stock” were made in phage dilution 
buffer,PDB, (10mM Tris HC1 pH7.4, 10mM MgSOjj, 0.01% gelatin). 
From the expected packaging efficiency 1x10^-1x10^ pfu/ug of DNA 
packaged, dilutions of the ”phage stock” were calculated to give 
approximately 200 plaques when 50ul of the dilution was plated.
4
Dilutions 10-fold higher and lower also were prepared. To 100ul 
of the plating cells was added 50ul of the phage dilutions. This 
was incubated at 37°C for 15 minutes to allow the phage to adsorb 
to the E.coli cells. Then 3ml of molten (45°C) soft agar (BBL or 
LB) was added and the mix poured onto BBL or LB plates. After the
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overlay had set the plates were incubated overnight at M2°C for 
gt11 or 37°C for gt10. By counting the plaques the phage titre of 
the "phage stock" could be calculated and thus the efficiency of 
the packaging reaction, derived in pfu (plaque forming units) per 
mg of DNA packaged, could be calculated.
For a Agt11 library the percentage of recombinant phage 
in the "phage stock" was determined by the numbers of colourless 
and blue plaques. Plaques produced by parental \gt11 phage are 
blue on Xgal plates whereas recombinant phage produce colourless 
plaques. The percentage of recombinant phage in Agt10 libraries 
were recognised by their clear plaque morphology, the parental 
Agt10 phage form turbid plaques.
M:2:17 Screening the cDNA library with nucleic acid probes
The cDNA library in Agt10 was screened by hybridisation 
of nucleic acid probes to DNA from the plaques transferred to 
nylon filters (PALL). The method used was an adaptation of the 
Benton & Davis (1977) protocol. Aliquots of the "phage stock" 
containing 2.5x10** pfu in 50ul were incubated with 150ul plating 
cells at 37°C for 15 minutes. After the adsorption of the phage 
to the cells 5mis of molten (M5°C) soft LB agar was added and the 
mixes were poured onto dry LB plates which were incubated at 
37°C, until the plaques were just beginning to touch. After 
chilling at M°C for 1 hour the plates were returned to room
4
temperature and a dry nylon filter was placed on the surface of 
each-pi ate. Both the filter and the plate were marked for later 
orientation of plaques. As transfer of the phage DNA to the 
filter occurs rapidly the filter was removed from the plate 
after 1 minute and placed DNA side up on Whatmans 3MM paper
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soaked in denaturing solution (1.5M NaCI, 0.5M NaOH) for 5 
minutes, then transferred to neutralizing solution (3M NaAcetate 
pH5.5) for 5 minutes. The filter was blotted on Whatmans 3MM 
paper and air dried for 30 minute’s. After drying the DNA was 
fixed to the filter by baking the filter at 80°C for 1 hour. 
Duplicate filters were made by placing a second filter on the 
plate and leaving it in contact with the plaques for 2 minutes 
before removing the filter and proceding as above.
As hybridisation times and temperatures are a function 
of the probe concentration and sequence the procedure differed 
depending on the probe being used. The hybridisation temperature 
and time for each probe used is shown in table 4.1. All the 
filters were prehybridised, in sealed bags, for 1 hour with 
4ml/100cm^ of hybridisation buffer (5x denhardts buffer, 5xSSPE, 
0.2/5SDS, 0.1 mg/ml denatured nonhomologous DNA). After
prehybridisation the labelled probe (2x10^cpm/filter) was added 
to the bag and the filter hybridised. After hybridisation the 
filters were washed at the temperatures and salt concentrations 
shown in table.. After washing, the filters were autoradiographed 
using Kodak X-Omat S film.
4:2:18 Preparation of DNA probes
a. Placental cDNA Probe The single stranded cDNA probe was 
prepared by reverse transcribing human placental poly (A+) RNA.
4
In a sterile eppendorf tube was added 10U RNasin, 1ug poly (A+) 
RNA, 10ul Random primer (1ug/ml) and 1ul of 10x 1st stand buffer 
to a final volume of 10ul. The sample was heated at 70°C for 5 
minutes and quenched on ice. To it was added 4ul 10x 1st strand 
buffer, 7.5ul of 5mM d(G,C,T)TP, 2.5ul 20uM dATP, 100uCi
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TABLE 4.1
Probe
placental cDNA 
PLAPollgonucIeotide( 14) 
PLAP oligonucleotide (26) 
hPL oligonucleotide (14) 
FHPL815 
pDPOOl
Hybridisation 
tenperature low stringency
65°C 2xSSPE RT
RT 5xSSPE RT
35°C 5xSSPE RT
RT 5xSSPE RT
65°C 2XSSPE RT
65°C 2xSSPE RT
WASH D C  CONDITIONS 
high stringency
0.2xSSPE + 0.2% SDS, 65°C 
IxSSPE ♦ 0.2JSDS, 30°C 
IxSSPE + 0.2% SDS, 55°C 
IxSSPE + 0.2% SDS, 30°C 
0.2xS3PE + 0.2% SDS, 65°C 
0.2xSSPE + 0.2% SDS, 65°C
very high stringency
0.IxSSPE + 0.2% SDS, 70°C 
IxSSPE ♦ 0.2% SDS, 32-40°C 
IxSSPE + 0.2% SDS, 65-85°C 
IxSSPE ♦ 0.2% SDS, 40°C 
0.IxSSPE 0.2% SDS, 70°C 
0.IxSSPE + 0.2% SDS, 70°C
Table 4.1: The syncytiotrophoblast cDNA library in \gt10 was 
screened by hybridisation of nucleic acid probes to DNA from the 
plaques transferred to nylon filters. The hybridisation* 
temperatures depended on the probe employed and are shown in the 
table. After hybridisation the filters were washed 3x at each of 
the stringency stages shown in the table. If the filter was kept 
moist, by sealing in a plastic bag, it was possible to 
autoradiograph after any of the washing stages and then resuming 
washing afterwards.
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[a”32p]dATP, 2 0 U reverse transcriptase and to a final volume 
of 50ul. This was incubated at 42°C for 2 hours then the reaction 
stopped by the addition of EDTA to 20mM. To separate cDNA from 
the unincorporated nucleotides the sample was run on a small G-50 
column.
b. Oligonucleotide Probes These probes were prepared as shown in 
chapter 3 .
c. pDP001 This HLA class I insert in pBR322 (Snood £t al, 1981; 
Devilee et al, 1984) and cultures of plasmid were kindly provided 
by Drs J.J. van Rood, M.J. Giphart and M. Tilanus. The plasmid 
DNA was nick, translated in a total volume of 20ul. To 2ul (200ng) 
of plasmid DNA, containing the probe, was added 2ul of 10x nick 
translation buffer (0.5M Tris HC1 (pH7.8), 50mM MgCl2 > 100mM.B- 
mercaptoethanol) 1ul (50pmol) each of dATP and dCTP, 1ul 
OOOpmol) each of dGTP and dTTP, 5ul (50uCi, 600Ci/mmol) each of 
[a-3 2 P] dATP and [a-3 2 P] dCTP, 1ul (0.04ng) DN-ase and 1ul (5u) 
DNA polymerase. This was incubated at 15°C for 1 hour. The 
labelled probe was isolated from the unincorporated nucleotides 
by sephadex G-50 chromatograpy (Devilee et al 1984).
d. pHPL8l5 This full length cDNA insert for human placental 
lactogen in pBR322 (Barrera-Saldana, Robberson & Saunder, 1982) 
was a kind gift of Dr G Saunders. It was nick translated using 
the same protocol as shown for pDPOOI.
4:2:19 Screening the cDNA library with antibody Probes
^gt11 libraries can be screened with antibody probes as 
plaques on a lawn of E.coli Y1090 (11cmx 11cm). 100ul of Y1088 
plating cells were incubated with 2 .5x1 0** pfu of the library for 
each plate at 37°C for 15 minutes, then 3 0 0 ul Y1090 plating cells
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are added. After the adsorption of the phage to the cells 5 mls of 
molten (45°C) soft BBL agar was added and the mix was poured onto 
dry BBL plates which were incubated at M2°C for three hours. Then 
the plates were removed to a 3 7 °C’incubator and overlaid with 
dry nitrocellulose filters which had been soaked in 10mM IPTG. 
The plates were incubated at 37°C for 5 hours then removed to RT. 
The position of the filter on each plate was marked and the 
filters removed. The filters were washed 5x in TS buffer (5 0 mM 
Tris HC1 pH8 , 150mM NaCl) for 30 minutes then incubated at RT in 
5% BSA in TS buffer (10-15ml/filter) for 1 hour. Ihe filters were 
then incubated overnight, at RT, with antibody (rabbit antisera
directed against PLAP or hPL) diluted 1:100 in 5% BSA in TS
t
buffer. The filters were then washed again in TS buffer for 30 
minutes before incubating in 1 : 1 0 0 0  dilution of peroxidase- 
conjugated goat anti-rabbit IgG in 5% BSA in TS buffer for 4 
hours. After a further 5 washes in TS buffer the reaction was 
developed by soaking the filters in either 3 ,3 'diaminobenzidine 
(30mg/ml) in 50mM Tris HC1 pH7.4 or o-phenylenediamine in 
phosphate-citrate buffer pH 5.0, 0.05% H2 O2 was added to both 
solutions just before use. The reaction was terminated by washing 
the filters with water and drying.
As the antibodies used contained components which bind 
to antigens produced by E.coli the antibodies used were 
preadsorbed three times with E.coli lysate bound to
4
nitrocellulose filters at a 1 : 1 0 dilution for 30 minutes.
4:2:20 Amplification of the cJM library
The cDNA library was amplified by plating out the 
library at a density of 2 .5 x 1 0  ^pfu per 9 0 mm petri dish using
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100ul of plating cells per plate and freshly made plates. After 
incubation for 6 hours the plate stock was prepared by overlaying 
the plates with cold PDB then leaving at 4°C overnight to allow 
the phage to diffuse into the PDB: The'overlay solution was 
removed from the plates and to it was added a few drops of CHCl^ . 
This amplified phage stock was stored at 4°C (Davis, Botstein & 
Roth, 1980).
4:2:21 Phage mini preps
Individual colourless plaques for \gt11 and clear 
plaques for \gt1 0 were picked, using a pasteur pipette, from 
f,phage stock” dilutions which give well seperated plaques. The 
plaques and put into 1ml of PDB containing 20ul of chloroform and 
these phage suspensions were stored at 4°C, to allow the phage to 
diffuse into the buffer. Several different procedures were used 
for the isolation of DNA from the phage suspensions.
a. Liquid culture method!- This method is an adaptation of the 
procedure of Leder et al (1977). To 4.5ml of LB plus was added 
1 0 0 ul of fresh bacterial cells from an overnight culture and 
0.5ml of a 'phage suspension. The mixture was incubated with 
aeration overnight (at 37°C for gt10 or 42°C for gt 11), until 
lysis occured. Then 100ul of chloroform was added to the culture 
and it was incubated for a further 15 minutes before centrifuging 
at 8000g for 10 minutes at 4°C to remove the bacterial debris and
4
the supernatant treated with RNase A (1mg/ml) and DNase I 
(1mg/ml) at 37°C for 30 minutes.
b. Plate lysate method|- This is an adaptation of the procedure 
described by Maniatis et al (1982), To 100ul of plating cells was 
added 50ul of the 'phage suspension this was incubated at 37°C
130
for 15 minutes. Mol ton BBL 0.65% agarose was added and the mixes 
were poured onto freshly made BBL plates which were incubated at 
42°C, until the plaques were beginning to touch. The phage were 
eluted from the agarose by adding 5 ml of PDB to each plate and 
storing for 2-4 hours at RT with constant gentle shaking or at 
4°C overnight. The bacterial debris was removed from the solution 
by centrifuging at 8000g for 10 minutes at 4°C. The supernatant 
was also treated with RNase A (1mg/ml) and DNase I (1mg/ml) at 
37°C for 30 minutes.
The 'phage particles were recovered from the 
supernatants by centrifugation at 48000g for 30 minutes at 4°C, 
the pellet was resuspended in 0.5ml of PDB. To isolate the DNA 
the resuspended phage particles were adjusted to 0.1% SDS and 
incubated at 65°C for 10 minutes with either 5ul of 0.5M EDTA 
(pH 8.0) or with 75ul of 2M NaCl/0.1M EDTA. The mix was extracted
a.
twice with phenol/chloroform, once with chloroform and once with 
ether. The final aqueous phase was precipitated using either an 
equal -volume of isopropanol at -70°C or 2 volumes of ethanol. The 
pellet was washed with 70% ethanol, dried and resuspended in TE.
The DNA was restricted in a total volume of 20ul using 
2ul of 10xHSB or 10x core buffer and 2 units of EcoRI. The DNA 
fragments of the restriction digest were analysed by gel 
electrophoresis.
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4:3 RESULTS
4:3:1 Estimate of the amount of cDNA synthesised
j
From the incorporation of.32P into the DNA during the 
first strand synthesis reaction, assayed by TCA precipitation 
(table 4.2), it is possible to estimate the amount of cDNA 
synthesised. Between 5-50% of the concentration of poly(A+) RNA 
used should be reverse transcribed into cDNA. Using 2ug of 
placental poly(A+) RNA the mass of cDNA synthesised was between 
0.41-0.58ug (21-29%).
4:3:2 Analysis of the size distribution of the cDNA
The reserved 1% sample reaction volumes from the first 
and second strand synthesis of the cDNA and after S1 nuclease 
treatment were used to analyse the size distribution of the 
reaction products by running the three samples in adjacent tracks 
in an 1.2% alkaline agarose gel. Figure 4.1 (tracks 1 & 2) shows 
that the average size of the cDNA after first strand synthesis 
1kb. After second strand synthesis the size of the cDNA doubled, 
due to the presence of the nhair pin” structure (figure 4.1, 
tracks 3 & 4). The "hair pin" was digested with S1 nuclease 
(figure 4.1, tracks 5-9). The optimal amount of S1 needed to 
reduce the size of the cDNA to that of the first strand reaction 
products was shown by the titration of S1 nuclease to be 
24000u/ml (figure 4.1, track 6 ). '
4:3:3 Analysis of EcoRI Linker addition to the double-stranded 
cDHA
A 10% polyacrylamide gel in TBE buffer was run to check
132
TABLE 4.2
% TCA p re c ip ita b le  counts, a f t e r  f i r s t  strand synthesis  : (a )  0 .6 2 *
(b) 0.657
(c )  0.897.
(d) 0 .8 5 *
(e )  0.797
cDNA synthesised = 4 x 7  in c o rp o ra tio n  o f  [32p]dATP x re ac tio n  volume (u l)  x m o les /u l x mw o f dNTP
100
= 4 x 7  in c o rp o ra tio n  o f [32p]dATP x 50 x 10” 3 x 330 
100 106 
'= * in c o rp o ra tio n  o f  [32p]dATP x 6.6 x 10“^ g
cDNA synthesised using 2ug o f poly (A+ ) RMA: (a )  0.41ug
(b ) 0.43ug
(c )  0.59ug
(d ) 0.56ug
(e )  0.52ug
Table 4.2: Estimation of the amount of cDNA synthesised by 
assaying the incorporation of 3 2 P into the cDNA during the first 
strand synthesis by TCA precipitation.
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Figure 4.1: 1% samples of syncytiotrophoblast cDNA
were run on 1.2% alkaline agarose gels, the gel was dried and 
autoradiographed.
1: Size standards, \ Hind III 
2: First strand cDNA product 
3: First strand cDNA product 
4: Second strand cDNA product
5: cDNA after digestion with 4800u/ml S1 nuclease
6: cDNA after digestion with 2400u/ml S1 nuclease
7: cDNA after digestion with 1200u/ml S1 nuclease
8: cDNA after digestion with 600u/rnl S1 nuclease
9: cDNA after digestion with 300u/ml S1 nuclease
12345
m  i i i
34 56789
ii > ii 11
Figure 4.2: 10% TBE polyacrylamide gel, showing the removal of excess 
EcoR1 linkers with isopropanol precipitations and EcoRI digestions.
1: cDNA, EcoRI linker ligation mix
2: supernatant from the 1st isopropanol precipitation
3: precipitate v " n 1 "
4: supernatant from the 2nd isopropanol precipitation
5: precipitate " " ” n M
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that the excess EcoRI linkers were removed from the cDNA sample 
by the isopropanol precipitations and EcoRI digestion (figure 
4.2). In track 1, a ladder of linker oligomers can be seen, due 
to the 100:1 molar excess of, linkers present in the 
cDNA:(EcoRI)linker ligation. The first isopropanol precipitation 
has the effect of removing the linker ladder below 100bps (track 
2 &3), as only DNA of >100bps was precipitated. The remaining 
linker oligomers were shown to have been digested by EcoRI 
using a second isopropanol precipitation. Track 4, the non­
precipitated material, shows that the linkers have been digested 
by the EcoRI to unligated linkers and track 5, the precipitated 
material, shows the linkerrcDNA free from excess linkers.
4:3*.4 Size fractionation of cDNA
The size fractionation of ds cDNA using a bio-Gel 50 
column gives an elution profile as shown in figure 4.3. By 
comparing this profile with that obtained with Hinf I pBR322 
fragments the actual size of the cDNA in each fraction was 
determined and is shown in figure 4.3. From this it was possible 
to determine the actual size of cDNA used in the cDNA cloning 
procedure. Only cDNA fractions with a size of 1Kb and greater 
were used in the cloning of cDNA into \gt10.
4:3:5 Screening ihg cDNA library with nucleic acid probes
The cDNA library cloned into \gt10 contained 7.8 x 10^ 
recombinants (table 4.3). To ascertain that these recombinants 
were of a placental origin they were screened using a placental 
cDNA probe. The results (figure 4.4) show that 10% of the 
recombinants hybridised to this probe.
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Figure 4.3: Size fractionation of 3 2 p _ i a b e l l e d
syncytiotrophoblast cDNA. (a) The elution profile of the cDNA from a 
bio-gel 50 column, (b) The column was calibrated with Hinf I pBR322 
fragments.
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>TABLE 4.3
\gt10:cDNA Total pfu/ug clear pfu/ug % Recombinants
1 0 2.3 x 105 5.0 x 102 0.22
a 1 1 2.4 x 105 3.0 X 104 12.50
b 1 1 2.5 x 105 2.0 x 104 8.00
c 1 1 2.2 x 105 1.6 x 104 7.27
d 1 1 2.2 x 105 1.2 x 102* 5.45
Table 4.3: Efficiency of syncytiotrophoblast cDNA cloning into 
\gt10. The total number of recombinant clones obtained was 7.8 x
1 04.
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Figure 4.4: Screening of the recombinant \gt10 library with 
placental cDNA probe. Approximately 10$ of the recombinants 
hybridized to the cDNA probe under stringent hybridization 
conditions.
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The 14 base PLAP oligonucleotide probe did not hybridise 
to any of the recombinants in this \gt10:cDNA library, at low 
stringency washes. However, the 26 base PLAP oligonucleotide 
detected 24 recombinants in the amplified, library; 55°C at high 
stringency washes. As the library was screened at a density of 
250pfu/cm^ the PLAP recombinants could not be picked without also 
picking some of the surrounding non-PLAP recombinants. These 
recombinants, after amplification, are in the process of being 
rescreened. Figure 4.5 shows that PLAP clones compose 
approximately a third of the recombinant clones present in the 
PLAP amplified stock.
The library was also screened with the 14 base 
oligonucleotide for hPL. Figure 4.6a shows that 0.01% of the 
)tlibary screened remained hybridised to the hPL oligonucleotide 
probe after stringent washing conditions. This result was also 
seen with the full length hPL probe pHPL8l5 (figure 4.6b). The 
hPL mRNA accounts for 15-20% of the total mRNA present in the 
syncytiotrophoblast mRNA and thus one would expect a higher 
percentage of the recombinants to be hPL clones (Barrera-Saldana 
et al, 1982). However, the hPL gene has a known mRNA sequence of 
815 bases and only cDNA fragments of 1Kb and greater were cloned. 
Thus hPL cDNA sequences may be under-represented in this library.
The library has also been preliminarily probed using the 
class I HLA cDNA probe pDP001. Under high stringency washing 
conditions this probe hybridised to 0.1% of the amplified library 
screened, figure 4.7.
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Figure 4.5: Rescreening of the 'PLAP' recombinant,amplified, 
\gt10 clones with 26mer PLAP oligonucleotide. Approximately a 
third of the recombinants hybridized to the PLAP probe under 
stringent hybridization conditions.
140
A B
••
Figure 4.6: Screening the amplified recombinant \gt10 library 
with hPL probes, (a) hPL, 14mer, oligonucleotide (b) pHPL8l5 hPL 
cDNA probe. From a total of 25,000pfu plated only three of the 
recombinants hybridized to the probes under stringent hybridization 
conditions.
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Figure A.7: Screening the recombinant, amplified, \gt10 library 
with the class I HLA probe pDPOOI. Using stringent hybridization 
conditions. 30 clones hybridized to the HLA probe from a total of 
25,000pfu plated
4:3:6 Screening \ gt11 clones
With the protocol outlined in the methods one expects up 
to 30% recombinants in a \gt11 library. Even with the DNA in 
great molar excess (table 4.4A) the maximum percentage of 
recombinants obtained was 3.4%. These recombinants were screened 
with antibody probes for hPL and PLAP on a lawn of Y1090. As no 
hybridisation was detected DNA was prepared from 10 randomly 
chosen clear plaques and digested with Eco RI. None of the DNA 
from these or other plaques tested showed insert fragments. In 
most of the cases this was due to the insensitivity of the DNA to 
digestion with EcoRI.
To obtain a higher percentage of recombinant phage, 
commercially obtained dephosphorylated ^ gt11 arms were used. The 
advantage of this is that with the removal of the 5' terminal 
phosphate the vector arms cannot be ligated together in the 
absence of insert DNA. Using VCS \£t11 arms 91-98% of the plaques 
obtained were colourless and thus recombinants. However, the 
total number of recombinants obtained was only 120, table 4.4B, 
the expected number was between 5x10^ and 1x10^ . Several control 
ligations (table 4.4C) using the test insert, 4Kb EcoRI Rheo
q
fragment, provided with dephosphorylated gt11 arms gave 3.3x10-’ 
recombinants. This was a thousand fold lower than quoted in the 
data sheet. The 120 placental cDNA recombinants were screened 
using antibody probes without sucess. A second batch of 
dephosphorylated ^gt11 arms were obtained from VCS. The results 
obtained from test ligations was indicitive of poor 
dephosphorylation (table 4.4D).
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TABLE 4.4
Total Recombinant
Molar ratio pfu/ug pfu/ug % Recombinants
Agt11 :cDNA
a 1 0 5.9 X 107
1 1 5.0 X 10? _
1 2.3 X 107 - -
b 1 0 1.5 X 1 0 6 _
1 1 1.4 X 10I 5.1 x 105 3.6
1 3.0 X 1 0 6 - -
c 1 0 1.1 X 107
1 . 1 1.8 X 107 2.7 x 105 1.5
d 1 0 1.6 X 10I 1.6 x 105 0.11 1 7.0 X 106 3.5 x 101* 0.5
1 2 1.0 X 1 3.4 X 105 3.4
1 4 7.1 X 106 1.33x 105 1.9
2 1 1.0 X 106 2.6 x 104 2.6
4 1 2.3 X 107 2.0 x 1011 0.08
B. VCS1 ^gt11:cDNA
a 1 : 1  120 120 100
b 1 : 1 104 103 99
C. VCS-j ^gt11:Rheo
a 1 : 1 3.9 x 103 3 . 8 5 x 103 99
b 1 : 1  3.2 x 103 3.2 x 103 100
c 1 : 1  2.9 x 103 2.85 x 103 9 8
d 2 : 1  5.44x 103 5 . 3 8  x 103 99
D. VCS2 Agt11:Rheo
a 1 : 1  9.7 x 1oJ 4.0 x 103 4
b 1 : 1 1.5 x 105 5.0 x 103 3.3
Table 4.4: Efficiency of cDNA cloning into^gt11:
A: Using different molar ratios of \gt11 arms and. 
syncy tiotrophoblast cDNA.
B: Using VCS dephosphorylated Agt11 arms (1st batch) and 
syncytiotrophoblast cDNA.
C: Using VCS dephosphorylated Agt11 arms (1st batch) and 
the 4Kb EcoRI Rheo fragment as a test of the efficiency of cDNA 
cloning.
D: Using VCS dephosphorylated N^ gtl 1 arms (2nd batch) and 
the 4Kb EcoRI Rheo fragment as a test of the efficiency of cDNA 
cloning.
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4:4 DISCUSSION
A syncytiotrophoblast cDNA.library has been cloned into 
\>gt10. This is not a total library as only cDNA fragments of 1Kb 
and greater were cloned. The reason for this was primarily to 
ensure the presence of PLAP sequences capable of hybridising to 
the 5’ oligonucleotides, it also seemed likely to exclude hPL 
clones from the library. As the hPL message accounts for 15-20% 
of the mRNA present it was hoped that its removal would enhance 
the chance of detecting PLAP clones. The short 14 base 
oligonucleotide for PLAP did not detect any clones whereas the 
longer PLAP oligonucleotide did. This is probably due to its 
increased size, though it was also slightly further (36 bases) 
from the 5'end.
The clones isolated for PLAP need to be further 
characterised, to ascertain the size of the cDNA inserts and to 
determine their homology to each other and to the PLAP probe used 
in their isolation. Once characterised, these clones can be used 
to screen the library for longer cDNA clones and in the stepwise 
method it may be possible to isolate cDNA clones covering the 
whole coding region for PLAP.
cDNA clones showing homology to the HLA class I DNA 
pDP001 were also detected in this library. This is interesting 
and these clones definitely need characterising since serological 
evidence to date indicates that classical class I determinants' 
are thought to be absent from the syncytiotrophoblast (chapter 
1). The main avenues for the investigation of these these clones 
would be restriction mapping, sequencing and the comparison of 
hybridisation patterns of these clones and other HLA cDNA probes
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(see chapter 5).
Polyvalent antibodies have been used sucessfully to 
isolate genes from Agt11 libraries .but this is very dependent on 
the titre of the antibody and whether it can bind to antigenic 
determinants on.the fusion protein expressed in the gt11 vector. 
Colourless, recombinant, plaques were isolated from the gt11 
library. However, no plaques were isolated by screening with hPL 
or PLAP antibody probes and no DNA insert fragments were 
detected. As the excess linkers were removed from the cDNA used 
for this library by isopropanol precipitation and not size 
fractionation, it was assumed that linker contamination had lead 
to the appearance of false recombinants. Unfortunately the 
commercially obtained VCS \gt11 dephosphorylated arms did not 
live up to expectations and only 120 recombinant plaques were 
obtained. At least 10^  recombinants are needed to have a library 
containing clones of rare mRNAs.
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CHAPTER 5
D I S C U S S I O N
/
4
DISCUSSION
In the last decade since the first reports of molecular 
cloning (Efstratiadis et al 1976), this technology has evolved 
into a invaluable tool in the molecular analysis of eukaryotic 
genes. The use of \ cloning vectors now make it possible to clone 
and express mRNAs which are of low abundance in the mRNA 
population (Huynh, Young & Davis, 1984).
A syncytiotrophoblast cDNA library was constructed 
(chapter 4) in the lambda vector \gt10 and consisted of 7.8x10^ 
recombinants. This was not a complete library of all the 
synthesised cDNA sequences, as the cDNA has been size 
fractionated. Only cDNAs of 1Kb and greater were cloned 
representing 42% of the total cDNA synthesised. The evidence that 
the recombinant 'phage did contain placental cDNA inserts was 
obtained by screening both the syncytiotrophoblast cDNA library 
and a control, Rheo, library with a random primed 
syncytiotrophoblast cDNA probe. Approximately 10% of the 
syncytiotrophoblast cDNA recombinants hybridised to this probe 
but none of the rheo recombinants.
Khalaf (1985) has done an extensive immunohistological 
study to measure the level of contamination in cytotrophoblast 
preparations from the chorionic plate. In the placental 
preparations she studied between 65-85% of the cells were
4
cytotrophoblast, the main contaminants being endothelial cells 
and lymphocytes. No immunohistological work has been done to 
determine the level of contaminating cells in the 
syncytiotrophoblast preparations used in the creation of the cDNA 
library. The analysis of the mRNA in vitro translations shows
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the major synthesised polypeptide to be hPL, a trophoblast tissue 
specific protein with an abundant message. By screening the 
syncytiotrophoblast library with DNA probes for genes known to be 
absent from the syncytiotrophoblast and present in the possible 
contaminants the percentage contamination could be assessed. 
Also the tissue specificity of interesting clones isolated can 
determined by dot hybridisations using RNA from placental and 
other tissue.
This placental syncytiotrophoblast cDNA library contains 
clones which hybridise to the PLAP oligonucleotide probes; if 
these clones are found to be of PLAP cDNA, they will be among the 
first human enzyme polymorphisms to be cloned. First one needs to 
determining the homology of the PLAP clones to each other, this 
can be done by restriction mapping of the clones. Southern blots 
of 32p-labelled pl p^ clones to restriction enzyme digested human 
DNA, and northern blots of placental RNA will enable the 
hybridisation patterns of the different PLAP clones to be 
compared. To ascertain without doubt that these clones do indeed 
contain PLAP sequences would involve comparison of the known 
amino acid sequence of PLAP with the di-deoxy sequenced PLAP cDNA 
inserts. These PLAP clones can be used to screen the library for 
longer cDNA clones, as these clones were detected by an 
oligonucleotide from the amino-terminal end of the PLAP amino 
acid sequence one would expect them to be near full-length.
4
Because S1 nuclease is used to digest the hairpin structure the 
cDNA clones will lack some sequences corresponding to the 5' 
untranslated region of the mRNAs.
PLAP polymorphisms have been investigated at the protein 
level through monozygotic and dizygotic twin studies and by
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population studies in different racial groups (Robson & Harris, 
1965 & 1967; Beckman & Beckman, 1968 & 1969). At the protein 
level three common , alleles and 15 rare alleles have been 
identified by starch gel electophoresis, though the structural 
basis for this polymorphism has not been determined (Donald & 
Robson, 1973; Harris et al, 197*0. Clearly they must involve 
amino acid substitutions, these substitutions may be extensive 
since some monoclonal antibodies are known to recognise 
different PLAP phenotypes seen on starch gels as well as other 
phenotypes not detected by starch gels (Slaughter et al, 1981; 
Millan et al, 1982b). Sequencing of cDNA clones will reveal the 
extent of these amino acid substitutions.
As some of the amino acid substitutions alter 
restriction enzyme cleavage sites they can be detected in total 
genomic DNA by the use of cocktails of restriction enzymes and 
specific probes, also any restriction sites which map outside the 
gene but are in linkage disequilibrium will aid the detection of 
the different alleles. By using the cloned PLAP gene it may be 
possible to distinguish the PLAP genotypes at the DNA level. This 
has the advantage that one can phenotype any individual in the 
population rather than the placentae from a small subset of the 
population. At the moment the maternal genotype is deduced from 
placental phenotypes. The aim is to use the cloned PLAP gene to 
determine whether there is any correlation between PLAP genotype
4
and pregnancy diseases. By determining the genotype of PLAP for 
mother, father and placenta in normal pregnancies, spontaneous 
abortions and complications of pregnancy, one may be able to 
detect a relationship between PLAP genotype and the success of 
pregnancy.
The evolution of the different forms of AP is of great 
interest, the structural basis of the unusual polymorphism of 
PLAP and the differences between the three human isoenzymes is 
not known. Post-translational modifications may account for the 
different catalytic and electrophoretic properties shown by these 
enzymes and the altered glycosylation could change the antigenic 
sites of the different enzymes. To determine the relationship 
between PLAP, PLAP-variants and the other human AP’s requires 
structural studies. At the protein level Ezra et al (1983) have 
reported, to date, the 40 N-terminal amino acids for PLAP and 
PLAP-like variants to be identical. By studying PLAP at the 
molecular level one may be able to detect the reason for PLAP’s 
high level of genetic polymorphism, which may be due to gene 
conversion. Also as PLAP or PLAP-like proteins are expressed in 
ovarian and some other tumours we can compare the nature of the 
villous PLAP gene with the PLAP-like gene expressed in tumours. 
The use of PLAP clones will enable us to determine how closely 
related the placental PLAP and tumour PLAP genes are. The PLAP 
clones can also be used to screen human genomic libraries for 
other alkaline phosphatase genes.
Immunohistology has indicated that HLA class I genes are 
only expressed on non-villous trophoblast (Sunderland et al, 
1981 a&b; Redman etai, 1984). Screening my syncytiotrophoblast 
cDNA library with the full length class I probe pDP001 has
4
detected cDNA clones which hybridise to this probe. As no HLA 
class I determinants have been detected on the villous 
trophoblast by immunohistology the study of these HPL-like 
syncytiotrophoblast cDNA clones will determine the relationship 
between these syncytiotrophoblast HLA u e uerniiiicinus anu ouner
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tissue HLA determinants. It is already known that the HLA 
determinants expressed on the non-villous cytotrophoblast are not 
the fetal or maternal HLA A and B allotypes (Redman, 1983). The 
further characterization of the human 7:cytiotrophoblast class I 
determinants depended on a supply of purified cytotrophoblast 
cells. Khalaf (1985) purified cytotrophoblast cells from the 
chorionic plate of term placenta. The resultant mRNA was analysed 
together with mRNA from the syncytiotrophoblast and is being used 
as a source of mRNA for the creation of a cytotrophoblast cDNA 
library. By probing future cytotrophoblast cDNA libraries with 
established clones of HLA class I genes, we will be able to 
detect cytotrophoblast HLA clones and establish the nature of the 
HLA genes expressed in this type of human cytotrophoblast. The 
available evidence suggests that they will either belong to HLA C 
or to a yet unknown HLA class I locus. The latter possibility 
would mirror murine H-2 where 36 distinct class I genes are 
found in the BALB/C genomic cosmid library, of which 10 are, as 
yet, uncharacterised (Goodenow et al, 1982; Steinmetz, 1984; 
Redman, 1983).
The placental cDNA libraries, both syncytiotrophoblastic 
and cytotrophoblastic, can also be screened for HLA class II 
antigens, though most of the available immunohistological results 
indicate that no class II determinants are detectable on 
placental tissue in situ (Faulk & Temple, 1976; Goodfellow £t al,
4
1976; Sunderland et a!, 198la&b). Whether this is the case in 
vitro is not yet clear. HLA-DR antigens have been reported to be 
present in first trimester placental cultures, this work has yet 
to be confirmed by other groups (Brami £t al, 1983). Khalaf 
(1985) failed to find class II expression in cultured
cytotrophoblast at term.
Allotypic expression of some paternal HLA antigens and 
ABO blood group antigens are known to be absent from the placenta 
(Faulk & Temple, 1976; Redman, 1983). Other minor 
histocompatibility antigens are very probably present in man 
since in the mouse is known to have more than 30 minor 
histocompatibility antigen loci. However, in neither mouse nor 
man have the expression of such systems been explored in detail 
in the placenta. The evidence for trophoblast components acting 
as antigenic determinants which elicit a maternal immune response 
is varied. The results presented in chapter 2 show that though 
agglutinins were present in term maternal sera they were not an 
antibody response against trophoblast components. Davies & Browne 
(1985a&b) using an ELIZA assay have detected anti-trophoblast 
antibodies in maternal sera during pregnancy, whereas N. Hole and 
P.M. Johnson (Liverpool group, unpublished observations) using a 
similar ELIZA assay detected no maternal antibody reactivity 
against trophoblast surface determinants. The cDNA libraries 
which are originally cloned into Agt10 can be easily transferred 
to Agt11 by digesting the ^gt10 cDNA recombinant DNA with EcoRIT 
recovering the cDNA inserts from low melting point agarose and 
ligating this with EcoRI cut ^gt11 DNA. If maternally-recognised 
trophoblast antigens are detected and purified, polyclonal 
antibodies could be raised. Though it is almost certain that
4
these antibodies would be of a low affinity they could be used to 
screen placental cDNA libraries constructed in the lambda 
expression vector g^t11. The ^gt11 placental cDNA library could 
be screened with high affinity monoclonal antibodies from 
hybridomas formed from Epstein-Barr transformed maternal
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lymphocytes as this method produces antibodies to antigens 
present in normal lymphocytes the antibody specificity needs to 
be confirmed before the antibodies are used. Several trophoblast 
antigens and antigen systems have been identified by xenogeneic 
antisera or monoclonal antibodies (Faulk £t al, 1978; Johnson jst 
alT 19 8 1; Brown et a!, 1983). Again by using a \ expression 
vector such as \ gt11 it may be, possible to probe a placental 
cDNA library with these antibodies and characterise the genes 
involved.
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TROPHOBLASTIC CELLS AND MARKERS
S.A. K h a la f ,  J.C. L iv in g s to n e ,  D.A. N ic k s o n , S.J. H enderson  and 
R.G. S u t c l i f f e *
In s t i t u t e  o f  G ene tics , U n iv e rs ity  o f Glasgow, Church S tre e t ,
Glasgow G il  5JS, S c o tla n d , UK.
INTRODUCTION
In  re c e n t years the  plasma membrane components o f the  human tro p h o b las t  
have a t t r a c t e d  in c r e a s in g  in t e r e s t .  T h is  p a p e r d e s c r ib e s  p ro g re s s  in  two  
d ir e c t io n s , the  f i r s t  being to  is o la te  norm al human p la c e n ta l c y to tro p h o -  
b la s t  c e l ls  in  Order to  c h a ra c te r is e  t h e i r  h is to c o m p a t ib i l i ty  a n tigen s . The 
second r e la te s  to  the  enzyme p la c e n ta l a lk a l in e  phosphatase (PLAP), which is  
the  q u a n t i ta t iv e ly  m ajo r c e l l  membrane p ro te in  o f the  s y n c y tio tro p h o b la s tic  
m ic r o v i l l i .
ISOLATION AND ANALYSIS OF CYTOTROPHOBLAST
The tro p h o b la s t o f the  p la c e n ta l v i l l i  la c k  ^ -m ic r o g lo b u lin  ( ^ M )  and the  
m onom orphic d e te rm in a n ts  o f th e  .HLA c la s s  I  h eavy c h a in , d e f in e d  by 
m o n o c lo n a l a n t ib o d ie s  such as W 6/32  and PA 2.6  ( 6 ,2 1 ) .  T h is  seems to  a p p ly  
to  both  the  s y n c y t ia l la y e r  o f tro p h o b la s t and th e  u n d erly in g  zone o f c y to -  
tro p h o b la s t. C onversely , the  c y to tro p h o b la s t o f  the  u te ro p la c e n ta l in t e r ­
fa c e , w hich invades the  u te r in e  decidua expresses HLA c la ss  I  determ inan ts  
and ^ M ,  as a ls o  does the  c y to tro p h o b la s t o f  the  r e f le c te d  chorion  (1 8 ,2 2 ). 
A s i m i l a r  p a t t e r n  o f  MHC e x p re s s io n  e x is t s  in  th e  mouse ( 1 2 ) .  The f u r t h e r  
c h a ra c te r is a t io n  o f human c y to tro p h o b la s tic  c la ss  I  d ete rm inan ts  depends in  
p a r t  on the  supply o f  p u r if ie d  c y to tro p h o b la s t c e l ls .  Id e a l ly  these should 
come from  norm al p lacen tae  ra th e r  than choriocarc inom as, e s p e c ia lly  s ince  
some c e l ls  change t h e i r  p a tte rn  o f MHC a n tig e n  expression  when transform ed . 
The c h o r io n ic  p la t e  o f  th e  p la c e n ta  a t  te rm  c o n ta in s  a s u b s ta n t ia l  
p o p u la t io n  o f  c y to tr o p h o b la s t  (F ig u r e  l a ) .  These c e l l s  s t a in  r e a d i l y  f o r  
c y to k e ra tin s  ( f ig u r e  lc )  w hich a re  e p i t h e l ia l  m arkers w hich can be used to  
d if f e r e n t ia t e  th e  c e l ls  from  mesenchymal and e n d o th e lia l c e l ls  (1 6 ,2 4 ). The 
c e l ls  a re  embedded in  dense reg ions o f f ib r o n e c t in  ( f ig u r e  lb ) ,  covered by 
am n io tic  low  colum nar e p ith e liu m  on i t s  f e t a l  aspect. A f te r  rem oval o f  the  
amnion s e r ia l  fro ze n  sectio ns  ( f ig u r e  2) o f the  c h o rio n ic  p la te  showed c e l ls
To whom correspondence should be addressed.
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Figure 1. Sections of the chorionic plate of human placenta at term, stained 
(a) with H & E; (b) with rabbit anti fibronectin; (c) with mouse monoclonal 
PKK1 antibody to cytokeratin. In (c), the amniotic epithelium does not stain 
with PKK1. A = amnion; X = separation zone between amnion and chorionic 
plate; B = intervillus space; V = placental villus. Magnified x33.
staining for cytokeratins, anc^  class I HLA determinant W6/32.
We wished to characterise these HLA determinants for several reasons. 
Firstly, it is clear that in the mouse there are multiple class I genes in 
addition to the classic serologically detectable K and D loci; most of these 
genes map in the Qa/Tla region of mouse MHC (20). Since there is remarkable 
homology between many of the genes of human and mouse MHC, these genes may 
exist and be expressed in the human MHC. A recent report (18) on pregnancies 
in which the maternal and fetal HLA types were known to be different, showed 
that the expected fetal allotype could not be detected on cytotrophoblasts 
that expressed the monomorphic determinant.
We therefore attempted to purify the cytotrophoblast of the chorionic 
plate. Briefly, the amnion was removed, together with the main blood vessels 
and the underlying villus material. The dissected chorionic plate was 
trypsinised with 0.25% trypsin in culture medium containing antibiotics. 
After lh the supernatant was discarded and four further aliquots of fresh 
trypsin were added in succession at 15 min intervals at 37C. The supernat­
ants of these digestions were retained and the cells were recovered by 
filtration through muslin, followed by centrifugation to the interface of
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Figure 2. Serial frozen sections of chorionic plate stained (a) with 
monoclonal PKK1 anti-cytokeratin and (b) W6/32. Magnified x56.
TABLE PERCENTAGES OF ISOLATED CHORIONIC PLATE CELLS STAINING FOR VARIOUS
DETERMINANTS
PLACENTA: A B C D E ¥_ G
SPECIFICITIES
W6/32 (Class I) 50 62 79 58 64 89 76
(SjM (Class I) 59 70 75 53 60 75 70
DA6.231 (Class II) 15 21 6 - - - -
Troma 1 (Int. filament) 57 59 80 - - - -
Cytokeratin 68 69 86 61 65 83 70
Vimentin 4 6 11 4 9 10 8
Leucocyte common ag. 1 3 4 4 7 5 7
Blood group substance 10 8 12 2 10 11 6
Fibronectin 50 69 78 - - - -
PAPP-A 60 70 73 - - - -
SP1 42 51 58 - - - -
hPL 39 52 56 - - - -
o(-hCG 19 25 23 13 10 22 23
(S-hCG 12 13 9 2 9 10 11
H315 17 19 25 - - - -
H316 36 49 58 - - - -
7A11 - - - 55 60 62 73
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15% and 52% p e r c o l l ,  in  a d isco n tin u o u s  g ra d ie n t. Where necessary , re s id u a l  
red blood c e l ls  were removed w ith  a s in g le  tre a tm e n t w ith  Gray's s o lu tio n .  
The v i a b i l i t y  o f  th e  f i n a l  c e l l  p r e p a r a t io n s  ran ged  fro m  40-98%  . F u l l e r  
d e ta i ls  o f the  method a re  to  be found e lsew here (1 4 ) .
C ytospin p re p a ra tio n s  o f  th e  is o la te d  c e l ls  w ere s ta in e d  f o r  a v a r ie t y  
o f h is to c o m p a tib i l i ty  and p la c e n ta l  s p e c i f ic i t ie s ,  as shown in  ta b le  1. The 
m a jo r ity  o f the  c e l ls  s ta in e d  f o r  c y to k e ra t in s , as expected , and s u b s ta n tia l  
numbers o f c e l ls  expressed d e te rm in a n ts  f o r  W 6/32, (ijM , f ib r o n e c t in ,  PAPP-A, 
SP1 and hPL. 10-25%  e x p re s s e d  th e  a lp h a  c h a in  o f  hCG, and 2-13%  th e  b e ta  
chain . I t  is  probable th a t  these c e l ls  a re  s im i la r  to  in te rm e d ia te  c y to t r o -  
p h o b las tic  c e l ls ,  w hich express hPL and a re  somewhat v a r ia b le  in  morphology 
and in  t h e i r  expression  o f SP1 and b eta  hCG (1 5 ). Leucocyte common a n tig e n  
and v im e n tin  s ta in ed  a s m a ll f r a c t io n  o f th e  is o la te d  c h o rio n ic  p la te  c e l ls ,  
in d ic a tin g  th a t  th e re  was l i t t l e  c o n tam in a tio n  w ith  n o n -e p ith e l ia l  c e l ls  or 
le u c o c y te s . The p re s e n c e  o f  e n d o t h e l ia l  c e l l s  was assayed  th ro u g h  th e  
a f f i n i t y  o f the le c t in  U lex europaeus I  f o r  the  fucose res id ues  o f  th e  ABH 
b lo od  group sub s tan ce  ( 9 ) .  On t h i s  b a s is  e n d o t h e l ia l  c o n ta m in a t io n  was 2 -  
11%. T h ere  was no e v id e n c e  o f  f i b r o b la s t  c o n ta m in a t io n  in  th e s e  p r e p a r ­
a t io n s ;  no f i b r o b la s t  o u tg ro w th s  w e re  e v e r  o bserved  in  c u l t u r e .  H o w ev e r, 
d es p ite  the  h igh  v i a b i l i t y  o f  th e  c e l l s ,  th e re  was no susta ined  d iv is io n  in  
the  c u ltu re s  and we w ere unab le  to  m a in ta in  the  c e l ls  in  v i t r o  fo r  more than  
3 -4  months. The p ro v is io n  o f  plasm a c lo t  as a c u ltu re  s u b s tra te  seemed to  be 
b e n e f ic ia l  and th e  c e l l s  d ig e s te d  th e  c l o t  th ro u g h  th e  a c t i v a t io n  o f  
p la s m in o g e n . S in c e  th e  c e l l s  can o f te n  be found  in  a s s o c ia t io n  w i t h  
f ib r in o id  (w hich is  la r g e ly  plasm a c lo t ;  2 3 ), i t  was hoped th a t  th is  would  
h e lp  to  e s ta b l is h  lo n g  te rm  c u l t u r e s ;  b u t th e  c e l l s  f a i l e d  to  become 
e s ta b lish e d  beyond one o r two passages.
An a t te m p t  was made to  ty p e  th e  c e l l s  f o r  HLA a n t ig e n s  u s in g  th e  
s ta n d a rd  T e r a s a k i m ic r o c y t o t o x ic i t y  t e s t .  C y t o t o x ic i t y  to  a ra n g e  o f  
a n tib o d ie s  was assessed by e o s in  dye exc lu s io n , w ith  the  re a c t io n  o f  human 
lym p h o cy tes  as a p o s i t i v e  c o n t r o l .  The r e s u l ts  (T a b le  2 ) show t h a t ,  u n d er  
the  p re v a ilin g  c u ltu re  c o n d it io n s , the  ch o rio n ic  p la te  c e l ls  a re  r e s is ta n t  
to  com plem ent-m ediated a t ta c k . Im m unofluorescence s ta in in g  showed th a t  the  
a n tib o d ie s  were indeed b in d in g  to  the  c e l ls  in  the  m ic r o c y to to x ic ity  assay, 
and a ls o  t h a t  com plem ent com ponent C3 was f i x i n g  to  th e  c e l l  s u r fa c e .  The 
f a i l u r e  to  ly s e  th e  c e l l s  was n o t  overcom e by th e  use o f  sod ium  a z id e to  
i n h i b i t  a n t ig e n ic  m o d u la t io n , o r  by th e  a d d i t io n  o f  a second a n t ib o d y  to  
increase complement f ix a t io n .  We sp ecu la te  th a t  the  c e l ls  a re  a b le  e i th e r  to
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TABLE 2 . PERCENTAGES OF VIABLE CHORIONIC PLATE CELLS AFTER TREATMENT WITH 
ANTIBODY AND RABBIT COMPLEMENT
CHORIONIC PLATE CELLS LYMPHOCYTES
Ab +_ c l  £ 1 Ab Ab i  c;
FIRST ANTIBODY
Normal Human Serum 69 65 68 98
56 55 50 90
80 77 75 85
W6/32 67 63 65 0 .0 9
(a n t i -c la s s  I ) 53 50 50 0
73 76 70 0 .0 5
a n t i -  2 *1 65 60 65 0
51 50 50 0 .0 2
75 70 67 0 .0 6
DA6.231 63 65 59 0 .1 0
(a n t i -c la s s  I I ) 52 50 50 0 .0 5
75 69 72 0 .0 9
Mouse a n t i - 60 61 59 0 .0 9
tro p h o b las t 54 50 52 0
71 72 70 0 .0 5
Lymphocyte v i a b i l i t i e s  in c o n tro ls (C';Ab) were 85-98%.
in h ib i t  the  e f fe c t  o f  com plem ent, o r th a t  plasma membrane re p a ir  proceeds a t  
a ra te  w hich can overcome th e  e f fe c t  o f  complement a tta c k .
The c e l ls  a re  now being used as a source o f  mRNA f o r  the  c re a t io n  o f  a 
cDNA l ib r a r y .  Th is  l ib r a r y  w i l l  be probed w ith  e s ta b lis h e d  clones o f human 
c la s s  I  genes to  e s t a b l is h  th e  n a tu re  o f  th e  MHC genes e x p re s s e d  in  t h is  
type  o f  human c y to tro p h o b la s t.
PLACENTAL ALKALINE PHOSPHATASE
The s y n c y t io t r o p h o b la s t ic  m i c r o v i l l i  o f  th e  human p la c e n ta  a re  th e  
m ajor source o f p la c e n ta l a lk a l in e  phosphatase (PLAP) durin g  the  second and 
th i r d  t r im e s te rs  o f pregnancy. PLAP is  a t is s u e -s p e c if ic  polym orphic s ia lo -  
g ly c o p ro te in , composed o f  p a irs  o f d isu lph ide-bonded  p o ly p e p tid e  chains each 
o f 69K m o le c u la r w e ig h t. When e x tra c te d  from  homogenates o f w hole p la c e n ta e  
( 7 ,1 9 )  PLAP can be r e s o lv e d  on s ta r c h  g e ls  in t o  tw o  bands (A-PLAP and B -
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n o  d e t e r g e n t  t r i t o n  X - 1 0 0
2-21-1 2-1 1-12-12-2 2-1 1-1 2-2
t o t a l  p l a c e n t a  *    m i c r o v i l l i  *
Figure 3. Diagram of the electrophoretic mobility of PLAP isoenzymes in 
starch gels, in the presence or absence of 0.5% triton X-100 in the gel. The 
phenotypes of each sample (2-2, 2-1, 1-1) are shown under each track.
Figure 4. Triton-starch gel to show the effect of serum and of phospholipase 
C on M-PLAP. Tracks 1,6 = markers of A, M & B-PLAP; track 5 = A-PLAP; track 
4 = M-PLAP; track 3 = M-PLAP treated with phospholipase C; track 2 = M-PLAP 
treated with human serum.
PLAP); A-PLAP has a native molecular weight of 140K and B-PLAP is about 
200K. Recent studies from this laboratory (1-4) have shown that PLAP 
extracted from syncytiotrophoblastic microvilli has a native molecular 
weight of 725K and can be resolved in starch gels containing detergent as a 
band running between the A and B forms. We named this form M-PLAP (Figure 
3). M-PLAP has a similar Km, pH optimum and heat stability to A-PLAP and 
gives reactions of identity with antibodies against A-PLAP. Notably, M-PLAP 
expresses the same genetic polymorphism as A-PLAP, showing that both iso­
enzymes are the product of the same transcriptional system. Initially, the 
finding of a high molecular weight form of PLAP suggested that this was an 
aggregation artifact due to the inherent insolubility of extracted membrane 
proteins. However, several pieces of evidence argued against this view. Use 
of detergents during the extraction of microvilli did not affect the yield 
of M-PLAP. On hydrophobic chromatography, the A form did not bind to alkyl-
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1 2 3 4 5 6 7 8
Figure 5. Reducing SDS polyacrylamide gel to show 
the effect of phospholipases on M-PLAP (the 
mobility of which is marked P^ on the gel). Tracks 
1,8 = molecular weight markers; tracks 2,7 = M- 
PLAP; track 3 = M-PLAP + protease inhibitors (PI); 
track 4 = M-PLAP + phospholipase-A2 + PI; track 5 
= M-PLAP + phospholipase-C + PI; track 6 = M-PLAP 
+ phospholipase-D + PI.
♦
agarose, whereas the M form bound to the column and was eluted with hydro- 
phobic solvents. In non-reducing SDS gels, the mobility of A-PLAP dimers 
corresponded to 140K, as expected. The mobility of M-PLAP dimers 
corresponded to 116-118K, suggesting a hydrodynamically more compact 
molecule (2-4).
The structural relationships between the PLAP isoenzymes might be 
better understood if we had some knowledge of the association of the M form 
with the plasma membrane. Cleavage of external membrane proteins with the 
protease subtilisin showed that M-PLAP can be cleaved off the microvilli as 
a virtually pure protein species, differing from uncleaved M-PLAP by lacking 
about 2K from its carboxy-terminus (3,4). We do not yet know whether the M 
form is anchored in the membrane by a sequence of hydrophobic amino acids, 
bui b u b j j c v - L  L h o t  c cv il cn tl y- bo r ’r’'1 l i p i d  m a y  provide an additional or altern­
ative means of attachment to the plasma membrane. Figures 4 & 5 show the 
effect of various phospholipases on the mobility of M-PLAP in starch and SDS 
gels. As shown in figure 5, track 5, phospholipase C increases the mobility 
of the M polypeptide under reducing conditions (17). This suggests that 
there is a glyceryl moiety in covalent linkage with the protein and invites 
speculation that the hydrophobicity of M-PLAP is due to fatty acyl chains. 
To determine whether PLAP has a C-terminal hydrophobic sequence of amino 
acids requires amino acid sequencing or an analysis of cDNA clones. Poly(A)+ 
RNA can be extracted from the placenta and can be translated in vitro into 
various polypeptides, including hPL (Figure 6). Our current work involves 
the cloning of placental cDNA into lambda gtlO and gtll and the screening of
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Figure 6. Translation of term placental poly (A)+ RNA in a 
rabbit reticulocyte lysate cell-free system (Amersham 
International PLC). The polypeptides were resolved in a 
reducing 9% polyacrylamide gel and the incorporated 35S- 
methionine was detected by autoradiography. Track 3 = 
total translated polypeptides; track 2 ■ molecular weight 
markers ( see kdal values at left-hand side); track 1 ■ 
immunoprecipitation of translated polypeptides with rabbit 
anti-hPL and formalin-fixed staphylococci. The arrow in 
track 1 shows the immunoprecipitated hPL polypeptide.
such clones with synthetic oligonucleotide probes and anti-PLAP antibodies, 
respectively.
Although we have never been able to interconvert purified samples of 
the A and M forms by simple physical means, such as freezing or changes of 
solvent, we have recently found (17) that there is an apparently distinct 
protein factor in serum which can convert M-PLAP to the A and B forms 
(Figure 4). This conversion could not be inhibited by a wide range of 
exogenous protease inhibitors, suggesting that the factor is not proteo­
lytic. The conversion activity does not fractionate with the serum lipo­
protein fractions. Treatment of a volunteer (RGS) with intravenous heparin 
did not lead to a stimulation of conversion activity, indicating that 
neither the hepatic nor the endothelial forms of serum lipoprotein lipase 
(LPL) were the causative factors. On AcA 34 gel filtration chromatography, 
the factor elutes as a unimodal peak of about 60K molecular weight. It 
behaves as a glycoprotein in binding to Con-A sepharose. It elutes as a 
unimodal peak on DEAE sepharose at the same point as has been reported (5) 
for lecithin cholesterol acyl transferase (LCAT), which is capable of acting 
as a lipoprotein phospholipase. The ability of LCAT to convert M-PLAP to the 
A and B forms is currently being tested.
The foregoing results strongly indicate to us that the A and B forms of 
placental alkaline phosphatase are a conversion product of M-PLAP. It also 
explains why the majority of PLAP in maternal serum is of the A form rather 
than the M form (N.S. Abu-Hasan, unpublished). The conversion must involve 
some distinct chemical process, since the native sizes of the A and B forms
1 23
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a re  less  than  M-PLAP. F u rth e r , s ince the  d im ers o f  M-PLAP a re  q u ite  d is t in c t  
in  s iz e  from  those o f the  A form , th e  A and B form s p ro bab ly  do n o t a c tu a l ly  
e x is t  in  th e  M complex u n t i l  the  l a t t e r  is  con verted . However, th e re  is  some 
evidence (2 ,  and J.C.L. unpublished) th a t  M-PLAP e x h ib its  m o le c u la r h e te ro ­
g e n e ity  in  d iscontinuous p o lyacry lam id e  g e ls . T h is  may perhaps account fo r  
the  g e n e ra tio n  o f  two conversion products from  M-PLAP.
The f u n c t io n  o f  PLAP re m a in s  e n ig m a t ic .  I t s  e x p re s s io n  is  l i m i t e d  to  
th e  s y n c y tio tro p h o b la s tic  m ic r o v i l l i  and our b io c h e m ica l d a ta  (3 ,4 )  support 
th e  e le c t r o n  m ic ro s c o p ic  e v id e n c e  (1 3 )  t h a t  th e  enzym e is  exposed to  th e  
c ir c u la t in g  m a te rn a l b lood. Th is  tends to  argue a g a in s t th e  p o s s ib i l i t y  th a t  
PLAP a c ts  as a p ro te in  phosphatase w hich  m ig ht an tago n ise  o r d o w n -reg u la te  
th e  e f fe c ts  o f  membrane re c e p to r p ho sp h o ry la tio n  ( f o r  exam ple, o f th e  EGF o r 
in s u l in  re c e p to r) . Such re c e p to r p h o sp h o ry la tio n  occurs on the  cy to p lasm ic  
dom ain  o f  th e  r e c e p to r  p r o t e in ,  and i t  is  d i f f i c u l t  to  u n d e rs ta n d  how an 
e x te rn a l phosphatase l ik e  PLAP could a c t  on such a s u b s tra te . However, PLAP 
has been  fo u n d  to  be a c t iv e  on a r t i f i c i a l l y  c o n s tr u c te d  p h o sp h o p ro te in B  
(1 0 ) , so the  p o s s ib i l i t y  cannot be ru le d  out a t  th is  t im e .
S ince th e  a c t iv e  s i te  o f the  enzyme is  lo c a te d  on the  m a te rn a l s id e  o f  
th e  m ic r o v il lu s  plasma membrane, our thoughts tu rn  tow ard  a fu n c tio n  f o r  the  
enzyme in  c o n ta c t w ith  m atern a l b lood , w hich m ig ht be o f s ig n if ic a n c e  in  the  
second h a l f  o f  pregnancy, when le v e ls  o f the  enzyme a re  m axim al. The fo rm a l 
a l te r n a t iv e s  a re  th a t  PLAP fu n c tio n s  e i th e r  as a s o lu b le  o r as a membrane- 
bound enzym e. Because i t  is  m em brane-bound and n o t  s im p ly  s e c r e te d ,  we 
b e lie v e  i t  has a r o le  on the  plasma membrane, though i t  may a ls o  be p resen t  
on e x fo l ia te d  s y n c y t ia l fragm ents c ir c u la t in g  in  m a te rn a l b lood and i t s  heat 
s t a b i l i t y  and lo n g  h a l f - l i f e  mean t h a t  th e r e  may be some le s s e r  e f f e c t  o f  
s o lu b le  enzym e in  th e  s y s te m ic  c i r c u l a t i o n .  T h e re  is  some e v id e n c e  t h a t
-FLAP—help® —'hr* pfoupnt innnriroTirinte a c t iv a t io n  o f  b lood p la t e le ts  by dephos—
p h o r y la t in g  ADP ( 1 1 ) .  When s t im u la te d  b y  a v a r i e t y  o f  a g e n ts ,  in c lu d in g  
c o lla g e n  I I I  and throm bin , p la te le ts  become a c t iv a te d  and s e c re te  ADP, w hich  
t r ig g e rs  th e  a c t iv a t io n  o f  fu r th e r  p la t e le ts  and so he lp s  to  e s ta b lis h  blood  
c o a g u la tio n . The a b i l i t y  o f PLAP to  use ADP as a s u b s tra te  encourages us to  
pursue th e  hypoth es is  th a t PLAP fu n c tio n s  to  p re v e n t p la t e le t  a c t iv a t io n  on 
th e  s u rfa c e  o f  p la c e n ta l m ic r o v i l l i .
ACKNOWLEDGEMENTS T h is  w ork was s u p p o rte d  by g r a n ts  fro m  th e  M e d ic a l  
Research C o u n c il.
150
REFERENCES
1 . Abu-Hasan, N.S., D av ies , M. and S u t c l i f f e ,  R.G. (1984) A h igh m o lecu la r  
w e ig h t  s p e c ie s  o f  p la c e n t a l  a l k a l i n e  p h o sp h a ta s e  in  human s y n c y t io -  
tro p h o b las t m ic r o v i l l i .  P la c e n ta  5 , 1 5 9 -174 .
2 . A b u -H asan , N.S. and S u t c l i f f e ,  R.G. (1 9 8 4 )  P u r i f i c a t i o n  and
a n a ly s is  o f  th e  m ic r o v i l lo u s  (M ) and A fo rm s  o f  p la c e n t a l  a lk a l in e  
phosphatase. P la c e n ta  5 , 7 1 -8 2 .
3 . A bu-H asan , N.S. and S u t c l i f f e ,  R.G. (1 9 8 4 )  M o le c u la r  h e te r o g e n e ity  o f  
p la c e n ta l a lk a l in e  phosphatase a s s o c ia te d  w ith  m ic ro v illo u s  membranes. 
In :  "Human A lk a l in e  P h o s p h a ta s e s " , Eds: T . S t ig b ra n d  and W.H. F ish m an . 
A lan  R L is s  in c .,  New Y o rk , 1 1 7 -126 .
4 . A b u -H a s a n , N .S . and S u t c l i f f e ,  R .G . ( 1 9 8 5 )  P la c e n t a l  a l k a l i n e  
phosphatase in te g ra te s  v ia  i t s  c a rb o x y - te r m in u s  in t o  th e  m ic r o v i l lu s  
membrane; i t s  a llo ty p e s  d i f f e r  in  co n fo rm a tio n . P la c e n ta  ( in  p re s s ).
5 . D o i, Y. and N is h id a , T. (1981) L e c ith in -c h o le s te r o l  a c y ltra n s fe ra s e  from  
human plasm a. M eths. Enzym ol. 7 1 , 7 5 3 -7 6 7 .
6 . F a u lk ,  W.P. and T e m p le , A. (1 9 7 6 )  D i s t r i b u t i o n  o f  b e ta  2 m ic r o g lo b u l in  
and HLA in  cho rio n ic  v i l l i  o f  human p la c e n ta e . N atu re  262, 299 -802 .
7 . Ghosh, N.K. and Fishman, W.H. (1968) P u r i f ic a t io n  and p ro p e rtie s  o f  
m o lecu la r w eigh t v a r ia n ts  o f  p la c e n ta l a lk a l in e  phosphatase. Biochem. 
J . 1 0 3 , 7 7 9 -7 9 2 .
8 . H a r r is ,  H. (1 9 8 2 )  M u l t i lo c u s  enzym e sys tem s  and th e  e v o lu t io n  o f  gene  
e x p re s s io n :  The a l k a l i n e  p h o sp h a ta s e s  as a m odel e x a m p le . In :  H a rv e y  
L ec tu re s , s e r ie s  76 , London: Academic P re s s , 95.
9 . H o l t h o f e r ,  H ., V ir ta n e n ,  I . ,  K a r in ie m i ,  A . - L . ,  H o rm ia , M, L in d e r ,  E. and 
M ie t t in e n ,  A. (1 9 8 2 )  U le x  eu ro n aeu s  I  l e c t i n  as a m a rk e r fo r v a s c u la r  
endothelium  in  human t is s u e . Lab. In v e s t .  4 7 , 6 0 -6 6 .
10 . Huang, K .-P .,  R o b in so n , J .C . and Chou, J .Y . (1 9 7 6 )  P h o s p h o p ro te in -  
p h o sp h a tase  a c t i v i t y  a s s o c ia t e d  w i t h  hum an p l a c e n t a l  a l k a l i n e  
phosphatase. Biochem. B iophys. Res. Comm. 7 0 , 1 8 6 -1 9 2 .
11 . H u t t o n ,  R .A ., C how , F .P .R . ,  C r a f t ,  I . L .  and  D a n d o n a , P . ( 1 9 8 0 )  
In h i b i t o r s  o f  p l a t e l e t  a g g r e g a t io n  in  th e  f e t o p la c e n t a l  u n i t  and 
myometrium w ith  p a r t ic u la r  re fe re n c e  to  th e  ADP-degrading p ro p e rty  o f  
p la c e n ta . P la c e n ta  1 , 125-130 .
12 . J e n k in s o n , E .J . and Owen, V . (1 9 8 0 )  O ntogeny and d i s t r i b u t i o n  o f  m a jo r  
h is t o c o m p a t ib i l i t y  (MHC) a n t ig e n s  on mouse p la c e n t a l  t r o p h o b la s t .  J .  
Reprod. Immunol. 2 , 173 -181 .
13 . J o n e s , C .J .P . and F ox , H. (1 9 7 6 )  An u l t r a h is t o c h e m ic a l  s tu d y  o f  th e  
d is t r ib u t io n  o f a c id  and a lk a l in e  phosphatase in  p la c e n ta e  from  norm al 
and com plica ted  p regnancies . J . P a th . 118 , 143 -151 .
14 . K h a la f ,  S .A ., H end erso n , S .J . and S u t c l i f f e ,  R.G. (1 9 8 5 )  P u r i f i c a t i o n  
and a n a ly s is  o f tro p h o b la s tic  c e l ls  from  th e  human p la c e n ta l c h o rio n ic  
p la t e .  ( In  p re p a ra t io n .)
15 . Ku rin  a n .  R J . # —M “ i r . ,— C.-S.— and  C h e n , H . -  C. ( 1 9 8 4 )  I n t e r  me d i  a t  e
tro p h o b la s t: a d is t in c t iv e  form  o f  tro p h o b la s t w ith  s p e c if ic  m orphol­
o g ic a l,  b io chem ica l and fu n c t io n a l fe a tu re s . P la c e n ta  5 , 349 -370 .
16 . L a za r id e s , E. (1980) In te rm e d ia te  f i la m e n ts  as m echanical in te g ra to rs  o f  
c e l lu la r  space. N ature 283 , 2 4 9 -2 5 6 .
17 . L iv in g s to n e ,  J .C ., A b u -H asan , N .S ., C le g g , R .J ., H e n d e rs o n , S .J .,  
M ars d e n , H .S. and S u t c l i f f e ,  R.G. (1 9 8 5 )  S t r u c t u r a l  r e la t io n s h ip s  
between the  isoenz-m es o f human p la c e n ta l a lk a l in e  phosphatase; a serum 
fa c to r  converts  t'ue membrane fo rm . ( In  p re p a ra tio n ) .
18 . Redman, C.W.G., M c M ic h a e l,  A .J . ,  S t i r r a t ,  G .M ., S u n d e rla n d , C.A. and 
T in g ,  A. (1 9 8 4 )  C la s s I m a jo r  h is t o c o m p a t i b i l i t y  co m p lex  a n t ig e n s  on 
human e x t r a -v i l lo u s  tro p h o b la s t. Immunology 52 , 4 5 7 -468 .
19 . Robson, E.B. and H a r r i s ,  H. (1 9 6 5 ) .  G e n e t ic s  o f  th e  a l k a l i n e  
phosphatase polymorphism o f  th e  human p la c e n ta . N ature  207, 1257-1259.
2 0 . S te in m e tz ,  M. (1 9 8 4 )  S t r u c tu r e ,  fu n c t io n  and e v o lu t io n  o f  th e  m a jo r
151
h is to c o m p a tib i l i ty  o f the  mouse. Trends Biochem. S c i. 9 , 224 -226 .
2 1 . S u n d e rla n d , C .A ., N a ie m , M ., M ason, D .Y ., Redman, C.W.G., and S t i r r a t ,  
G.M. (1981) The expression o f m ajo r h is to c o m p a t ib i l i ty  an tigens by human 
c h o rio n ic  v i l l i .  J . Reprod. Immunol. 3 , 323 -331 .
2 2 . S u n d e rla n d , C .A ., Redman, C.tf.G. and S t i r r a t ,  G.M. (1 9 8 1 ) HLA-A,B,C  
a n t ig e n s  a re  expressed  in  n o n -v i l lo u s  t r o p h o b la s t  o f  th e  e a r ly  human 
p la c e n ta . J . Immunol. 127, 2614-2618.
2 3 . S u t c l i f f e ,  R .G ., D a v ie s , M ., H u n te r ,  J .B ., W a te rs , J .J . and P a r r y ,  J .E . 
(1 9 8 2 )  The p r o te in  c o m p o s itio n  o f  th e  f i b r i n o i d  m a t e r ia l  a t  th e  human 
u te ro p la c e n ta l in te r fa c e . P lacen ta  3 , 297-308 .
2 4 . Wu, Y . - J . ,  P a r k e r ,  L .M ., B in d e r ,  N .E ., B e c k e t t ,  M .A ., S in a rd , J .H ., 
G r i f f i t h s ,  C .T. and R h e in w a ld , J.G . (1 9 8 2 )  The m e s o th e l ia l  k e r a t in s :  A 
new fa m ily  o f c y to s k e le ta l p ro te in s  id e n t i f ie d  in  c u ltu re d  m e s o th e lia l 
c e l ls  and n o n -k e ra t in is in g  e p i th e l ia .  C e l l  31 , 693 -703 .
